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Summary 
Cellular metabolic pathways and their interconnected branches constitute metabolic 
networks. Knowledge of such networks provides close understanding of the 
biochemical phenotype of cells. Fluxes of metabolites through metabolic networks, 
therefore, represent, integrated responses of cells to extrinsic and intrinsic signals. 
Plant secondary metabolites, such as phenylpropanoids play a critical role in plant 
defence against biotic and abiotic stresses. Their biosynthetic pathways are highly 
interconnected to form a densely interconnected network. To understand the 
properties of the phenylpropanoid metabolic network and its association with other 
metabolic networks, we perturbed the flavonoid sub-network using genetic tools and 
studied the perturbational responses at both metabolite and gene expression levels. 
 
Previously, our laboratory had characterized a bacterial oxidoreductase coding gene, 
QuoA, which converts the flavonoid, naringenin to quercetin. QuoA gene was 
previously isolated and expressed ectopically in transgenic Arabidopsis to effectively 
reverse the native biosynthesis of quercetin to naringenin.  Here, three QuoA 
expressing transgeniclines were chosen from a screen of 16 independent transformed 
lines on the basis of transgene expression levels and enzymatic activity for further 
characterization. Lignins and anthocyanins had increased levels in QuoA lines, while 
metabolites from phenolamide pathway had reduced levels. These increased levels 
were corroborated with phenotype of increased stem stiffness and hypocotyl 
coloration. This is the first report showing accumulation of both lignins and 
anthocyanins at metabolite levels and phenotypes. Results here suggest that 
phenolamide pathway plays a major role in channelling of metabolic intermediates to 
the lignin pathway. Five branch points in phenylpropanoid metabolic network had 
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increased levels of first product with a concomitant decreased expression of the 
biosynthetic gene encoding the branch points enzyme. This indicated feedback 
controls at both biochemical and genetic levels at these branch points within the 
phenylpropanoid network.  
 
Non-targeted metabolomics studies of QuoA transgenic lines revealed perturbational 
effects in seemingly distant pathways of isoprenoid metabolic network as compared to 
the point of perturbation in the flavonoid pathway. As these results cannot be 
explained solely by changes in metabolic channelling, we tested the hypothesis 
whether these distant pathways could be co-ordinately regulated by a common 
mechanism. Arabidopsis mutant lines of the transcriptional factor TTG1 singly or in 
combination with selected flavonoid tt mutant lines had a metabolic pheno-copy of 
QuoA lines, including the perturbation in isoprenoid metabolic network. This raised a 
question whether TTG1 could be a common transcription factor that is regulating both 
phenylpropanoid and isoprenoid networks? 
 
To identify direct effects of TTG1 perturbation, we identified metabolic pathways 
responding to increased activity of TTG1 upon induction by dexamethasone (dex) in 
transgenic lines. TTG1 over-expression resulted in accumulation of isoprenoids 
besides the expected increase in anthocyanins. As TTG1 complexes with TT8 to 
regulate anthocyanin genes, we also tested the effects of latter regulator. Transgenic 
lines with TT8 induction behaved somewhat similarbut with less pronounced effect 
than  that in TTG1 induction lines. Further, TT8 loss-of-function and induced over-
expression lines showed that TT8 regulates glycosylation of metabolites other than 
previously shown flavonoids. Glycosylation of several nucleotides and flavonoids 
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were up-regulated in dex-induced TT8 transgenic lines. Microarray analysis of TT8 
loss-of-function and dex-induced TT8 transgenic lines showed several carbohydrate-
active genes to be directly affected by TT8. Quantitative real-time PCR validated 
these results for selected genes. 
 
After identifying the metabolic pathways directly affected by TTG1 and TT8, we next 
identified the genes directly affected by both these transcriptional factors. For this 
purpose, we first performed microarray profiling of RNA from inducible over-
expression transgenic lines of TTG1 and TT8, respectively which were created in this 
study. Eleven genes from isoprenoid metabolic network were up-regulated in response 
to induced over-expression of TTG1 and eight were down-regulated in TTG1 loss-of-
function mutant lines. TT8 induction led to up-regulation of five genes from 
isoprenoid metabolic network, but, the effect and number of genes affected were less 
pronounced than in TTG1 over-expression lines. Interestingly, several stress-
responsive genes such as PCC1, UGT75B1, and PDR12 were up-regulated by TTG1. 
These genes are involved in pathogen response mechanism. Next, we established that 
these changes in RNA levels of selected genes were due to transcript changes induced 
by TTG1 and TT8 induction by applying the translation inhibitor cycloheximide (chx) 
in combination with the TTG1 and TT8 inducing chemical, dex. Quantitative real-
time PCR of 32 genes selected from the above treatments confirmed these results. 
Lastly, using chromatin immunoprecipitation assay, we were able to show that TTG1 
direct binds to promoters of 10 of these 32 selected genes, thus established novel 
targets of TTG1. 
Overall, this study has demonstrated the utility of a bacterial enzyme to reveal novel 
properties of secondary metabolism network, which can be used for metabolic 
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engineering of lignin pathways. We have also identified a common regulatory 
mechanism for stress-response pathways and distant secondary metabolic networks. 
Therefore, a longstanding question of how secondary network triggered during stress 
response seems to have been partially answered. Further studies involving this 
mechanism will be useful in better understanding of how plants co-ordinate their 
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1.1 General Introduction 
Metabolites are the intermediates and end products of metabolic pathways. They are 
the closest link to biochemical phenotype of cells. Many of these metabolites 
additionally serve as (i) second messengers within cellular signalling system, (ii) 
ligands of DNA, mRNA and proteins, thereby altering their structures and functions 
or (iii) modes of inter-cellular or inter-organisimal communication. Hence, system 
level understanding of the response behaviour of a biological system in a particular 
environment or state is increasingly relying on knowledge of the metabolic content 
together with the knowledge of genome, gene and protein expression. While gene 
expression and proteome analyses by themselves do not provide a holistic 
understanding of cellular function, metabolic profiling can give an instantaneous 
snapshot of the biochemistry of that cell. Systems level approaches to interrogate 
genomic and proteomic state of an organism have been developed for longer time, 
while those for metabolite analyses have gained interest more recently. The study of 
metabolic state in a biological system is termed as metabolomics, which involves non-
targeted measurements of changes in the relative concentrations of metabolites in 
response to perturbations. Metabolomics studies of a biological system in a particular 
state lead to description of the metabolites and pathways, which are critical to the 
adaptation and survival of the organism in that state. Among different biological 
systems, plants are particularly useful for metabolomics studies. They produce more 
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than 200,000 metabolites with large diversity, a lot of which are beneficial to mankind 
as food, medicines and industrial raw materials.  
 
Metabolic pathways are defined as series of chemical reactions occurring within a cell 
with each step leading to production of a metabolite. Metabolic network is the 
complete set of interconnected metabolic pathways and physical processes that 
determine the biochemical phenotype of a cell, which includes metabolism and its 
regulation. Metabolic network is characterized by its plasticity, robustness, modularity 
and interconnectivity with several other metabolic network modules in a species. 
Regulatory and metabolic functions of biological systems are mediated by networks 
of interacting biochemical components. Although most specific functions involve a 
limited set of components, several studies have shown that connectivity among 
proteins or metabolites extends far beyond the limits of individual function.. 
Understanding of metabolic networks and its properties plays an important role in 
designing and engineering novel metabolic networks with improved metabolic 
processes that can increase product yield and enhance cellular properties.  Studies on 
microbial metabolic network have played an exceptional role in improving S. 
cerevisiae strains for industrial applications such as baking, brewing, and wine 
making industries. Golden rice is another example of metabolic engineering 
application which leads to vitamin A biosynthesis, thus improving nutritional value of 
this important cereal grain. Although, metabolic engineering approaches have been 
extremely successful in microbial systems, it has not achieved expected success in 
engineering transgenic plants with desired features. Microbial metabolic systems are 
relatively simple compared to plant metabolic networks, which get further 
complicated by subcellular compartmentalization of various pathways and interaction 
Introduction 
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of different networks. Efforts to modify the biosynthesis of a variety of plant primary 
and secondary metabolites have been confounded by the very metabolic flexibility 
that researchers are trying to exploit.  
 
Metabolic networks in general and plant metabolic networks in particular are highly 
complex. Components of metabolic network i.e. genome, gene expression, protein 
levels and metabolites all change in a synchronized manner in response to genetic or 
environmental perturbation. A number of studies have shown that perturbations in a 
particular metabolic network are not only confined to that metabolic network, but are 
extended to other networks as well. Such links between metabolic networks are 
referred to as crosstalk. Thus, it is very difficult to understand properties of metabolic 
network by a single systems level or „omics‟ approach. Holistic approach to 
understand metabolic network is required to achieve desired success in plant 
metabolic engineering. Application of integrative omics approaches to study 
metabolic pathways and networks are being increasingly adopted in recent times. For 
example, gene-to-metabolite networks regulating sulphur and nitrogen nutrition and 
secondary metabolism in Arabidopsis have been investigated (Hirai et al., 2004). 
Transcriptome and metabolome analysis revealed that specific responses are induced 
when deficiency of sulphur or nitrogen is observed in several metabolic pathways. 
Glucosinolates, important bioactive secondary product, are found in the family 
Brassicaceae. Using integrative omics approach that combined transcriptome and 
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Metabolic networks are connected to other pathways or network through several hub 
metabolites such as NADH or ATP. Interconnectivity in networks and existence of 
such hubs tends to affect several pathways at the same time in response to changes in 
specific biological system. Although such an interconnected design could in principle 
lead to the simultaneous flow of substrates in numerous directions, in practice 
metabolic fluxes pass through specific pathways. Moreover, the flux is readily 
optimized to maximize metabolic efficiency under different conditions. This suggests 
connectivity of network is not random but is specific and is under tight regulation. 
While effects of metabolic channelling on networks are better understood, recent 
genome-wide expression studies have revealed the prominent role of transcription in 
regulating metabolic flow in response to specific perturbations (Almaas et al., 2006). 
However, it remains unclear as to how and to what extent the modulation of enzyme 
expression determines functional metabolic units and how this affects the global 
properties of the metabolic network.  
 
Perturbing is one of the approaches used to understand properties of metabolic 
network. Perturbations can be caused in uncover relationships that exist between 
different parts of the networks. While physiological or environmental perturbations 
can be used to study such relationships, they can simultaneously affect different 
points in multiple pathways. Genetic approaches, on the other hand, have been used to 
cause perturbations of specific steps in targeted metabolic pathways. These 
perturbations can be induced via loss-of-function approaches such as by gene 
deletions or silencing. In comparison to these approaches, expression of plant or 
bacterial enzymes in transgenic plants provides a means for perturbing metabolic 
pathways by gain-of-function. This approach has been effective in introducing new 
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functions to increase the accumulation of desired compounds or to reroute 
metabolites. Expression of bacterial enoyl-CoA hydratase/lyase, for example, results 
in rerouting in the phenylpropanoid pathway and leads to depletion of phenolics and 
accumulation of vanillic acid (Mayer et al., 2001). During perturbation of the 
isoprenoid pathway by the expression of a bacterial gene encoding 1-deoxy-D-
xylulose-5-phosphate synthase in transgenic potato tubers, metabolic channelling of 
trans-zeatin riboside and carotenoids increases twofold and levels of phytoene 
increase six- to sevenfold (Morris et al., 2006).  
 
Phenylpropanoids are secondary metabolites derived from phenylalanine.  In 
plants, they play a critical role in signalling and defence against abiotic or biotic 
stresses. Phenylpropanoid-based polymers in plants, such as lignin, suberin, or 
condensed tannins, contribute to the physical stability and robustness towards 
environmental damages from drought or wounding. Metabolic intermediates from 
the upper phenylpropanoid biosynthesis pathway serve as starting point for 
multiple pathways connected by branches to form flavonoids, phytoalexins, 
anthocyanins, proanthocyanins, lignins and phenolamides. Together, all these 
pathways constitute the phenylpropanoid metabolic network. A plethora of 
phenylpropanoid biosynthetic mutants have facilitated the identification and 
functional characterization of genes and enzymes of the phenylpropanoid 
metabolic network. Among these, several enzymes of the flavonoid pathway, such 
as chalcone synthase (CHS), chalcone isomerase (CHI) and dihydroflavonol 4-
reductase (DFR) form a complex in order to regulate the partitioning of 
intermediates among competing pathways and determine the intracellular 
deposition of end-products (Burbulis et al., 1999). These enzyme complexes are 
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present in the compartments, and play an important role in channelling of 
intermediates, limiting their diffusion into the surrounding milieu, which 
determines metabolic network properties under different conditions. Hence, 
keeping such complexes intact, while perturbing metabolic pathways in order to 
estimate network behaviour, would be an ideal approach. Given the highly 
complex nature of phenylpropanoid metabolic network and the importance of its 
constituent metabolites, it makes an ideal target to decipher the relationships 
among the pathways of this network. Phenylpropanoid pathways contribute to all 
aspects of plant responses to biotic and abiotic stimuli, which suggest possibility of 
its participation to a larger network with other secondary metabolic pathways 
coordinating towards all stresses. 
 
We previously reported a Pseudomonas putida strain PML2 capable of utilizing 
quercetin as a sole carbon source for growth and elucidated a catabolic pathway for 
quercetin degradation in this strain using a comparative metabolomics approach 
(Pillai and Swarup, 2002). The first step in this pathway is the conversion of quercetin 
to naringenin involving dehydroxylation at two sites. The corresponding gene has 
been designated as Quercetin oxidoreductaseA (QuoA), which is the new name of 
PhpA as reported by Pilli and Swarup (2002). Since, phenylpropanoid biosynthesis in 
plants involve formation of quercetin from naringenin, we envisaged that QuoA 
expression in plants will provide us with a genetic tool to “reverse” this biosynthetic 
step using gain-of-function approach and enable us to monitor the perturbational 
effects in metabolic networks. Thus, QuoA transgenic lines, and transparent testa 
mutant lines provides us a tool to understand network properties of phenylpropanoid 
metabolic network properties. Several studies reported gene-to-metabolites 
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relationship or regulation of genes in phenylpropanoid metabolic network, hence, 
providing a sound knowledge base in this network (Vogt, 2010). Previous studies in 
our lab on QuoA transgenic lines revealed several interesting properties of 
phenylpropanoid metabolic network (Reuben et al., 2012 (manuscript submitted)). 
This study is an extension of our previous work on understanding of metabolic 
perturbational response to gain-of-function QuoA transgenic lines. The overall aim of 
this study is to understand properties of the phenylpropanoid metabolic network, and 
global network response to its perturbation.  
 
1.2 Objectives 
Objective 1 To understand network properties of phenylpropanoid metabolic 
network using systems biology approach 
To understand metabolic network properties, gain- and loss-of-function transgenic 
Arabidopsis lines were generated. These lines were used to obtain their metabolic and 
expression profiles at different developmental stages. We selected three QuoA 
transgenic lines, and compared with F3H loss-of-function mutant lines. We selected 
three independent QuoA transgenic lines based on high, moderate and low levels of 
gene expression and QuoA enzyme activity. Gain-of-function and loss-of-function 
transparent testa (tt) mutant lines were compared to understand network properties of 
phenylpropanoid metabolic network. Using multi-omics approaches, we investigated 
global effects in response to the above metabolic perturbations. This enabled us to 
understand effect of perturbation in a linear manner, and helped to understand local 
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Objective 2 To understand role of F3H and TTG1 loss-of-function in 
perturbational response of Arabidopsis.  
Perturbational response of QuoA gain-of-function and F3H loss-of-function 
transgenic lines showed several metabolic pathways other than phenylpropanoid 
metabolic network were perturbed. Since point of perturbation was at 
phenylpropanoid metabolic network, we hypothesized that observed perturbational 
responses were due to QuoA activity and specific mutations in endogenous pathway 
would produce its phenocopy. To test this hypothesis, we compared metabolic profile 
of ten loss-of-function lines of phenylpropanoid metabolic network. Of these, ttg1 and 
tt6 mutant lines emerged as sharing similar profiles as that of QuoA transgenic lines.  
 
Objective 3 To identify direct and indirect targets of TTG1 and its interacting 
partner TT8 
Metabolic profiling of ttg1 mutant and its double mutant with tt3, tt4, tt5 and tt6 
mutant lines suggested that TTG1 could regulate metabolic pathways other than 
phenylpropanoid metabolic network. To study this, inducible over-expression and 
inducible silencing transgenic lines of TTG1 and its known interacting partner, TT8 
were created. RNA and metabolic profiling were used to identify possible targets of 
TTG1 and TTG1-TT8 complex, which were verified using RT-PCR. ChIP experiment 
was performed to verify in-vivo binding of TTG1 to its target genes.  
 
Objective 4 To study genetic regulation of glycosylation of secondary metabolites  
Based on previous reports about TT8 regulating flavonoid glycosylation and this 
study that it regulates multiple metabolic pathways, we studied the role of TT8 in 
regulating glycosylation at a systems level. Microarray and metabolic profiling of TT8 
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loss-of-function and inducible over-expression line was performed to identify 










2.1 Biology of plant metabolites 
2.1.1 Metabolites and Metabolism 
Metabolites are the products of enzyme-catalyzed reactions that occur naturally within 
cells. They are synthesized for both essential functions, such as growth and 
development by “primary metabolites”, and for specialized functions, such as 
environmental response or defence against pathogens by “secondary metabolites”. 
Since primary metabolites are directly involved in growth and development, they are 
present in all organisms including plants. But, absence of secondary metabolites can 
result in immediate as well as long-term impairment of the organism's survivability, 
fecundity, or aesthetics. Primary metabolites (e.g. amino acids, sugars, sugar 
phosphates, and organic acids) as well as secondary metabolites (e.g. 
phenylpropanoids) are components of the complex networks of biochemical pathways 
in plant metabolism. However, this classification is now considered obsolete because 
many secondary metabolites have essential functions and contribute towards plant 
growth and development (Hartmann, 2007). For instance, isoprenoid end products 
participate in a wide range of physiological processes acting in plants both 
synergistically, such as chlorophyll and carotenoids during photosynthesis and 
antagonistically, such as gibberellic acid and abscisic acid during seed germination. 
Metabolic profile of a biological system represents its overall environmental, 
developmental or growth condition which is specific to that state (Messerli et al., 
2007). Specificity of metabolic profile or a metabolite to a tissue, developmental stage 
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or environmental condition emphasize important role that metabolites play in the 
response of the system  to that state and its closest association with its phenotype 
(Messerli et al., 2007; Park et al., 2012). Metabolism is the set of chemical reactions 
that result in metabolite synthesis and plays an important role to sustain life. These 
processes allow organisms to grow and reproduce, maintain their structures, and 
respond to their environments. Metabolism allows optimized trade-offs among several 
requirements, such as defence response and adaptability via tolerance to various 
perturbations and evolvability in metabolite networks. 
 
The diversity of metabolites found in plants is by far greater than in most other 
organisms. Metabolites in the plant kingdom are extremely diverse chemically, with 
estimates indicating as many as 200,000 different types of chemical substances 
(Riedelsheimer et al., 2012). The structural diversity of secondary metabolites is an 
important part of the nature of plants as a rich source of useful phytochemicals for 
humans. Different conjugation processes, such as glycosylation, acylation from a few 
parent molecules results in huge metabolic diversity of secondary metabolites. 
Comparison of the metabolite compositions of plant tissues investigated for speciﬁc 
secondary metabolites in Arabidopsis (Brown et al., 2003) and for primary 
metabolites in Lotus japonicus (Desbrosses et al., 2005) revealed that plants have 
evolved metabolic systems for producing a variety of metabolites in a tissue-
dependent manner to improve plant ﬁtness. Genome sequencing has uncovered the 
genetic background of the diversity of plant genomes, which encode large families of 
metabolism-related genes such as cytochrome P450s and glycosyltransferases 
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2.1.2 Conjugation of metabolites 
Conjugation in a biological system is a result of specialized enzymatic reaction, 
leading to modification of a metabolite by linking it to a molecule or a chemical 
group. Conjugation of parent metabolites changes its property, a strategy that 
biological systems use to regulate metabolic network by regulating the availability of 
metabolites. Conjugation reactions, such as the formation of sulphates, glycosylated 
forms, glucuronides and amino acid derivatives of biologically active compounds, are 
classically considered as detoxification processes. There are eight types of 
biochemical reactions that are involved as the process of conjugation namely 
glucuronidation, glycosylation, sulfation, methylation, acetylation, cyanide 
detoxication, glutathione conjugation and amino acid conjugation.  
 
Conjugation not only leads to production of a large number of bio-active metabolites 
from a small number of precursor metabolites, this also works for detoxification of 
metabolites and regulation of biological system. In order to combat the phytotoxicity 
of xenobiotics, plants have developed versatile detoxification systems. Modification 
of xenobiotics through covalent linkage to glutathione is one of the important 
detoxification mechanisms. The resulting glutathione conjugates are exported from 
cytosol to vacuole by ATP-dependent tonoplast transporter (Coleman et al., 1997). 
This reaction is catalyzed by glutathione transferases (Dixon et al., 2010). The 
flavonoid skeletons are modified by glycosylation, malonylation, methylation, 
hydroxylation, acylation, prenylation, or polymerization, leading to the diversity of 
end-products (Winkel-Shirley, 2001). These substitutions have important effects on 
flavonoid function, availability, mobility, and degradation. Several metabolites, such 
as flavonoids are toxic in nature and thus are stored in conjugated form. Conjugation 
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of flavonoids, mainly glycosylation leads to conversion of flavonoids into less toxic 
molecules and in this form, flavonoids are stored. Deglycosylation takes place to 
make flavonoids available when it is required to the system. Transport of flavonoids 
takes place by conjugation of glutathione with flavonoids in the cytoplasm, followed 
by ATP-driven transport via glutathione S-transferase pumps (Mueller et al., 2000; 
Goodman et al., 2004).  Glycosylation gives rise to nearly 4,000 flavonoid structures 
from nearly 30 common skeleton molecules (Heim et al., 2002). It changes the basic 
chemical properties of lipophilic acceptor metabolites thus affecting their subcellular 
mobility, stability, compartmentalization as well as bioactivity. Highly complex 
families of carbohydrate-active proteins, such as transporters and enzymes, are 
implicated in these processes. Recently, in a comprehensive study, a 
rhamnosyltransferase for flavonols was described in Arabidopsis and its gene placed 
in a pathway with other glycosyltransferases using metabolomics and transcriptomics 
approach (Yonekura-Sakakibara et al., 2007). However, role of other carbohydrate-
active proteins such as transporters and hydrolases, aspects of coordinated regulation, 
use of mutants for pathway validation of metabolic pathways were not addressed. 
There are very few reports on regulators of glycosylation of metabolites.  
 
Conjugations of metabolites are also used as a regulatory mechanism to control the 
availability and activity of bioactive compounds. Several reports on plant hormones 
have shown conjugation as an important tool to regulate biological processes. 
Cytokinins level depends on the balance between de novo synthesis, the import and 
export rate, interconversion of distinct forms, transient inactivation by conjugation 
(mainly glucosylation), and catabolic reactions resulting in a complete loss of 
biological activity (Sakakibara, 2006). Auxin conjugates are generally considered as 
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temporary reservoirs of inactive growth hormone Indole-3-acetic acid (IAA), 
releasing the free active hormone upon hydrolysis (Fluck et al., 2000; Jakubowska 
and Kowalczyk, 2005). Increased amount of auxin leads to its increased conjugation, 
and thus plants survive against high auxin level (Staswick et al., 2005; Jutta Ludwig-
Muller, 2011). Experimental evidence connects auxin conjugates to the development 
of a body plan, vasculature, and embryo development (Sztein et al., 1999, 2000; 
Cooke et al., 2002). Work from Sztein et al. (1999, 2000) has revealed evidence for 
auxin conjugate formation in mosses (e.g. Funaria, Polytrichum, Sphagnum) and 
hornworts (Phaeoceros), whereas in liverworts (e.g. Marchantia, Pallavicinia, 
Sphaerocarpus) the auxin conjugate levels/synthesis of conjugates was very low and 
occurred at a slow rate. Zea mays regulates its growth by glycosylation of IAA.  
 
2.1.3 Metabolome and Metabolomics 
Metabolome refers to total metabolites present in a particular cell, tissue, organ or 
organism (Fiehn et al., 2001; Goodacre et al., 2004). It comprises the complete set of 
metabolites, the non-genetically encoded substrate, intermediates, and products of 
metabolic pathways, associated to a cell. Metabolomics is metabolome analysis, 
which seeks to identify and quantify the entire collection of intracellular and 
extracellular metabolites (Oliver et al., 1998; Tweeddale et al., 1998; Fiehn et al., 
2001). The general aim of metabolomics is to identify, measure and interpret the 
complex time related concentration, activity and flux of metabolites in cells and 
tissues (Weckwerth et al., 2004; Saito and Matsuda, 2010).  
 
Metabolomics involves a non-targeted analysis of metabolic profile of an organism in 
response to several factors such as abiotic stress or genetic manipulation, which then 
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works towards narrowing the gap in understanding gene functions in one form of 
functional genomics. One advantage of metabolomics as an approach for functional 
genomics is that it can be used on any biological system without knowing about their 
metabolome or genome (Macel et al., 2010). Metabolites are chemical compounds 
and thus applying principles of basic chemistry and analytical tools such as mass 
spectrometry enables one to study effect of genetic or environmental perturbation 
without knowing its genetic sequences. Finally, in contrast to transcripts or protein 
identification, metabolites are not organism-specific and thus same analytical protocol 
equally works to prokaryotes, fungi, plants and animal kingdom (Goodacre et al., 
2007). The early biochemical changes that occur in any diseased condition can also be 
mapped by the metabolomics approach, which can be helpful in developing predictive 
biomarker (Kaddurah-Daouk et al., 2008).  
 
The study of metabolomics has gained attention in the past few years. One of the 
earliest attempts of metabolomics was by Roger Williams in the late 1940s where he 
used paper chromatography to identify specific metabolic patterns in urine and saliva 
suggesting that all individuals have a particular metabolic profile of their biological 
fluids. This field has come a long distance by then and is evolving rapidly. While in 
1999, three articles containing keywords metabolomics were published, the number 
increased to 203 articles in 2004 and now, it has further increased to 4,683. Whenever 
a perturbation is introduced in the living system, it responds by changing its behaviour 
on genetic level by altering gene expression as well as metabolic level by changing 
composition or abundance of metabolites. Evaluation of interaction between the level 
of metabolites, RNA and protein in response to applied perturbation result in 
generation of “omics” data. Metabolomics focuses on detection, identification and 
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quantification of metabolites present and hence has become an important tool to 
facilitate functional genomics. Metabolic profiling can be performed by targeted or 
non-targeted manner. Non-targeted metabolomics enables us to identify the broad 
metabolite proﬁles of samples and to find novel metabolites that can be used as 
biomarkers (Glinski and Weckwerth., 2006). However, many difficulties exist in 
achieving this goal, e.g. it is technically difﬁcult and extremely time-consuming to 
merge all the data obtained in different formats by different instruments, and to 
identify the unknown metabolites (Werner et al., 2008). Targeted metabolomics is, in 
general, used to test a specific biological hypothesis by detecting and quantify 
analytes from biological system. Since this approach involves a small number of 
metabolites to capture, it has high sensitivity with high accuracy. Knowledge of 
metabolites and its chemical nature is prerequisite for this approach. Several 
metabolomics studies use combination of targeted and non-targeted approaches to 
identify novel metabolites. 
 
2.1.4 Metabolic profiling and metabolomics technology platforms 
Unlike transcripts and proteins, the identification of metabolites cannot be deduced 
from genomic information. Thus, the identification and quantification of metabolites 
must rely on sophisticated and highly sensitive instrumentation based methods such as 
Mass Spectrometry (MS), Nuclear Magnetic Resonance spectroscopy (NMR), and 
laser-induced fluorescence detection. Each of these instruments has its own 
advantages and limitations and selection of a particular technology depends on the 
nature of research questions. These instruments differ in sensitivity, selectivity, and 




Page | 17  
 
NMR spectroscopy is one of the most used techniques in structural analysis because 
of its highly selective and non-destructive approach (Quinones et al., 2009). It is 
generally accepted as the gold standard in metabolite structural elucidation, but it 
suffers from relatively low sensitivity (Dunn et al. 2005), which restricts metabolic 
coverage that can be achieved from it, and hence is not very useful in non-targeted 
approach of metabolomics. Due to high sensitivity, resolution and high throughput 
approach for identification and quantification of metabolite, MS is the most widely 
applied technology in both targeted and non-targeted metabolomics. 
 
Mass spectrometry is an analytical technique that measures the mass-to-charge ratio 
of charged particles. Equipped with research and advancement of technology, modern 
MS provides highly specific chemical information directly related to the chemical 
structure such as accurate mass, isotope distribution patterns for elemental formula 
determination, and characteristic daughter ions by fragmentation for structural 
elucidation or identification via spectral matching to authentic compound data. High 
sensitivity of MS allows detection and measurement of primary and secondary 
metabolites even at picomole to femtomole levels, thus allows identifying even those 
metabolites which are present at very low levels (Bedair et al., 2008). Structural 
elucidation of metabolites is achieved by its fragmentation to daughter ions by tandem 
MS/MS technique and its comparison with fragmentation pattern of target or putative 
metabolite. Although, with development of several tools and software, one can predict 
putative structure and chemical formula of an unknown metabolite using 
fragmentation profile of a metabolite, NMR is still preferred for confirming chemical 
structure of an unknown metabolite. 
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 Recent advancement in MS offers an array of technologies that differ in operational 
principles and performance. These variations include ionization technique, mass 
analyzer technology, resolving power, and mass accuracy. Since MS is based on 
ionization of metabolites and its detection against an electric field, ionization 
technology plays an important role in terms of kind of metabolites identified. The 
ionization techniques in metabolomics include electron ionization (EI), electrospray 
ionization (ESI), atmospheric pressure chemical ionization (APCI), chemical 
ionization (CI), Matrix-assisted laser desorption/ionization (MALDI), and, more 
recently, desorption ESI (DESI) and extractive ESI (EESI) have also been used. Each 
ionization technology has different range and nature of metabolites that can be ionized 
and selection of one is based on type of metabolites under investigation (Nordstrom et 
al., 2008). ESI is most used ionization technology for small molecules (primary and 
secondary metabolites) and covers wide range including polar and non-polar 
metabolites. Ionization of metabolites followed by separation of ionized metabolites 
based on their mass to charge ratio and its detection. Mass analyzers with different 
resolving powers have also been used in metabolomics. These include mass analyzers 
with low mass resolution such as ion-trap both linear (Q-trap) and three-dimensional 
(quadrupoles) or ultrahigh and high resolution MS such as Fourier transform ion 
cyclotron resonance MS (FT-ICR-MS), Orbitrap MS, and multipass TOF-MS. Each 
of these mass analyzers has its own advantages and limitations. Selection of a specific 
MS platform for metabolomics depends on the goal of the metabolomics projects, 
throughput, and instrumental costs. For instance, ion-trap MS with low mass accuracy 
are still used in targeted approach such as metabolite quantification (Multiple reaction 
monitoring (MRM) or Single ion monitoring approach (SIM)). Mass analyzers such 
as FT-ICR or orbitrap offers mass accuracy up-to 1ppm level. Such high mass 
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accuracy with high sensitivity makes FT-ICR-MS or orbitrap MS a valuable tool 
owing to its ability to analyze carbohydrates, amino acids, lipids and fatty acids as 
well as proteins and polysaccharides simultaneously (Harrigan et al., 2004). 
 
MS-based metabolic profiling can be done either by directly injecting complex 
metabolite matrix in MS or separating metabolites by chromatography before 
injecting into MS. Direct injection approach produces less complex spectra but does 
provide a high throughput screening tool that is often the only practical choice for 
large sample numbers. Although, metabolites can be identified by directly injecting 
metabolites in MS, direct MS methods are very susceptible to ion suppression or 
enhancement. In addition, direct MS data interpretations are very challenging, as 
unique metabolite ions are difficult to distinguish from adduct and product ions. On 
the other hand, chromatography coupled to MS offers an excellent solution to 
complex mixture analyses and has been extensively used in metabolomics (Abian et 
al., 1999). Chromatographic separation of metabolites prior to MS analyses has 
several advantages such as it reduces matrix effects and ionization suppression, it 
separates isomers, provides additional and orthogonal data (i.e. retention time/factor/ 
index) valuable for metabolite annotation, and finally allows for more accurate 
quantification of individual metabolites. Gas chromatography (GC), liquid 
chromatography (LC), and capillary electrophoresis (CE) are three predominant 
chromatographic techniques that have been incorporated in MS-based metabolomics. 
Additionally, multidimensional separation techniques such as two-dimensional GC 
and LC have further enabled the separation of even more complex biological mixtures 
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GC-MS based approaches are suitable for the analyses of both volatile and non-
volatile compounds following derivatization. Since GC based chromatography 
requires metabolites to be in gas phase, metabolites are required to be thermo-labile. 
However, relatively few compounds meet this requirement in their native state (e.g. 
short chain alcohols, acid, esters, and hydrocarbons (Broeckling et al., 2005; Begley et 
al., 2009). Plants are the source of a large number of volatiles metabolites that 
contribute to vegetable and fruit aromas and plant defence responses. This has made 
GC-MS as a popular choice for plant metabolomics (Hall et al., 2002; Bleeker et al., 
2009; Mayer et al., 2008). However, the limitation as to the size and types of 
metabolites that can be analyzed and extensive preparation and derivatization required 
is a big concern.  
 
In comparison with GC-MS, LC-MS uses mild heating and is suitable for both 
thermo-labile and thermo-stable metabolites. It thus gives better coverage and is most 
suitable for non-targeted metabolic profiling. More recently, there has been 
development of fast and more efficient ultra-HPLC (UHPLC), which utilizes higher 
column pressures (12,000–15,000 p.s.i. compared with 6000 p.s.i. for HPLC) and less 
than 2µm size of column packing particle. This has substantially increased 
chromatographic resolution, decreased the analysis time and peak capacity compared 
with HPLC. UHPLC has been shown to increase number of detectable compounds by 
20% compared with HPLC or LC method (Nordstrom et al., 2008). Since changing 
HPLC or UHPLC ends systems and their running conditions changes orthogonal data 
of metabolites, the LC-MS results are not that reproducible across different labs and 
does not have extensive database as is the case in GC-MS. Hence, LC-MS based 
metabolomics uses high mass accuracy combined with MS/MS fragmentation for 
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identification of metabolites. For this reason, rather than retention time, mass 
spectrometers that provide high resolution combined with higher mass accuracy 
(HRAMS) are essential for metabolomics analysis. 
 
2.2 Conceptual approaches to study metabolic pathways and network  
Metabolic pathways consist of series of biochemical reactions that are connected by 
their intermediates, leading to production of specific metabolites. Metabolic pathways 
in an organism serve a specific purpose and are tightly regulated against any 
perturbation. Glycolysis, which serves to produce energy molecules in cells, was the 
first metabolic pathway discovered (Bordel et al., 2010). The metabolism 
encompasses all biochemical reactions that are catalyzed by enzymes in a cell. Taken 
together, these reactions form interconnected metabolic pathway that shape a 
dynamical circuitry referred to as metabolic network (Schilling et al., 2002; Reed et 
al., 2003). These networks are highly connected chains of metabolic pathways that 
encompass heterogeneous biological entities including DNA, mRNA, proteins and 
metabolites. Metabolic networks are a reflection of various biological processes that 
take place in the cells such as metabolism, transcription, translation and post-
translational modifications. Thus, to interrogate a metabolic network, integrative 
omics approach needs to be adopted. The combination of several high-throughput 
technologies, such as high mass accuracy mass spectrometry, microarray, protein 
array, next generation DNA/RNA sequencing and others have generated huge dataset 
capturing capacity at the level of genes, proteins, metabolites, and the associated 
interactions among them (Zhang et al., 2010, Dietmair et al., 2012). These studies 
have resulted in the generation of large data sets that have served as the foundation for 
the reconstruction of metabolic regulatory, signalling and protein-protein interaction 
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networks (Klein et al., 2012). An important goal of building metabolic network is to 
integrate detailed biochemical information with biological intuition to produce 
testable predictions and thus apply it in metabolic engineering. Hence, the knowledge 
here in metabolic network is evolving with new information being added and hence 
predictability of outcome from a perturbation in a network is becoming more accurate 
(Zhao et al., 2006, Mithani et al., 2009, Handorf et al., 2005). Since functional states 
of metabolic networks that correspond to phenotypic functions are accessible, 
structural properties of networks can be accurately compared for their functional 
states.  
 
Application of modelling approach such as constraint-based modelling (CBM) and 
relying on simple physical-chemical constraints and gene to metabolite relationships 
were used to create large-scale microbial metabolic networks. These have proven to 
be highly successful in predicting metabolic phenotypes in metabolic engineering and 
many other applications (Feist and Palsson, 2008; Henry et al., 2010). Construction of 
metabolic network models for multicellular eukaryotes is signiﬁcantly more 
challenging than that for bacteria, because of the larger size of the networks, the 
subcellular compartmentalization of metabolic processes, and the considerable 
variation in tissue-speciﬁc metabolic activity (Shira Mintz-Oron, 2011). Plant 
metabolic networks are even more complex compared to other organismal models due 
to its metabolome size and high-level complexity because of extensive secondary 
metabolism. Subcellular compartmentalization of metabolic pathways, which share 
common substrate in plants further increases complexity of metabolic network. 
Several efforts on plants serving as factories for biomass in energy generation and 
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nutraceuticals are going on. However, much more has to be achieved in plant system 
as compared to what has been achieved in microbial metabolic engineering.  
 
Currently, plant metabolic engineering mostly involves trial-and-error approaches 
(Shira Mintz-Oron, 2011), but studies are increasingly showing that perturbations due 
to genetic or environmental factors are not subjected to single but multiple pathways 
(Kooke and Keurentjes, 2011). Systems biology approach and integration of multi-
omics data will help to build pathways-to-pathways and metabolic network-to-
network relationships. Knowledge of metabolic networks, their interaction and 
regulation will improve our understanding of biological processes that take place in 
plants. This would be instrumental for developing strategies for metabolic 
engineering, eventually leading to synthetic biology applications (See section 2.6.4).  
 
2.3 Properties of metabolic networks 
2.3.1 Connectivity of metabolic networks 
Metabolic networks in a biological system are characterized by high connectivity with 
metabolites serving as common substrate to a number of different processes. 
Traditionally, metabolism has been divided into discrete pathways. However, it has 
become increasingly clear that metabolism operates as a highly integrated network 
(Sweetlove et al., 2008). Metabolites undergo several processes, such as conjugation 
to produce various bio-active metabolites or in regulatory process in a biological 
system, thus increasing interconnectivity between metabolic networks. Presence of 
isoenzymes further increases complexity of metabolic network as network possesses 
alternative pathways for the same functions. In most of the metabolic networks, about 
half of the metabolites can be only converted to a very limited number (usually less 
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than 10) of metabolites (Hong et al., 2003). It was shown that the probability of a path 
existing between randomly chosen substrate and product pair is less than 20% which 
indicated that a metabolic network is far from a fully connected network. Metabolic 
networks characteristically have some key metabolites such as NADH or ATP, which 
are involved in a number of reactions and are referred to as hub metabolites (Pfeiffer 
et al., 2005). Group transfer reactions are involved in production of hub metabolites 
and these hubs participate in the transfer of different biochemical groups. These hub 
metabolites increase connectivity between metabolic networks. Several studies on 
metabolic pathways regulation in Arabidopsis has shown multiple pathways affected 
in response to perturbational effect. Studies on salicylic acid (SA) and jasmonic acid 
(JA) crosstalk have shown mutual antagonistic interaction between SA and JA 
dependent signalling, while in a few cases, synergistic interactions have been 
described as well (Schenk et al., 2000; Van Wees et al., 2000; Mur et al., 2006). Such 
cross-talk of signalling process can occur through connectivity of metabolic network. 
Comprehensive metabolic shift of reproductive transitions was explained by observed 
feedback mechanisms to optimally channel resources, suggesting strong 
interconnectivity of metabolic network in Artemisia annua (Arsenault et al., 2010).  
 
2.3.2 Topology of gene expression networks  
Topology of a metabolic network is a schematic description of the arrangement of a 
network, including its nodes and connecting lines. The nature of the links between 
nodes determines the topology of a network. It reflects dynamic nature of metabolic 
network and evolution of metabolic process (Wagner et al., 2001). Although many 
biological networks are described as being scale free, i.e. does not depend upon length 
scale at which the network is observed, networks with hierarchical structures that 
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allow hubs and module structures within the network currently seem to be best suited 
for capturing most of the features of biological networks (Barabasi et al., 2004). The 
global topological properties and local structural characteristics, network motifs, 
network comparison approach and query, detection of functional modules, function 
prediction from network analysis, inferring molecular networks from biological data 
as well as representative databases and software tools has been reviewed with respect 
to molecular network (Zhang et al., 2007). The structure and properties of metabolic 
network especially the topology have been described in detail in a book by Palsson 
(2006).  
                                                                                                                                                     
2.3.3 Plasticity of metabolic networks 
Plasticity of a system or a network may be defined as its ability to tolerate alterations 
in its components or structure and it cannot be directly measured (Dalmolin et al., 
2011). Every metabolic network has a fundamental property of being robust that 
allows them to adapt to the perturbations introduced by environment or genes. 
Metabolic networks exhibit robustness even under genetic perturbation caused by 
elimination of enzyme-coding genes. Their structure evolves rapidly through 
mutations which results in elimination of such genes and addition of new enzyme-
coding genes through horizontal gene transfer. Single mutation introduced in two 
different genotypes having similar phenotype yielded different novel phenotype 
(Rodrigues et al. 2009). This implicated the application of evolutionary plasticity and 
robustness of metabolic networks in the emergence of new metabolic abilities.  
 
Plasticity of metabolic network is also related to importance of particular pathways 
for the biological system. Adaptability of metabolic networks to perform the functions 
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by a number of alternative pathways increases the survivability of the organisms 
under diverse environmental conditions. In general, primary metabolic pathways are 
more robust to the changes, as they are important and directly related to growth and 
survival of the system and hence are under tight regulatory control (Hart et al., 2011; 
Stitt et al., 2010). Secondary metabolic networks, on the other hand, do not have tight 
regulatory systems. This comparison underlines role of evolutionary processes to the 
plasticity of metabolic network. One component of this robustness is redundancy 
mediated by isoenzymes performing the same catalytic reaction (Skinner and Cooper 
1974; Primerano and Burns 1983), multiple pathways or routes that generate a 
particular metabolite (Ramos et al. 2008), and systems that maintain homeostasis of 
the cellular environment (Takahashi et al.,2002).  
 
An in vivo genetic analysis demonstrated that thiamine synthesis can be uncoupled 
from the early purine biosynthetic pathway in Salmonella enterica (Bazurto et al., 
2011). The study provided evidence that the five steps of the common HMP/purine 
biosynthetic pathway can be bypassed in the synthesis of 5-aminoimidazole 
ribonucleotide.  Robustness of a regulatory network in any organism decreases when 
they switch to stable environment (Soyer et al., 2010). Computer simulation depicting 
metabolic network evolution was performed under stable and fluctuating conditions. 
The study showed that those networks that evolved in fluctuating environment were 
able to tolerate the effect of single gene mutation in specific environment more 
efficiently than the networks evolving in stable environment. When the evolution of 
those networks was examined in stable environment, the robustness was found to be 
completely lost. These studies thus suggested evolution as major player towards 
plasticity of a metabolic network in an organism. Investigations of functional 
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plasticity of reconstructed metabolic networks in Helicobacter pylori, Escherichia 
coli, and Saccharomyces cerevisiae by computational method of flux-based analysis 
revealed a set of metabolic reactions forming a connected metabolic core and carrying 
non-zero fluxes under all growth conditions and had highly correlated flux variations 
(Almaas et al., 2005).  It was further shown that the large numbers of species-specific 
reactions of cellular metabolism which are indispensable for the growth of 
microorganisms were organized around that evolutionary active metabolic core. The 
effect of available oxygen on central metabolism with different concentration of 
available oxygen to Arabidopsis suspension culture has been studied, which revealed 
stability of the central metabolic network and its capacity to respond to physiological 
perturbations with the minimum of rearrangement of metabolic processes. Although 
steady-state metabolic ﬂux analysis (MFA) using [1- 13C]Glc showed differences in 
the metabolite proﬁle of organic acids, amino acids, and carbohydrates at different O2 
levels, balance between biosynthesis and respiration within the tricarboxylic acid 
cycle (TCA) was unchanged, suggesting stability of central metabolic network 
(Williams et al., 2008). Due to high plasticity of metabolic network, knocking out a 
gene in an organism often causes no phenotypic affect. One possible explanation 
could be existence of duplicate genes due to which loss of one is compensated by its 
homologs. The Arabidopsis genes, TT8, GL2 and EGL3 have been shown to be able 
to replace and complement each other. Thus, loss-of-function of any one of these 
transcriptional factors does not bring distinct changes in metabolic network (Zhang et 
al., 2003, Morohashi et al., 2007). Another explanation for this could be the existence 
of alternative pathways. Study on functional compensation of primary and secondary 
metabolites by duplicate genes in Arabidopsis concluded existence of alternative 
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pathways and high connectivity of metabolic network as main cause of plasticity of 
metabolic network (Hanada et al., 2011).   
 
2.3.4 Modularity in metabolic network 
The concept of modularity stands for independent and self-contained property of a 
system. Biological systems often display modularity, in the sense that they can be 
decomposed into nearly independent subsystems, which can perform specific 
functions. Studies have suggested that modular structure of a network emerges in 
response to change in environmental conditions, since a small part of metabolic 
network is needed to establish homeostasis against the applied changes. This property 
of the metabolic system is also supported by the fact that different biological systems 
are unique only in small part of metabolic system whileshares great similarity. It is 
suggested that, during evolution, only a subset of metabolic network changed in 
biological system. Parter et al., (2007) have supported this theory by their study on the 
modularity of networks. The authors observed that the metabolic networks of 
organisms in variable environments were significantly more modular than networks of 
organisms that evolved under more constant conditions. Metabolites that participate in 
only a few reactions but connect different modules are more conserved than hubs 
whose links are mostly within a single module. Some other studies suggested 
evolution of modularity of metabolic network was in response to need for biological 
system to accommodate different niches (Kashtan et al., 2007; Parter et al., 2007; 
Kreimer et al., 2008).  
 
Comparison of metabolic network in hundreds of bacterial species showed modularity 
to be moderately concordant with organismal phylogeny along the tree of life 
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(Kreimer et al., 2008). This study also showed network size as a key determinant of 
metabolic network modularity. Endosymbiotic organisms, which have smaller 
network, had lower modularity scores than non-symbiotic organism. The modularity 
values of pathogens and commensals were as low as or lower than those of 
endosymbionts. Analysis of Homo sapiens metabolic network revealed a defined 
topology based on functional and evolutionary modularity (Zhao et al., 2007). The 
analysis of the metabolic network showed that it had core modules that performed 
basic metabolic functions and peripheral modules that were highly modular and 
performed specialized functions. Isoprenoid metabolic network in Arabidopsis 
presents an excellent example of network modularity where different branches such as 
carotenoids, brassinosteroids metabolic pathways exist independently despite being 
connected at branch points. Isoprenoid metabolic network has two alternative routes 
for synthesis of metabolites due to subcellular compartmentalization of metabolic 
pathways (Vranova et al., 2012). In Arabidopsis, both mevalonate and non-
mevalonate pathways operate independently with mevalonate pathway being 
associated with synthesis of sterols, sesquiterpenes and the side chain of ubiquinone 
while non-mevalonate pathway for synthesis of isoprenes, carotenoids, side chains of 
chlorophyll and plastoquinone. But, studies have established interaction between them 
(Wille et al., 2004). 
 
2.4 Experimental approaches to study metabolic network  
Metabolic network of biochemical pathways are studied by introducing 
perturbations through environmental stress, chemical inhibitions or mutations 
targeted to specific steps in the pathways under study. In order to overcome the 
introduced changes, the metabolic networks self-organize and re-accommodate to 
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allow the organism to perform stablely and reliably (Moran et al., 2005). This 
process of reorganization and adaptability is captured using metabolic profiling 
and flux measurement, expressional profiling as well as biochemical analysis of 
enzymes related to the pathways. The integration of these studies establishes 
metabolic network. Among several approaches to introduce perturbation in 
metabolic pathways, genetic approach is considered as a more directed approach 
towards studies of a particular pathway. Genetic perturbation can be achieved by 
either gain- of-function or loss-of-function approach. In gain-of-function approach, 
a foreign gene or endogenous gene related to the pathways is introduced in the 
target pathways in such a way that the expression of the gene uses metabolite from 
the target pathways as its substrate. Overexpression lines are an example of gain-
of-function approach. In loss-of-function approach, mutation or silencing of 
endogenous gene from metabolic pathway is created through transposon 
mutagenesis, chemical inhibitors or using RNAi or amiRNA approaches. 
Metabolic perturbation can also be achieved by applying biotic such as pathogens 
or abiotic stress such as UV radiation or pathogenic stress, which causes metabolic 
pathways to respond to overcome this environmental stress.  Gain-of-function 
approach together with loss-of-function approach has been used to characterize 
PDR9 gene in Arabidopsis (Ito et al., 2006). In this study, gain-of-function mutant 
exhibited increased tolerance to 2,4-dichlorophenoxyacetic (2,4-D) acid while 
loss-of-function showing hypersensitivity to it suggesting role of PDR9 transporter 
in effluxing 2,4-D out of plant cells without having any effect on endogeneous 
auxin transport. Loss-of-function using chemical inhibitors lovastatin (inhibitor of 
mevalonate pathways) and formidomycin (inhibitor of mevalonate-independent 
pathways) showed cross-talk between cytosolic and plastidic pathways of 
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isoprenoid biosynthesis in Arabidopsis thaliana (Laule et al, 2003). Gain-of-
function approach used for functional study of MYB-like transcription factor 
PAP1 gene. The changes in the metabolic profiles caused by PAP1 over-
expression lines showed increased accumulation of anthocyanins. This was 
combined with gene expression studies which revealed expression of genes known 
to be involved in anthocyanin production was up-regulated and thus other up-
regulated genes could be tentatively assigned a role in the formation of 
anthocyanins, such as members of the glycosyltransferase, acyltransferase and 
glutathione S-transferase families.   
Expression of bacterial gene in plant system have also being used as an important 
tool to introduce perturbation in metabolic network and to genetically engineer the 
plant for enhanced growth, resistance and for over-production of desired products. 
It also helps in identifying regulatory mechanism and interaction among primary 
and secondary metabolism. In plants, arogenate is used as precursor to synthesize 
phenylalanine. To identify any alternative pathway for the production of 
phenylalanine, a bacterial bi-functional PheA (chorismate mutase/prephenate 
dehydratase) gene involved in conversion of chorismate via prephenate into 
phenylpyruvate has been expressed in Arabidopsis thaliana (Tzin et al., 2009). 
Transgenic lines expressing PheA transgene was reported to have increased level 
of phenylalanine suggesting the conversion of phenylpyruvate into phenylalanine. 
Also, the PheA-expressing lines were seen to be more sensitive towards 5-methyl-
Trp, a tryptophan biosynthesis inhibitor. This suggests that chorismate is the 
common precursor for the synthesis of phenylalanine and tryptophan. Other 
primary metabolites and transcriptome profiling was minimally affected by the 
increase in phenylalanine level but the secondary metabolites derived from 
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aromatic amino acids were altered. This suggests that minor regulatory cross-
interaction exists between the aromatic amino acid biosynthesis network and the 
Arabidopsis transcriptome and primary metabolism and regulatory cross-
interactions between the flux of aromatic amino acid biosynthesis from chorismate 
and their further metabolism into various secondary metabolites. Perturbation of 
isoprenoid pathway in potato tubers via expression of a bacterial gene encoding 1-
deoxy-D-xylulose5 5-phosphate synthase (DXS) has been reported to cause two-
fold increase the level of carotenoids, six to seven fold increase in phytoene and 
increase in level of trans-zeatin (Morris et al., 2006). A bacterial gene, enoyl-CoA 
hydratase, converting 4-coumaroyl-CoA, caffeoyl-CoA and feruloyl-CoA to their 
respective hydroxybenzaldehydes, when expressed in plants to perturb 
phenylpropanoid pathway has been shown to cause phenotypic abnormalities, 
depletion of phenolics and over-accumulation of several novel metabolites 
including the glucosides and glucose esters of 4-hydroxybenzoic acid and vanillic 
acid and the glucosides of 4-hydroxybenzyl alcohol and vanillyl alcohol (Mayer et 
al., 2001). Since, gain-of-function approach using bacterial gene to perturb 
metabolic network keeps enzyme complexes intact while acting on its specific 
substrate, bacterial genes are used to study metabolic network properties in a 
targeted manner. 
One of the most efficient tools to explore functionality of genes is to control gene 
expression during different developmental stages of plant (Masclaux et al., 2004).  
Therefore, inducible system is considered to be the best method for the functional 
study of gene as it allows spatial as well temporal control of transgene expression 
(Geng and Mackey, 2011). Also, inducible system causes local changes in level of 
gene expression thereby causing no change in development of the entire plant 
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(Borghi, 2010). While constitutive promoters have been routinely used for the 
expression of transgene, it proves unsuitable for those genes whose suppression or 
over-expression pose a detrimental effect or lethality to the host plant (Zuo et al., 
2006) and when the effect of expression of the target gene is to be seen at a particular 
developmental stage (Roslan et al., 2001), inducible system is preferred over it. There 
are several inducible systems used including ethanol-inducible expression with the 
AlcR/AlcA system, dexamethasone-inducible expression with GR fusions, GVG/UAS 
or pOp/LhGR systems, β-estradiol-inducible expression with the XVE/OlexA system, 
heat shock-inducible system and Tet (tetracycline)-regulated expression systems 
(Borghi, 2010). 
 
Since the introduction of inducible system as a tool for functional analysis of gene, it 
has been associated with several discoveries. The estradiol-inducible XVE/ pER8 
expression vector has also been used for the creation of COS library which provided 
controlled expression of cDNA so that their overexpression may not prove lethal. This 
COS system was screened multiple times aiming against a particular stress response. 
Several genes were identified which when overexpressed could confer the property 
like enhancement in the germination rate or increased survival rate of seedlings in 
saline environment by screening the seedlings for salt tolerance (Papdi et al., 2008). 
Glucocorticoid receptor based inducible system has been developed in rice 
(Ouwerkerk et al., 2001). GVG inducible system was used to study the function of 
two putative transcription factors namely LjNDX and LjCPP1 in L. japonicus. In this 
study, it was shown that growth disturbances were seen due to GVG system. The 
activation of chimeric GVG transcription factor affected shoot internode elongation 
and root pericycle cell division (Andersen et al., 2003). Glycolate oxidase (GLO) 
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antisense gene driven by an estradiol-inducible promoter has been used to study the 
functionality of glycolate oxidase by controlled suppression of GLO. The study 
suggested GLO to be a typical photorespiratory enzyme. It was also shown that 
possibly through feedback inhibition on rubisco activase exerts a strong regulation 
over photosynthesis and when GLO is supressed in rice, glyoxylate cycle may be 
partially activated in order to compensate for the photorespiratory glyoxylate (Xu et 
al., 2009). Functional estradiol inducible system along with microarray has been used 
to identify AGL-24 induced genes, including Suppressor of Overexpression of Co1 
(SOC1), a floral pathway integrator. The study suggested a positive feedback loop 
during floral transition which integrates flowering signals (Liu et al., 2008).  
Transgenic rice plants have been created in which cDNA of DREB1A and DREB1B 
were introduced under the control of the stress-inducible rd29 promoter to 
overexpress the DREB protein. It was shown that the transgenic plants showed 
increased tolerance to drought and salinity because of overexpression of DREB 
protein regulated by inducible rd29 promoter (Datta et al., 2012). 
 
2.5 Regulation of metabolic network 
The ability to regulate metabolism is a fundamental process in living systems. 
Understanding of metabolic network and its regulation enables a better understanding 
of the biochemical pathways that control development and is the key to the success of 
metabolic engineering. All life forms regulate their metabolism in order to adapt to 
the environment (Gutteridge et al., 2007). Biological system recruits a number of 
strategies for the regulation of metabolic networks in response to perturbations such 
as genetic/transcriptional regulation (Yeang et al., 2006), enzyme inhibition/activation 
by small molecules (Reichard, 2002), mRNA attenuation, ribo-switches (Winkler, 
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2005) and cellular compartmentalization (Baillie et al., 2005). Since regulation of 
metabolic pathways occurs in coordinated manner with all cellular components 
participating, integrative omics approach provides holistic view of regulatory process.  
 
Integrative „omics‟ approach was used to model lysine biosynthesis pathway in yeast 
by integrating data from gene expression, growth phenotypes, and proteomics data 
(Gat-Viks et al., 2004). The model enabled to identify novel regulatory mechanisms 
in the pathway which were then validated experimentally. Several regulatory 
processes occur in synchronized way to orchestrate homeostasis in biological system 
(Venkatesh et al., 2004). Escherichia coli trp regulon demonstrates control by genetic 
regulation, mRNA attenuation and enzyme inhibition, where tryptophan inhibits the 
enzymes as well as production of those enzymes that are required for its synthesis 
(Simão et al., 2005). Using systems biology approach on the metabolic network from 
genome-scale metabolic reconstruction, it was possible to identify common 
transcriptional response in the metabolic network pattern and hence successfully 
identify reporter metabolites (metabolites around which the most significant 
transcriptional changes occur) and a set of connected genes with significant and co-
ordinated response to genetic or environmental perturbations. It was observed that the 
cells respond to perturbation by changing the expression pattern of genes involved in 
that perturbed metabolic pathway, which results in perturbation  of other pathways 
due to high connectivity of metabolic network (Patil et al., 2005). Several instances 
has been reported where the enzyme gene expression was controlled through feedback 
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Regulation of metabolites and metabolic pathways in plants are particularly 
interesting, as the plant‟s sessile nature prevents its escape from unfavourable 
environments and hence they have evolved a highly dynamic and flexible metabolism 
to cope with changing conditions. Several factors play important role in determining 
metabolic state of plants. Untargeted metabolic profiling of Arabidopsis at different 
developmental stages, different tissues and different temperature conditions (cold or 
heat) showed metabolic profile specific to each condition (Giakountis and Coupland, 
2008; Espinoza et al., 2010). Since each developmental stage or tissue or temperature 
state brings specific requirements to be met by plants to survive and grow, each was 
represented by a specific metabolic profile. Synthesis of several primary metabolites 
in plants depends upon light; this brings specificity in regulation of metabolic 
pathways in day and night period. Starch, the major storage molecule in the plant 
kingdom, is linearly degraded during the night for the continuation of growth in dark 
conditions. Each day at dawn, 95% of the total starch reserve in form of starch 
granules is broken down to support metabolism and normal growth (Smith and Stitt, 
2007). Interestingly, a sudden, significant decrease in the length of the light period is 
followed by immediate modifications in the rate of starch breakdown such that there 
is a constant supply of starch during the unexpected, prolonged night (Graf et al., 
2010), suggesting that plants hold a timing mechanism, anticipated on the previous 
dawn, to optimize plant growth and productivity (Graf and Smith, 2011). This 
suggests two separate regulatory systems, one for synthesis and storage of starch and 
the second for starch degradation, which acts opposite to each other and activation of 
each depends on diurnal cycles. The transformation of a dormant seed into a 
photosynthetic active seedling requires conversion of storage compounds into 
essential building blocks and energy carriers. Imbibition leads to increased hexose 
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sugars level, followed by a large change in gene transcription (Fait et al., 2006; 
Howell et al., 2009). Most primary metabolites acquire a stable metabolic state which 
is more or less enhanced for 24 h after exposure to light and inductive temperature 
indicating synthesis of primary metabolites to increase or maintain high levels of 
storage molecules (Allen et al., 2010). Thereafter, a major metabolic switch takes 
place in which many metabolites are consumed to form building blocks and energy 
carriers. For instance, sucrose was found to decrease throughout the developmental 
period, and many transcripts were highly correlated with sucrose levels, suggesting 
metabolic regulation of transcript abundance. The causality in these cases is difficult 
to prove, and it is likely that there is a very complex feedback regulation between 
metabolic status, gene transcription, and the environment to maximize germination 
vigour (Kooke and Keurentjes., 2011). Distinct phases in a germinating seed can be 
characterized by transient metabolic profiles (Fait et al., 2006) which indicate highly 
regulated system that switches from one type of regulation to other depending upon 
the requirement of that state. 
 
2.6 Application of metabolic network 
Understanding of metabolic network has several applications. It allows us to analyse 
problems ranging from single pathway to multi-species studies. Some of the 
applications of metabolic network are explained below. 
 
2.6.1 Knowledge- gap filling-discovery of missing pathways 
The generation of metabolic networks has been greatly facilitated by the development 
of high throughput ‟omics‟ approaches and data integration from different platforms. 
Studies on metabolic flux analysis using steady-state metabolic ﬂux analysis (MFA) 
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approach have revealed the dynamic behavior of metabolic network (Gomes et al., 
2012). Despite this, systematic characterization of gene functions at a genomic scale 
remains challenging. For instance, up to 13% of gene functions in the intensively 
studied bacterium E.coli remain currently unknown (Peregrín-Alvarez et al., 2009; 
Vieira et al., 2011). Many of these genes have possible roles in the metabolic network. 
Improvement of metabolic network has an important role in identifying the missing 
pathways and enzymes in any system. Subgraph extraction technique, which can be 
applied to gene expression, protein levels, operons as well as phylogenetic proﬁles, 
has been developed to predict pathways from biological networks. In the evaluation 
process, the method was examined for 7 sub-network extraction approaches on 71 
known metabolic pathways from Saccharomyces cerevisiae (Faust et al., 2010). The 
metabolic network was obtained from MetaCyc (Caspi et al., 2012). The best results 
were found when random walk-based reduction of the graph was combined with a 
shortest paths based algorithm. It was shown to have an accuracy of ∼77%. 
Information from aberrant pathways and networks are now being successfully applied 
in the identification of groups of biological entities (e.g. gene, protein) termed 
„functional modules‟. These perform biological tasks (e.g. biological processes) which 
the constituent parts could not perform if they were dissociated (Wang et al. 2012). 
 
2.6.2 Contextualization of high throughput data in metabolic networks 
With the omics approach, which generates huge amount of data, challenges lie in how 
to organize, sort, interrelate, and contextualize these datasets. It motivated the 
development of top-down approach wherein statistical analysis of high throughput 
data inferred some biochemical network structure and function. But, it has a drawback 
as it provides computational and technological hurdle (Stark et al., 2003). Metabolic 
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network combines all the reactions, which relate the cellular compounds to each other. 
The reconstruction of metabolic network is now considered as powerful technique for 
contextualization of high throughput data. Metabolic reconstruction is highly useful in 
context of gene expression data. The mapping of high throughput data on the 
metabolic data helps to gain a deeper insight of the known metabolic pathways 
(Oberhardt et al., 2009). Metabolic network reconstructions enable complex 
relationships amongst molecular components to be represented formally in a 
biologically relevant manner while respecting physical constraints. Recently, in a 
comprehensive study, a rhamnosyltransferase for flavonols was described in 
Arabidopsis and its gene placed in a pathway with other glycosyltransferases using 
metabolomics and transcriptomics approach (Yonekura-Sakakibara et al., 2007). In-
silico models derived from such reconstructions can then be queried or interrogated 




2.6.3 Study of diseases through metabolic systems biology approach 
Previously, it was thought that the relationship between diseases and changes in a 
single or a few genes is the sole reason for diseases. However, currently there is a lot 
of evidence which infers that complex diseases results from multiple genetic 
aberrations in biological pathways and networks (Meyerson et al., 2010). While most 
of these studies have been carried out in mammalian models and humans, plants 
suffers from a number of complex diseases, whose study can benefit from biomedical 
work. Biological pathways represent series of actions among molecules that lead to a 
certain product or a specific change in a cell. A major challenge in the diagnosis and 
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treatment of such diseases is to identify characteristic aberrations in the biological 
pathways and molecular network activities and elucidate their relationship to the 
disease (Wang et al., 2011). Therefore, the study of metabolic network and integrating 
the gene expression with networks of protein–protein interactions and transcription 
factor binding revealed critical insights into cellular behavior and hence will make the 
study of diseases easier (Moxley et al., 2009). Any aberration in metabolic flux or 
topology of metabolic network can thus be measured and simulated to give the idea 
about the gene involved in pathology and effective drugs then can be made via the 
retrieved information. Systems biology approaches have been used in Arabidopsis to 
identify two Myb transcriptional factors associated with regulation of glucosinolate 
biosynthesis in response to sulphur and nitrogen deficiency (Hirai et al., 2007) and in 
barley to identify metabolites conferring resistance to Fusarium head blight (Bollina 
et al., 2010). 
 
2.6.4 Metabolic engineering and synthetic biology 
Existing metabolic networks can be altered to optimize specific cellular functions 
which might be either pre-existing or newly designed. This type of „engineering‟ is 
made at the molecular level by the introduction of mutations, deletions, insertions and 
up or down-regulations of enzymes of interest. Because efficient designs are often 
non-intuitive, predicting the right adjustments of metabolic fluxes necessary to reach 
the defined objective necessitates computational strategies based on constraint-
methods.  
 
Metabolic engineering refers to the use of molecular biological techniques to alter the 
metabolic pathway to improve cellular properties by designing and implementing 
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rational genetic modifications. Metabolic engineering generally focuses on the 
production of high levels of metabolites of medical or industrial interest. It is 
accomplished by introduction of mutations, deletions, insertions and up or down 
regulations of enzyme of interest. Because efficient designs are often non-intuitive, 
predicting the right adjustments of metabolic fluxes necessary to reach the defined 
objective necessitates computational strategies based on constraint-methods. A lot of 
studies have shown that changing expression of a single gene may not be sufficient to 
bring the desired changes, since regulation of metabolic network occurs at specific 
junctions (Hoefnage et al., 2002). Thus, knowledge of metabolic network behaviour 
and regulatory system becomes essential to enable us to achieve desired changes in 
the biological system. With the help of the knowledge obtained from metabolic 
pathway, the flux is directed towards those compounds without causing any damage 
to the cellular environment. They are so far mostly performed in bacteria or yeast. 
With the use of metabolic engineering, flower colour can be specifically modified 
without changing the other characteristics. Novel flower colour varieties such as brick 
red petunias and violet carnations have been successfully made by expression of 
heterologous flavonoid gene (Tanaka et al., 1998). Human steroid hormones such as 
hydroxycortisone can also be synthesized in yeast. A future field of application will 
likely be the area of synthetic biology, which has gained increased interest with the 
recent completion and incorporation of the first synthetic bacterial genome. However, 
the complexity of metabolic networks, compounded by multiple layers of 
transcriptional, protein, and substrate-level regulation of metabolic enzymes, renders 
predictable metabolic engineering extremely difficult, and often causes unwanted 
consequences or sub-optimal outcomes when local network maps or intuitive 
knowledge are the basis of engineering decisions (Kim et al., 2008; Nevoigt, 2008).  
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Synthetic biology focuses to assemble well-known nucleic acids and proteins into 
biological „devices‟ to design a novel cellular function whose behaviour can be 
predicted (Haynes et al., 2009). The first synthetic gene circuit were engineered in 
bacteria, as the components of bacterial cell are well-defined and thus offers an 
attractive system to operate these gene circuits. But, more recently, synthetic gene 
circuits are also being established in mammalian, yeast and plant cells (Drubin et al., 
2007). Synthetic biology has been used to produce cost effective anti-malarial 
precursor in yeast and bacteria (Ro et al., 2006; Anthony et al., 2009). Plants are 
source of numerous bioactive compounds known as natural products (NPs) that have 
widespread use in pharmaceutical and biotechnological industry. In the last 25 years, 
these NPs constitute 75% of antibiotic and anticancer drugs approved by FDA 
(Dudareva et al., 2012). But, the extraction of these NPs from plants is not favoured 
because of low yield as well as complicated down-stream process. Chemical 
processes also suffer with low-yield along with use of toxic catalyst and extreme 
reaction conditions (Koffas et al., 2008).  Thus synthetic biology approach involving 
microbial metabolic engineering is emerging as a promising approach to synthesize 
these products. E.coli and S.cervisiae have been engineered with plant secondary 
metabolic network and has been reported to synthesize diverse range of natural 
products including fatty acids, terpenoids, flavonoids, polyketides and alkaloids (Xu 
et al., 2012). Complete understanding of plant‟s metabolic network at systems level 
will further help us to employ synthetic biology approach and engineer the 
microorganisms in order to produce several beneficial compounds thus, 
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2.7 Phenylpropanoid metabolic network 
Starting from the amino acids phenylalanine and tyrosine, the phenylpropanoid 
pathway produces the majority of phenolic compounds found in nature. It has been 
estimated that approximately 20% of the carbon fixed by photosynthesis is 
directed into the phenylpropanoid pathway (Vogt, 2010). More than 100,000 
phenylpropanoid compounds have been identified from various species, making 
them one of the largest natural product families in the world. Phenylpropanoid 
pathway is one of the important secondary metabolic pathways and includes 
important class of compounds like anthocyanins, flavonoids, proanthocyanidins, 
catechins, sinapoyl esters, hydroxycinnamates, phenolamides and lignins (Fig 2.1). 
The magniﬁcent diversity of phenylpropanoids, in principle, is the result of 
efﬁcient modiﬁcation and ampliﬁcation of a very limited set of core structures, 
derived from the shikimate pathway (Herrmann, 1995). Many of these compounds 
such as quercetin, kaempferol, cyanidin and pelargonidin are essential for normal 
plant growth and development. Phenylpropanoid-based polymers, like lignin, 
suberin, or condensed tannins, contribute to the stability and robustness towards 
mechanical or environmental damage, like drought or wounding.  They also play 
important roles in defense against pathogens and plant–microbe/animal 
interactions. Phenylpropanoid pathway networks can be seen as complex 
biological regulatory systems that have evolved in vascular plants during their 
successful transition to land, and which are ultimately essential for their growth, 
development and survival. Furthermore, when considered from  both evolutionary 
and functional perspectives, such networks have afforded vascular plants with 
competitive advantages for successful land plant adaptation (Lewis and Davin, 
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1994, 1999; Lewis et al., 1999), which include mechanisms for obtaining  and  
transporting water  and  nutrients (Lewis and Yamamoto, 1990); maintenance of a 
high water potential which facilitates active metabolism in desiccating 
environments (Bernards et al., 1995; Bernards and Lewis, 1998); minimizing the 
effects of temperature, humidity and  (UV) light variations; withstanding and 
modulating forces of compression which act upon plant structures during growth 
and development (Lewis et al., 1999), and formation of specialized structures 
which permit maintenance of pollen grain viability (Wiermann and Gubatz, 1992).  
 
Phenylpropanoid pathways contribute to all aspects of plant responses to biotic and 
abiotic stimuli, which suggest the possibility of its participation in a larger network 
with other secondary metabolic pathways . A plethora of mutants for genes from 
phenylpropanoid metabolic pathways have facilitated the identiﬁcation and 
functional characterization of genes and enzymes (Alonso et al., 2003; Ossowski et 
al., 2008). Several flavonoid metabolic enzymes were shown to form complexes in 
order to regulate the partitioning of intermediates among competing pathways and 
determine the intracellular deposition of end products (Burbulis et al., 1999). 
Chalcone synthase (CHS), chalcone isomerase (CHI) and dihydroflavonol 4-
reductase (DFR) from the flavonoid biosynthesis pathway were shown to form a 
complex in an orientation dependent manner. In the same study, interactions were 
shown between CHS, CHI, and ﬂavonol-3-hydroxylase in lysates from 
Arabidopsis seedlings.  
 
Transparent testa (tt) mutant lines are mutations in genes encoding 
phenylpropanoid pathway enzyme (i.e F3H, Flavanone-3-hydroxylase) or 
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regulators (i.e. TTG1), which are not able to produce anthocyanin and thus their 
seeds are yellowish in colour (and hence called transparent testa (Table 2.1). 
Several studies have been done to characterize the effect of mutation in 
phenylpropanoid pathways in tt mutants (Peer et al., 2001). But these studies were 
directed towards observing changes at flavonoid level changes and their 
localization or regulation of transcriptional factors. There are no studies done till 
now upon interaction of phenylpropanoid with other secondary metabolic network. 
As phenylpropanoid plays an important role in several plant processes, it is highly 
likely that these pathways link with other metabolic networks to achieve multiple 
effects. Given their central role and diversity of metabolites produced from its 
several branches, phenylpropanoid pathways are ideal for deciphering the nature 
and properties of their metabolic network. Applications of systems biology 






















Table 2.1 List of transparent testa mutant lines used in this study 
Lines Enzyme lesion Locus References 
tt1 
WIP1 domain transcriptional factor 
(Zinc finger protein) AT1G34790 Sagasser et al., 2002 
tt2 MYB domain protein 123 AT5G35550 Nesi et al., 2001 
tt3 Dihydroflavonol 4-reductase AT5G42800 Shirley et al., 1995 
tt4 Chalcone synthase AT5G13930 Koornneef, 1990 
tt5 Chalcone isomerase AT3G55120 Shirley et al., 1995 
tt6 Flavanone 3-hydroxylase AT3G51240 Pelletier and Shirley, 1996 
tt7 Flavonoid 3' monooxygenase AT5G07990 Schoenbohm et al., 2000 
tt8 bHlH domain protein AT4G09820 Nesi et al., 2000 
tt9 Unknown not assigned 
 tt10 Laccase-15 AT5G48100 Pourcel et al., 2005 
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Fig 2.1 Phenylpropanoid metabolic network map in Arabidopsis (Sheela et al., 
2012) PAL: Phenylalanine ammonia lyase, C4H: Cinnamate 4-hydroxylase, 4CL: 4-
coumaroyl-coenzyme A ligase, CHS: Chalcone synthase, CHI: Chalcone-flavanone 
isomerase; F3H: Flavanone 3-hydroxylase, F3’H: Flavonoid 3‟monooxygenase DFR: 
Dihydroflavonol 4-reductase, FLS: Flavonol synthase, LAR: Leucoanthocyanidin 
reductase, LDOX: Leucoanthocyanidin dioxygenase, BAN: Banyuls, ANR: 
Anthocyanidin reductase, ANS: Anthocyanidin synthase, FGT: Flavonoid glycosyl 
transferases, C3H: Coumarate-3-hydroxylase, F5H: Ferulate-5-hydroxylase, CCR1: 
Cinnamoyl-CoA reductase 1, OMT1: Flavonol 3‟-o-methyltransferase, SGT: Sinapate-
1-glucosyltransferase, SNG1: Sinapoylglucose:malate sinapoyltransferase, HCT: 
Hydroxycinnamoyl-CoA shikimate/quinate hydroxycinnamoyl transferase, CAD: 
Cinnamyl alcohol dehydrogenase, CCoAOMT: Caffeoyl CoA o-methyltransferase, 
UDP-GT: UDP glucose transferase, SHT: Spermidine hydroxycinnamoyl transferase, 
bHLH: basic Helix-Loop-Helix, WDR: WD-repeat protein with WRKY domains, TT: 
transparent testa, TTG1: Transparent testa glabra 1. 
 
Material and methods 
 




MATERIALS AND METHODS 
3.1 Plant materials and growth conditions 
Arabidopsis seeds were obtained from the Arabidopsis stock centre (Arabidopsis 
Biological Resource Centre, USA). Seeds were stratified for 4 days at 4
0
C and then 
were sown to pots containing pre-mixed potting mixture. These pots were grown 
under standard room condition (22°C, long days: 16 h light/8 h dark cycle) with 




3.2 Growing seedlings on MS media    
Arabidopsis seeds were surface sterilized using 30% Clorox with 7 min incubation. 
This was followed by 6 times washing with autoclaved water. Seeds were then placed 
on full strength MS medium with 5% sucrose and 5% Phytoagar® for 4 days before 
placing them in growth chamber at 22°C for 16 h light/8 h dark cycle. Seedlings were 
harvested 6 days after transferring the plates in light. 
 
3.3 Chemicals and reagents 
HPLC grade acetonitrile and methanol (J. T. Baker, NJ, USA) were used for all the 
experiments. Analytical reagent (AR) grade hydrochloric acid; glacial acetic acid and 
sodium hydroxide were from Amersham Pharmacia Biotech (Uppsala, Sweden). 
Quercetin, spermidine, kaempferol and naringenin were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). Quercetin-3-glucoside, quercetin-3,4-
diglucoside and kaempferol-7-glucoside were obtained from Extrasynthese™ (United 
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States). Flavonoid stock solutions were prepared in 80% methanol (Pillai and Swarup, 
2002).  
 
3.4 Plasmid construction 
To construct p2x35s:tt8-GR and p2x35s:ttg1-GR, full length cDNA for tt8 and ttg1 
were amplified with introducing cla1 and xho1 restriction sites at 5’ and 3’ ends 
respectively. GR vector from Prof Yu Hao was used to create this construct. 
Amplified DNA was digested by Cla1 and Xho1, and cloned into GR vector. 
 
To create pER:ami_TT8 and pER:ami_TTG1, web microRNA designer was used to 
create artificial microRNA specific to its target TT8 and TTG1. Designed primers 
were used to amplify genes using artificial miRNA vectors pRS300, and were 
digested using Xho1 and Spe1 from 5’ to 3’ end respectively. Digested PCR product 
was cloned into pER8 vector. 
 
3.5 Anthocyanin extraction 
For anthocyanin extraction, six-day-old seedlings were used because it is the 
developmental stage when anthocyanin accumulation has been shown to be high 
(Pourcel et al., 2010). 0.1g seedlings ground in 0.2ml acidified methanol (1% v/v 
concentrated HCl) and stored at 4ºC overnight to facilitate the total extraction of 
anthocyanins. Three biological replicates each consisting of 40-50 seedlings (0.1g) 
were analyzed. The suspension was centrifuged at 14,000 rpm for 20 min. Absorbance 
was read at 530nm using Beckman Spectrophotometer DU 640 B (Beckman Coulter, 
Inc. CA, USA).  Relative anthocyanin units were calculated as A=A530-1/4xA650 per 
gram fresh weight (Pourcel et al., 2010). 
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3.6 Stem stiffness test 
Five-week-old Arabidopsis plants were used to test tensile strength. Inflorescence 
stems were measured for its cross sectional area, length and thickness. Stems were 
then placed from both ends to two fix ends of tensile strength tester (5900 series 
mechanical testing systems from Instron). Displacement speed for the two ends were 
fixed to 0.5mm/min. Maximum load and extension at breaking point was measured 
and modulus calculated as stress over strain in MPa using instruments and software 
provided by the manufacturer.  
 
3.7 Lignin staining 
Five-week-old stem tissues (near to the junction between stem and root) of WT (Col 
and Ler), pp10 and tt6 Arabidopsis lines were hand-sectioned and immediately 
immersed for 2 min in 10% phloroglucinol (Sigma-Aldrich Chemical Co., USA) 
dissolved in 100% ethanol. Following this, the sections were incubated in 
concentrated HCl for one minute. Sections were rinsed and images were taken at 80x 
magnification under a dissection microscope with bright field illumination.  
 
3.8 Plant transformation 
3.8.1 Preparation of Agrobacterium tumefaciens GV3101 competent cells 
Agrobacterium tumefaciens GV3101 cells were inoculated in 100ml LB media with 
gentamycine, riphampicin and tetracycline antibiotics, incubated at 28°C with shaking 
till it grows to OD600~0.6. The culture was placed on ice and then centrifuged at 
3500 rpm for 15 min at 4°C. Thepellet obtained was washed 5 times with ice-cold 
double autoclaved H2O by resuspension and centrifugation. A final 5ml cold double 
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autoclaved H2O was added to suspend all cell pellet and aliquots of 200µl/tube were 
flash frozen in liquid for future use. 
 
3.8.2 Electroporation to competent cell 
Prepared competent cells tubes were added with 200 ng plasmid and incubated on ice 
for 1 hour. Cells were transferred to 1mm Gene pulser cuvettes (Bio Rad, USA), and 
electroporated using MicroPulser Electropotor (Bio Rad, USA). Agrobacterium cells 
were recovered in 1ml of LB broth for 2 hours at 28°C with shaking. Cells were 
collected and plated on LB agar plate supplemented with 10µg/ml tetracycline, 
50µg/ml rifampicin, 10µg/ml gentamycin and kanamycin 100µg/ml for GR constructs 
or spectinomycin for pER constructs. The plates were incubated at 28°C for 2 days. 
Selected colonies were tested for insert and PCR confirmed colonies were used for 
floral dip.  
 
3.8.3 Method of transformation of Arabidopsis thaliana  
Plasmids were extracted from Agrobacterium colonies obtained from selection 
platesand were sequenced to confirm the presence of construct. Positive 
Agrobacterium colonies were inoculated into liquid LB medium supplemented with 
antibiotics and incubated at 28 °C with shaking until OD600 reached 0.6. The 
Agrobacterium cells pelleted by centrifugation at 8000rpm for 5 minuwere 
resuspended in the same volume of medium containing 5% sucrose and 0.01% Silvet 
L-77® (LEHLE Seeds, USA), incubated at room temperature for 1 h. Flower buds of 
Arabidopsis wild type Col-0 to be transformed were dipped into the Agrobacterium 
culture for around 2 min, after which plants were covered and placed in dark for 16 h 
Material and methods 
 
Page | 52  
 
to improve transformation efficiency. Plants were then placed back in growth 
chambers for normal growth and seeds  were harvested. 
 
3.8.4 Screening of transgenic plants 
Eight-day-old seedlings were screened by spraying 0.2% Basta® solution twice at one 
week interval with first spray on transgenic plants. Surviving T1 plants were 
genotyped to confirm the successful transformation. 
 
3.9 Genotyping  
One rosette leaf of ten-day-old putative transgenic plants was cut and ground in 200µl 
extraction buffer (0.2M tris-HCl, 0.4M LiCl, 25mM EDTA and 1% SDS) in 
Eppendrof tubes until the solution turned light green. The homogenized sample was 
centrifuged at 14000g in a mini-centrifuge for 5 min at room temperature. 150-µl of 
supernatant was mixed with 150µl isopropanol in a freshtube by inverting several 
times. After centrifuging at 14000g for 8 min, the pellet was washed with 70% 
ethanol and dried in a vacuum. Pellets were dissolved in 30µl nuclease-free water and 
used for genotyping by PCR. 
 
3.10 Gene expression analysis 
Total RNA was extracted from 0.1 g plants using Omega® plant RNA extraction kit 
(Omega BIO-TEK®, USA) using the manufacturer’s protocol. 1µg total RNA was 
used to convert into cDNA using RevertAid® first strand cDNA synthesis kit 
(Thermo Scientific, USA) using manufacturers’ instructions. Single stranded cDNA 
were diluted to a concentration of 50ng/µl and were used as template for quantitative 
real time PCR analysis. Quantitative real-time PCR was performed in triplicates using 
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an ABI 7500 real time PCR system (Applied Biosystems, USA) using Maxima SYBR 
Green qPCR mix (Thermo Scientific, USA). Delta delta Ct method was used to 
calculate relative expression level using TUB2 as endogenous control. 
 
3.11 Primer and Oligonucleotides 
Primers were designed using the NCBI primer designing tool and synthesized by 
Sigma Aldrich (Singapore). Lyophilized primers were dissolved in the appropriate 
volume of TE buffer to reach a final concentration of 100μM. For working solutions, 
primers were further diluted 1:10 with ddH2O. All primers used for this work are 
listed in Table 3.1. 
Table 3.1 List of all primers used in this study 
 
Primer Name Squence (5'-3') Annotation 
ttg1_(i)miR-s  GACTGATACGCCTTTGTTAAGACTCTCTCTTTTGTATTCC 





ttg1_(iii)miR-s*  GAGTATTAACAAAGGGGTATCAGTCACAGGTCGTGATATG 
ttg1_(iv)miR-a*  GACTGATACCCCTTTGTTAATACTCTACATATATATTCCT 
tt8_(i)miR-s  GATTAACGTATGGGTTGACTCAATCTCTCTTTTGTATTCC 
amiRNA primers for tt8 
silencing 
tt8_(ii)miR-a  GATTGAGTCAACCCATACGTTAATCAAAGAGAATCAATGA 
tt8_(iii)miR-s*  GATTAAGTCAACCCAAACGTTATTCACAGGTCGTGATATG 
tt8_(iv)miR-a*  GAATAACGTTTGGGTTGACTTAATCTACATATATATTCCT 
tt6_(i)miR-s  GATAATACGTTACAATCTCTCTGTCTCTCTTTTGTATTCC 





tt6_(iii)miR-s*  GACAAAGAGATTGTATCGTATTTTCACAGGTCGTGATATG 
tt6_(iv)miR-a*  GAAAATACGATACAATCTCTTTGTCTACATATATATTCCT 
primer a CTGCAAGGCGATTAAGTTGGGTAAC  
primers for Prs300 (miR319A 
Pbsk primer b GCGGATAACAATTTCACACAGGAAACAG  
tt2RT-PCRf TTGATGGTTTGGACTGTG Quantitative RT PCR primers 
tt2RT-PCRr GCAATATAGGCTCAACAAGT Quantitative RT PCR primers 
ttg2RT-PCRf CCCCACAACTTTCTAAGCAAACA Quantitative RT PCR primers 
ttg2RT-PCRr TGCTTAGGAAGTTGTGAGTGAAG Quantitative RT PCR primers 
myb118RT-PCRf ATGTGCATCACAAACCATCG Quantitative RT PCR primers 
myb118RT-PCRr AGTTGGTGGGGTGGTATAGG Quantitative RT PCR primers 
myb5RT-PCRf TCTCATCCTCCGTCTTCACC Quantitative RT PCR primers 
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myb5RT-PCRr TTGCATCAAGAGGCTTGTGG Quantitative RT PCR primers 
DFR-RT-PCRf TGGTGGTCGGTTCCATTCAT Quantitative RT PCR primers 
DFR-RT-PCRr GAGAGAGCGCGGTGATAAGG Quantitative RT PCR primers 
BAN-RT-PCRf ACATTTGCTGTCTTACAACACAAGT Quantitative RT PCR primers 
BAN-RT-PCRr CGAAAGCCTTCATTGATAAGTTTTTGCG Quantitative RT PCR primers 
p ER-f ACCCTTCCTCTATATAAGGAAGTTC 
Vector pER8 primers p ER-r TCGGTTTCGACAACGTTCGTCAA 
35Spromoter f GACCCTTCCTCTATATAAGGAAGTTC 
Vector HY109 primers PGP2r CGACGGCCAGTGAATTGTAATACG 
tt8:gr-f AACTCGAGATGGATGAATCAAGTATTATTC 
primers for tt8:gr construct tt8:gr-r ATTATCGATTAGATTAGTATCATGTATTATGAC 
ttg1:gr-f AAACTCGAGATGGATAATTCAGCTCC 
primers for ttg1:gr construct ttg1:gr-r ATATCGATAACTCTAAGGAGCTGCATTTTG 
GL2-RT-PCRf AAGCTCGTCGGCATGAGT Quantitative RT PCR primers 
GL2-RT-PCRr TTCTCTCGATTTCACTGTCTGG Quantitative RT PCR primers 
TT10-RT-PCRf CAATGCATTGGCATGGTGTAGAG Quantitative RT PCR primers 
TT10-RT-PCRr CTCACATCCCTCTTCCACCAC Quantitative RT PCR primers 
HMG2-RT-PCRf TACTCGGTGTGAAAGGATCAAACA Quantitative RT PCR primers 
HMG2-RT-PCRr CCGAACCAGCCACTATTCTTG Quantitative RT PCR primers 
ISPD-RT-PCRf GCGGTTGGAGCAGCTGTACTTG Quantitative RT PCR primers 
ISPD-RT-PCRr GGTGTCTGCATTTCCCATAGGGTTT Quantitative RT PCR primers 
GPPS-RT-PCRf ACGTCGCAAGTCTACTGCACGATGA Quantitative RT PCR primers 
GPPS-RT-PCRr AAGCCCGGGAGAGCAAGAAGTCTC Quantitative RT PCR primers 
BR6OX1-RT-PCRf TGGCCAATCTTTGGCGAA Quantitative RT PCR primers 
BR6OX1-RT-PCRr TCCCGTATCGGAGTCTTTGGT Quantitative RT PCR primers 
CBB2-RT-PCRf CCCTCCGCTACCGCTTAAAAGTC Quantitative RT PCR primers 
CBB2-RT-PCRr AACGCGAGTGATTCGAGAAGAGAAC Quantitative RT PCR primers 
GGR-RT-PCRf ACCGCCTGTGCCCTAGAAATGGT Quantitative RT PCR primers 
GGR-RT-PCRr GCCAGAGCCGTAGACAGTGTGGTTA Quantitative RT PCR primers 
PR5-RT-PCRf AAT GTC AAG CTG GGG A Quantitative RT PCR primers 
PR5-RT-PCRr AGG TGC TCG TTT CGT C  Quantitative RT PCR primers 
PR1-RT-PCRf TCC GAT AGC GGC AAA G  Quantitative RT PCR primers 
PR1-RT-PCRr CCC ACT GGC ATA GGA T  Quantitative RT PCR primers 
LURP1-RT-PCRf CAACTTCCATTCCGCAACAATTCG Quantitative RT PCR primers 
LURP1-RT-PCRr GAAGGGGTCAAAGACATGATTCTCG Quantitative RT PCR primers 
DOGT1-RT-PCRf CCGGGGTTGAACAGCCTATGAAA Quantitative RT PCR primers 
DOGT1-RT-PCRr TGGGTTCTGCCAGTTCCATTATGTC Quantitative RT PCR primers 
PCC1-RT-PCRf GCGTCAACCCCGAAGCCATAAT Quantitative RT PCR primers 
PCC1-RT-PCRr GGTTTGGGCAACGACTTCTGTCTC Quantitative RT PCR primers 
PDR12-RT-PCRf GTTTCTTGAGTTTCCAGAGGAGTTTC Quantitative RT PCR primers 
PDR12-RT-PCRr CCAAGCGAGTCCTAGTATGAGAAGAAAC Quantitative RT PCR primers 
SAG13-RT-PCRf GAACTCAAGATGGAGTCTTGG Quantitative RT PCR primers 
SAG13-RT-PCRr ATTGTTGACGAGGATGTTGAG Quantitative RT PCR primers 
CYP76C2-RT-
PCRf CCGTACCCCCACTAACTCGATACG Quantitative RT PCR primers 
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CYP76C2-RT-
PCRr GAGTCGCCGACAGTTTTCTCAAAAG Quantitative RT PCR primers 
WAK1-RT-PCRf GCA CAT GAC TTC TTT TCA CGA Quantitative RT PCR primers 
WAK1-RT-PCRr GCG GTA ACC AGA TTG ACA CTT Quantitative RT PCR primers 
SUS2-RT-PCRf TGCCATGAATAATGCCGATTTC Quantitative RT PCR primers 
SUS2-RT-PCRr TTGCCCAACATTGTTCTTGCTT Quantitative RT PCR primers 
SUS4-RT-PCRf AAGGAATCGTTCGCAAATGG Quantitative RT PCR primers 
SUS4-RT-PCRr TTTCAGCGGCAACATCCTC Quantitative RT PCR primers 
ATSUC7-RT-PCRf TTGGATGGGTCGTGAAGTGTATGGT Quantitative RT PCR primers 
ATSUC7-RT-PCRr TTGCCAAACACACGGCGAGAATAAT Quantitative RT PCR primers 
UGT85A1-RT-
PCRf ATCGAGAAGGGCTTATGTCCGCTAA Quantitative RT PCR primers 
UGT85A1-RT-
PCRr CGCGGAGGGCGAAACTAATCATAAC Quantitative RT PCR primers 
NIT4-RT-PCRf CGCCACGCTAGATAAGGCAGAGA Quantitative RT PCR primers 
NIT4-RT-PCRr TGGCCATTAACGCTAATCGTTCCAC Quantitative RT PCR primers 
WAK3-RT-PCRf CTGCACGAGGCCCGAATACAAAC Quantitative RT PCR primers 
WAK3-RT-PCRr TGTCGTCGGAGCTTGGTATACTTCC Quantitative RT PCR primers 
CSLE1-RT-PCRf CTCTCGCGAGCTGCACTTATGAGG Quantitative RT PCR primers 
CSLE1-RT-PCRr TTCCGGGTTCAGGTAGGCTGATTTC Quantitative RT PCR primers 
UGT75B1-RT-
PCRf CTTCCACAACTCCATGATCGCAAAC Quantitative RT PCR primers 
UGT75B1-RT-
PCRr TGAGATTCACCGACCTTTTCTGACG Quantitative RT PCR primers 
BAN-P1-f TCTTAGGTGAAGACAAGTTGGTT ChIP qRT PCR primers 
BAN-P1-r TGAGTTTATCGTCTTGAGACTTCTA ChIP qRT PCR primers 
BAN-P2-f TGCAACTCATTTTAAGATCGGCA ChIP qRT PCR primers 
BAN-P2-r ACCAACTTGTCTTCACCTAAGAA ChIP qRT PCR primers 
BAN-P3-f GCCTTCTTTTGTTTTCGATTTAGGA ChIP qRT PCR primers 
BAN-P3-r CGAGTCAATTCAACATAACTTGCT ChIP qRT PCR primers 
BAN-P4-f GCAATGGAGTTTGGTTTCGGT ChIP qRT PCR primers 
BAN-P4-r GGCATTGGCAATAGCATTCCG ChIP qRT PCR primers 
BAN-P5-f GTGTTTGCCGGTGGTTCTTC ChIP qRT PCR primers 
BAN-P5-r TCCAACTCCTTAGCTTGCAACA ChIP qRT PCR primers 
TT10-P1-f ACGGACCAAGAAGATGATGCT ChIP qRT PCR primers 
TT10-P1-r GAAGTTCATCAAAGAATAGAGAGGC ChIP qRT PCR primers 
TT10-P2-f TGCTTGGCCTAACAAAACTCA ChIP qRT PCR primers 
TT10-P2-r AGCATCATCTTCTTGGTCCGT ChIP qRT PCR primers 
TT10-P3-f ACATGTAGCTTTGGCGTGGA ChIP qRT PCR primers 
TT10-P3-r TGTTAGGCCAAGCATTACCTT ChIP qRT PCR primers 
TT10-P4-f AGAAATCGACATTTCACCAGTCA ChIP qRT PCR primers 
TT10-P4-r ACGAAAGAGATGTTTCGCTAAC ChIP qRT PCR primers 
TT10-P5-f GACATGAAGAGGTTTGACA ChIP qRT PCR primers 
TT10-P5-r CTGGTGAACTTCAAAGAATC ChIP qRT PCR primers 
GGR-P1-f TCGATGTTCTTCTTCTGTTCTTGT ChIP qRT PCR primers 
GGR-P1-r TGGGTTCAGCCAAACTCTCT ChIP qRT PCR primers 
GGR-P2-f GAAAGAGGGTTGCGAAGGGA ChIP qRT PCR primers 
GGR-P2-r ACAGCTTTTCATCTGTAAGAGAACC ChIP qRT PCR primers 
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GGR-P3-f AAAGCGGCATCGTGAGGTAA ChIP qRT PCR primers 
GGR-P3-r TCCCTTCGCAACCCTCTTTC ChIP qRT PCR primers 
GGR-P4-f CTTGTGGGGCATTGGACAGA ChIP qRT PCR primers 
GGR-P4-r TTACCTCACGATGCCGCTTT ChIP qRT PCR primers 
GGR-P5-f CTCTCCAATGCCCGTGTTCT ChIP qRT PCR primers 
GGR-P5-r AGGACGGCCTCATTTTCCTG ChIP qRT PCR primers 
CBB2-P1-f ACAGCTGTGACCACTCTTCC ChIP qRT PCR primers 
CBB2-P1-r TGTGAGAGAGAAAAGTGTGG ChIP qRT PCR primers 
CBB2-P2-f TGAGATTAAGGATTTTGTGATGCC ChIP qRT PCR primers 
CBB2-P2-r AAGGGAAGAGTGGTCACAGC ChIP qRT PCR primers 
CBB2-P3-f AGGTGGTTGGGGGTAAAATGT ChIP qRT PCR primers 
CBB2-P3-r TGGCATCACAAAATCCTTAATCT ChIP qRT PCR primers 
CBB2-P4-f TCACCGATCAAGATCCAACCA ChIP qRT PCR primers 
CBB2-P4-r ACCCCCAACCACCTATCTCT ChIP qRT PCR primers 
CBB2-P5-f TCACATTGAATGCTCCAAATC ChIP qRT PCR primers 
CBB2-P5-r TGCACTCACTGTCACCCAAT ChIP qRT PCR primers 
PCC1-P1-f CGCTAAGGTAGGTCTGTCCG ChIP qRT PCR primers 
PCC1-P1-r GGAGCTGAGGAGTGAGGATG ChIP qRT PCR primers 
PCC1-P2-f TCATGTACGTGACGAAAGCCA ChIP qRT PCR primers 
PCC1-P2-r CGGACAGACCTACCTTAGCG ChIP qRT PCR primers 
PCC1-P3-f CATGGTTCAAAGGCAGTTGGT ChIP qRT PCR primers 
PCC1-P3-r CACGTACATGACGTCGTAAAACA ChIP qRT PCR primers 
PCC1-P4-f CCATGATTCCCATTTGCTTCGT ChIP qRT PCR primers 
PCC1-P4-r TGGCTTTGTTCCTTATGTTGGTG ChIP qRT PCR primers 
PCC1-P5-f AGTTGTATCCAGGGTTGCGG ChIP qRT PCR primers 
PCC1-P5-r GGATCTCTTTCAACCAGTGAAGC ChIP qRT PCR primers 
PDR12-P1-f GTGGAAGAAAGATTCAGGAAG ChIP qRT PCR primers 
PDR12-P1-r GATTCCTTTCCTGAGACGATC ChIP qRT PCR primers 
PDR12-P2-f CAGAGGAGTCACAGCTGACG ChIP qRT PCR primers 
PDR12-P2-r TTGGGTTTGTGTGCTCCGTA ChIP qRT PCR primers 
PDR12-P3-f TGGCAAAGACAACAACGA ChIP qRT PCR primers 
PDR12-P3-r CGTCAGCTGTGACTCCTCTG ChIP qRT PCR primers 
PDR12-P4-f TCGTTTGTTTTCTTCTCCTCACG ChIP qRT PCR primers 
PDR12-P4-r TGCAACCACAAAACTTTAATTTG ChIP qRT PCR primers 
PDR12-P5-f TGAAGATAAAAAGTCCAAGGCTGA ChIP qRT PCR primers 
PDR12-P5-r ACGTGAGGAGAAGAAAACAAACG ChIP qRT PCR primers 
BR6OX1-P1-f GTTCCGCTCTCCTTCGATGGA ChIP qRT PCR primers 
BR6OX1-P1-r TGGTTTCTCATGAAGTTGG ChIP qRT PCR primers 
BR6OX1-P2-f GCTAGGAGACAACAAAAGTGA ChIP qRT PCR primers 
BR6OX1-P2-r AGTGCAGCATGCTCAAGAGA ChIP qRT PCR primers 
BR6OX1-P3-f CGAATCCCGTATATGATCGCGT ChIP qRT PCR primers 
BR6OX1-P3-r AGCATGATGGTGTTCAAAAGAGT ChIP qRT PCR primers 
BR6OX1-P4-f TGTTGTAAACGCTTAAAGTGC ChIP qRT PCR primers 
BR6OX1-P4-r ACGGGATTCGAATTTGGTGT ChIP qRT PCR primers 
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BR6OX1-P5-f GGTTTACGCGGTTGCCTAGG ChIP qRT PCR primers 
BR6OX1-P5-r CAATATAGGAAACTTAAGC ChIP qRT PCR primers 
GPPS-P1-f CACTGAACTTGTTGAGTTGG ChIP qRT PCR primers 
GPPS-P1-r GGCAACAAGCGAAAATGGGT ChIP qRT PCR primers 
GPPS-P2-f GGGTTACGTTTGCAGAACAACT ChIP qRT PCR primers 
GPPS-P2-r ACAACTGAAGCAATGTCCAACA ChIP qRT PCR primers 
GPPS-P3-f TCATGGGTCCTATTTGGATGC ChIP qRT PCR primers 
GPPS-P3-r TGTTCTGCAAACGTAACCCT ChIP qRT PCR primers 
GPPS-P4-f TGTGCTAATTATCTCGGTTTTTGT ChIP qRT PCR primers 
GPPS-P4-r CACTAGTTTTGGCTGATTACTCCA ChIP qRT PCR primers 
GPPS-P5-f CTCTCGCCTCTCATCGGTTC ChIP qRT PCR primers 
GPPS-P5-r TCCCCACAACACTCAATTATC ChIP qRT PCR primers 
HMG2-P1-f ACGATGATGACCCAACAACCT ChIP qRT PCR primers 
HMG2-P1-r TGGTTATGAGATTATTTTGGGCT ChIP qRT PCR primers 
HMG2-P2-f TCTTCACTGATCCATGTTGGA ChIP qRT PCR primers 
HMG2-P2-r TGTCTCCTCCGTCACAATCT ChIP qRT PCR primers 
HMG2-P3-f TGTGGCCAAATTTACCCAAGA ChIP qRT PCR primers 
HMG2-P3-r TGAGGCGTTTATTTTGGGTCT ChIP qRT PCR primers 
HMG2-P4-f GCAAAAGGATCGGGAAAC ChIP qRT PCR primers 
HMG2-P4-r GCTAATTATTTAGTGATG ChIP qRT PCR primers 
HMG2-P5-f ACTGCTGAATTCCAAAAGCCA ChIP qRT PCR primers 
HMG2-P5-r GTTTCCCGATCCTTTTGCGG ChIP qRT PCR primers 
ISPD-P1-f TCCCAACGGTTTCGCCA ChIP qRT PCR primers 
ISPD-P1-r AAGAAAGCTCCGGTTCCT ChIP qRT PCR primers 
ISPD-P2-f AGAAGGCACCAACACCGATT ChIP qRT PCR primers 
ISPD-P2-r CGAAACCGTTGGGAACAACC ChIP qRT PCR primers 
ISPD-P3-f CGTGACATTCTAAGAACTTTGC ChIP qRT PCR primers 
ISPD-P3-r GCATCAGAAACAACCCGCTC ChIP qRT PCR primers 
ISPD-P4-f TGCAAGGAATGGATTCATCTCAG ChIP qRT PCR primers 
ISPD-P4-r ATGGTTAGAATCAAGTTTTGGGATT ChIP qRT PCR primers 
ISPD-P5-f ACCTCAAGGAATGGATTCATCTCAA ChIP qRT PCR primers 
ISPD-P5-r TTTGAAGTCAAGTTTTGTGGAAGA ChIP qRT PCR primers 
 
3.12 ChIP Assay 
3.12.1 Tissue fixation 
Fresh plant materials from two developmental stages, six-day-old seedlings and five 
to seven-day-old siliques were collected into MC buffer (10mM potassium phosphate, 
pH 7.0, 50mM NaCl and 0.1 M sucrose) supplemented with 0.01% succinamide 
glutarate and were infiltrated by applying vacuum for 45 min at 4ºC. Thereafter, MC 
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buffer was replaced by fresh MC buffer containing 1% formaldehyde and re-
infiltrated by applying vacuum for another 45 min at 4ºC. Following this, the reaction 
was quenched by incubating with 0.15M glycine for 20 min at 4ºC. Fixed tissues were 
washed by cold MC buffer for 20 min and this process was repeated for three times. 
Fixed tissues were flash frozen in liquid nitrogen and stored at -80ºC until used for 
ChIP experiments as described below. 
 
3.12.2 Nuclear protein-DNA extraction 
Fixed tissues from the above treatment were ground into powder with mortar and 
pestle using liquid nitrogen. Freshly prepared chilled M1 buffer (10mM sodium 
phosphate buffer, pH 7.0, 0.1M NaCl, 10mM beta-mercaptoethanol, 1M hexylene 
glycol and half tablet of Roche protease inhibitor cocktail (Catalog no  05892791001) 
was added to the powder resulting in thick slurry. This slurry was transferred to an 
Eppendorf tube and centrifuged at 14,000rpm for 3 min at 4ºC. Supernatant was 
discarded and pellet was resuspended to 2ml prechilled M2 buffer (10mM sodium 
phosphate buffer, 10mM beta-mercaptoethanol, 1M hexylene glycol, 10mM 
MgCl2,0.5% Triton X-100 and one tablet of Roche protease inhibitor cocktail) 
followed by centrifugation at 14,000g at 4ºC for 3 min. This process of washing pellet 
with M2 was repeated for multiple times till pellet turned to light green. Pellet was 
then resuspended into pre-chilled M3 buffer (10mM sodium phosphate buffer, 10mM 
beta-mercaptoethanol and half tablet of Roche protease inhibitor cocktail) and 
centrifuged at 14,000 rpm for 3 mint at 4ºC. The supernatant was discarded, and the 
pellet was resuspended in sonication buffer. 
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3.12.3 Sonication of nucleus 
Resuspended nuclei pellet in 0.5ml sonication buffer (10mM sodium phosphate 
buffer, pH 7.0, 0.1M NaCl, 10mM EDTA pH 8.0, 0.5% sarkosyl, one tablet of Roche 
protease inhibitor cocktail (Catalog no-05892791001)) was placed in 1.5ml Eppendrof 
tube. The sample tube was kept in an iced water bath and samples were sheared with a 
probe sonicator for a 15 min continuous pulse at 10% amplitude output (BioRad®, 
USA). The sonicated sample was centrifuged at maximum speed for 5 min at 4°C. 
Supernatants were collected in a new tube, and pellet were resuspended in 0.25ml and 
centrifuged at maximum speed for 5 min at 4°C, supernatant was collected and added 
to last collected supernatant. 75µl of supernatant was saved in another tube, which 
was used to test sonication effects, while rest of the samples were subjected to 
immunoprecipitation. 
 
3.12.4 Chromatin immunoprecipitation (ChIP) 
200µl of 25% v/v agarose beads (Sigma Aldrich, USA) were equilibrated with 1ml of 
IP buffer (50Mm HEPES pH 7.5, 150mM KCl, 5mM MgCl2, 10µM ZnSO4, 1% 
Triton X-100 and 0.05% SDS), centrifuged at 2500g for one minute. 1ml of 
supernatant was removed. The final volume was maintained at 200µl. 800µl of 
solubilised chromatin solution was pre-incubated with 100µl agarose beads and equal 
volume of IP buffer on an orbital shaker for one hour at 4°C. This was followed by 
centrifugation at 3000g for 5 min at 4°C and supernatant was collected. Supernatant 
was incubated with 3µl of anti GR antibody (Milipore®, USA) at 4°C on an orbital 
shaker for two hours. After adding 100µl of agarose beads, the chromatin-antibody 
solution was further incubated overnight at 4°C on an orbital shaker. After overnight 
binding, the solution mix was centrifuged at 2500rpm for 3 min to remove 
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supernatant, and pellets were washed six times collecting the pellets and re-
suspending in IP buffer before re-suspending the beads at 2500rpm for 3 min. To 
elute the chromatin antibody complex, the beads were incubated with 200µl elution 
buffer (50mM Tris pH 8.0, 1% SDS and 10mM EDTA) at 65°C for 15 min on a 
shaker and the suspension was centrifuged at 14000g for 2 min at RT. Supernatant 
was collected as immunoprecipitated chromatin eluates. Additional elution buffer 
(100µl each time) was added to repeat the incubation step to improve recovery of 
chromatin complex. Out of total 500µl combined eluates, 40µl was used for Western 
blot analysis, while the rest was used for DNA recovery. 
 
3.12.5 Dex, chx and β-estradiol induction of gene expression   
Dexamethasone-inducible TTG1 and TT8 over-expression transgenic lines were 
created in Col-0 background to identify direct and indirect targets of the 
transcriptional factors tt8 and ttg1. Induction of GR in the transgenic Arabidopsis 
plants was performed according to Morohashi et al. (2007), with numerous 
modifications. To induce over-expression in the young seedlings, seeds were grown 
on MS media and 5-day-old seedlings were transferred to MS plate with 50µM 
dexamethasone prepared in ethanol and incubated for 24 h before RNA extraction. To 
induce over-expression in siliques, 50µM 0.015% v/v of Silwet L-77® (LEHLE 
Seeds, USA) was sprayed over 40-day-old transgenic lines till the plants were 
completely wet. Spray was repeated three times with 8 hours interval between each 
spray before 5-7 days-old siliques were harvested for RNA extraction. To study 
reciprocal effect of silencing of TTG1 and TT8, estradiol-inducible XVE system was 
generated for amiRNA targeted to TT8 and TTG1. In the inducible silencing 
experiment, 10µM β-estradiol was applied to the 5-day-old seedlings for 24 h before 
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harvesting tissues for RNA extraction and expression analysis. Cycloheximide 
treatment was performed similar to dex treatment with final concentration as 100µM 
used to apply on transgenic lines (Baudry et al., 2006). 
 
3.13 Microarray hybridization and gene expression analysis 
3.13.1 cDNA synthesis and sample labelling  
Total RNA extracted from siliques or seedlings were tested for their integrity using 
Agilent 2100 bioanalyzer and 6000 RNA nano chip from Agilent. Samples that had 
RIN (RNA integration number) value above 8 were used for double stranded cDNA 
synthesis according to application note for Nimblegen microarray kit (Roche,USA). 
Total 10µg of RNA were used for cDNA synthesis using Superscript2® (Invitrogen, 
USA) following the manufacturer’s protocol (Invitrogen). After conversion of RNA 
to cDNA; reaction mix was then purified using GeneJET PCR purification kit 
(Thermo Scientific, USA) to remove enzymes and exchange buffers from the reaction 
mix. Converted cDNA were then tested for its quality by Bioanalyzer™® run. 
Samples with cDNA size ranging from 200-800 bp with mean at 450 bp were selected 
to perform labelling and microarray hybridization. 1µg of total cDNA were used for 
Cy3 labelling using NimbleGen one-color cDNA labelling kit (Catalog Number: 
06370411001) following manufacturer’s protocol. Since Cy3 loses its sensitivity 
under light, whole experiment was performed with samples protected from light. Cy3 
labelled cDNA samples were quantified and 4µg of labelled DNA were transferred to 
a new 1.5ml eppendrof tube. Contents of the tube were dried under vacuum and 
preserved in -80
0
C protected from light before using them for microarray chip 
hybridization.     
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3.13.2 Hybridization and washing 
NimbleGen 12x135K Arabidopsis (TAIR 9.0) arrays were used for gene expression 
analysis. Dried Cy3 labelled sample were re-suspended in 3.3µl of sample tracking 
control provided by NimbleGen microarray kit. Each sample was spiked with a 
unique sample tracking control. Samples were vortexed briefly and the contents were 
collected back by centrifugation. NimbleGen hybridization kit was used and 
following the manufacture’s instruction, hybridization master mix was prepared. 
Prepared samples were added with 8.7µl of hybridization mix, and vortex for 15 s 
followed by collecting them back using centrifugation. Reaction mix were then 
incubated at 95ºC for 5 min protected from light. Sample tubes were then placed at 
42ºC till microarray chip were ready for sample loading. For gene expression study, 
NimbleGen 12x135K arrays were used. NimbleGen mixer was mounted on 
microarray slides using precision mixer alignment tool following manufacturer’s 
instructions. 8µl of prepared samples were loaded on individual port on microarray 
slides and ports were sealed using mixer seal material provided by NimbleGen. 
MAUI® Hybe Station (BioMicro® Systems) was kept at 42ºC for 3 h to ensure no 
temperature fluctuations were present before using them for hybridization. Microarray 
slides were placed in hybridization chamber and mixer was switched on to allow 
mixing of loaded samples on microarray slides for 16 h  at 42ºC. After hybridization, 
microarray slides were washed using NimbleGen wash buffer kit and NimbleGen 
array processing accessory following manufacturer’s protocol for washing microarray 
slides. Slides were dried by spinning in NimbleGen microarray dryer. 
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3.13.3 One colour array scanning and data extraction 
Axon GenePix® 4100A (Molecular Devices, USA) scanner was used to scan 
microarray slides, which was performed at different power value termed as PM in its 
software ranging from 300 to 600. Images thus obtained were processed in Deva® 
software from NimbleGen. Each slide had 12 individual arrays which were all 
together in the scanned image. Deva software was used to burst the single slide image 
into individual array, which were then aligned using default parameters. Each slide 
was then matched with array technology to assign gene name to each spot and to 
assign a signal intensity associated with expression level of that gene. Default 
parameters were selected for background correction to the expression profile and 
RMA analysis was performed. Data thus generated were used to for gene expression 
analysis using Genespring 12 software. Data were subjected quantile normalization 





 percentile of signal value thus removing low signal gene, followed by 
filtering data based on coefficient of variance with <20% as cut off. Filtered data were 
then used for statistical analysis to identify differentially expressed genes in different 
conditions. Differentially expressed genes were selected based on p value<0.05 and 2-
fold changes compared to its control. 
 
3.14 Total RNA extraction from siliqs 
50mg of siliques were homogenized using liquid N2 and transferred to a pre-chilled 
2ml tube with 8M LiCl with 2% β-mercaptoethanol and incubated at 4°C for 
overnight. This mixture was centrifuged at 13,500 rpm at 4°C for 30 min. Supernatant 
were removed and pallets were added with 75% EtOH kept at -20°C, washed by 
shaking vigorously and centrifuged at 13,500 rpm at 4°C for 5 min. Supernatant were 
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removed and pellets were allowed to air dry briefly. Pellets were resuspended in 
800µl of solubilisation buffer (100mM NaCl, 10mM Tris/HCl pH 7.6, 0.5% SDS, 
25mM EDTA, 2% β-mercaptoethanol (freshly added)) followed by adding 800µl of 
chloroform, shaken vigorously for 20 s and centrifuged at 4°C, 13,500rpm for 15 min. 
Aqueous phase was transferred to a new Eppendrof tube and previous step was 
repeated with phenol, phenol:chloroform:isoamylalcohol (25:24:1), chloroform/ 
isoamylalcohol (24:1). Last aqueous phase was distributed into 2 tubes containing 
600µl of 100% EtOH and 40µl of 3M NaOAc and mixture was incubated at -20°C for 
90 min. This was followed by centrifugation at 4°C; 13,500 rpm for 5min, and 
supernatant were removed. Pellets were washed with 1ml of cold 70% EtOH and 
centrifuged at 13,500 for 5 min. Supernatants were removed and pellets were air-dried 
briefly, and total RNA was dissolved in 30µl of DEPC-treated water.  
 
3.15 Metabolomics of Arabidopsis lines 
3.15.1 Extraction of metabolites  
Plant samples were snap frozen by liquid N2 and homogenized using mortar and 
pestle. 100mg of homogenized samples were transferred to a 1.5ml Eppendrof tube 
and 1ml of ice cold 80% methanol was added immediately. This was followed by 
centrifugation at 4°C, 13,500 rpm for 30 min. Supernatants were transferred to a new 
Eppendrof tube and centrifuged at maximum speed at 4°C for 10 min. Supernatants 
were collected and were used to analyze through mass spectrometry. 
 
3.15.2 Ultra high performance liquid chromatography 
Agilent 1290 UHPLC system was used for the separation of metabolites through 
chromatography. Zorbox eclipse plus C18 column with particle size 1.8 µm and 
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dimensions of 10cm length and 2.1cm diameter was used in-line with UHPLC to 
perform metabolite separation based their hydrophobicity. Acetonitrile (buffer B) and 
water (buffer A) were acidified by adding 0.1% formic acid in and used as organic 
and aqueous buffer, respectively. To achieve separation of metabolites based on their 
chemical properties, a linear gradient was established across column for 18 min with a 
flow rate of 300µl/min. The column was subjected to 10% of buffer B for 0.5 min 
followed by a linear gradient to reach to 100% buffer B at 12
th
 min, was maintained at 
100% buffer B till 15
th
 min followed by 10% buffer B at 15.1 min and was maintained 
till 18
th
 min of run. Column was maintained at 50ºC and 6µl as injection volume. 
Each run was followed by washing of the column for 5 min using 50% buffer B at 
0.4ml/min flow rate. 
 
3.15.3 Electrospray Ionization Mass Spectrometry 
Untargeted Mass Profiling was performed by Agilent quadruple time of flight mass 
spectrometry (Agilent Q-ToF 6540) using ESI probe in positive mode of ionization. 
UHPLC system with column was in-line with mass spectrometry, and sample run 
time was 18 min. Drying gas temperature was set at 350ºC with 10L/min (nitrogen) 
flow rate, sheath gas temperature was set at 400ºC with 12L/min flow rate and 
capillary voltage was set at 4000V. Data acquisition was performed in centroide mode 
for MS scan with acquisition rate of 4 spectra/s with mass range set to 50-1200 m/z. 
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3.15.4 Metabolite data analysis 
Metabolic profile data was acquired in “.d” format using Data Acquisition software. 
Mass Hunter software was used to de-convolute the raw data and data was extracted 
based on their mass spectral and chromatographic characteristics, a process called as 
Molecular Feature Extraction (MFE). Any feature (m/z) with a signal value of less 
than 500cps was considered as noise and deleted from any analysis. Metabolite 
features with single positive charge with +H, +Na and +K adducts allowed were 
considered for data extraction and further analysis. Extracted data were then subjected 
to statistical analysis using Mass Profile Professional software from Agilent. Mass 
alignment was performed with 2mDa±15ppm window and RT correction was 
performed with 2mDa±15ppm as parameter. Samples were grouped based on the 
treatment or mutant groups with allowing only those metabolite features which were 
present in at-least 75% of a particular group. Aligned metabolic data with p value 
<0.05 and fold change 2 w.r.t control were selected for interpretation. 
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RESULTS AND DISCUSSION 
 
Data presented in this Chapter are on gene expression and metabolic state of gain- and 
loss-of-function transgenic lines and associated phenotypes. First, results are 
presented from gain-of-function transgenic lines that express a bacterial quercetin 
oxidoreductase (QuoA) encoding gene, which could induce perturbation in 
phenylpropanoid metabolic network (Section 4.1). These lines were characterized for 
their lignin and anthocyanin related phenotypes, metabolites and gene expression 
levels. Second, in order to ascertain the observed phenotype and metabolic properties 
of QuoA transgenic lines were not due to QuoA activity on unspecific substrate, 
metabolic profiling of loss-of-function tt mutant lines was performed and compared 
with QuoA transgenic lines (Section 4.2). Among selected mutant lines, tt6 and ttg1 
mutant lines were identified to have metabolic phenocopy of QuoA transgenic line. 
Next, metabolic profiling of double mutants of tt6, and ttg1 with tt3, tt4 and tt5 
mutant lines were performed and analysed to identify TTG1 as important for co-
ordinated perturbation of phenylpropanoid metabolic network with distant pathways 
such as brassinosteroids and carotenoids biosynthesis pathways (Section 4.2). In the 
last part of this study, inducible over-expression lines of TTG1 were used to further 
understand the role of transcriptional factor TTG1 and TT8, and to identify their 
direct targets (Section 4.3). Taken together, combination of non-targeted metabolic 
profiling and gene expression analysis of genetically perturbed lines was used to 
understand relationships between the branches of phenylpropanoid pathways and its 
association with other metabolic networks. All Sections start with a brief introduction 
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and background, followed by results and discussion. All figures for subsections are 
included at their end. 
 
4.1 Properties of phenylpropanoid metabolic network revealed by comparing 
QuoA high, moderate and low expression transgenic lines and loss-of-function 
tt6 mutant line 
We previously reported a Pseudomonas putida strain PML2 capable of utilizing 
quercetin as a sole carbon source for growth and elucidated its catabolic pathway for 
quercetin degradation using a comparative metabolomics approach (Pillai and 
Swarup, 2002). The corresponding gene has been designated as QuoA. Since, 
phenylpropanoid biosynthesis in plants involve formation of quercetin from 
naringenin, we envisaged that QuoA expression in plants will provide us with a 
genetic tool to “reverse” this biosynthetic step using gain-of-function approach (Fig 
4.1) and enable us to monitor the perturbational effects in metabolic networks. In 
previous study we created gain-of-function QuoA transgenic lines in Arabidopsis. 
Sixteen independent QuoA gain-of-function transgenic lines were characterized using 
gene expression and metabolite profiling approaches. Non-targeted metabolic 
profiling of QuoA transgenic lines revealed several metabolic channels within the 
phenylpropanoid pathway. QuoA-mediated perturbation in phenylpropanoid 
metabolic network resulted in widespread changes in metabolic channelling within the 
phenylpropanoid network. From screening of sixteen independent QuoA transgenic 
lines (Reuben, 2008), namely Q10, Q2 and Q11, were further characterized based on 
their high, moderate and low expression and activity of QuoA, respectively. QuoA 
activity was observed to be consistent with its expression levels in these three 
transgenic lines in converting quercetin to naringenin. Selected three transgenic lines 
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based on different levels of QuoA activity were, considered respectively, to have three 




Fig 4.1 Phenylpropanoid metabolic network. A bacterial oxidoreductase QuoA that 
converts quercetin to naringenin was introduced in Arabidopsis to perturb 
phenylpropanoid network. Enzyme names are mentioned in Fig 2.1. Here, bold 
arrows refer to direct gene to substrate and product relationship while dotted arrows 
refer to additional metabolic reactions in between which have not been shown here. 
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(Adapted from Petroni et al., 2011) Abbreviations for genes have been shown in Fig 
2.1. 
 
4.1.1 QuoA expression results in increased coloration of hypocotyls and stem 
stiffness  
In the Arabidopsis flavonoid pathway, naringenin is converted to quercetin via the 
intermediate dihydrokaempferol by flavanone-3-hydroxylase (F3H) encoded by tt6. 
Since this affected step is at the junction of upper and lower phenylpropanoid 
pathways, we reasoned that the perturbation could possibly have to change in both 
directions. Lower phenylpropanoid pathway leads to anthocyanin production, which 
gives a characteristic color to various plant parts. Indeed, QuoA transgenic seedlings 
had distinct purple coloration in their hypocotyls (Fig. 4.2A), which indicated 
anthocyanin accumulation. Transgenic lines, Q10 and Q2, showed high and moderate 
levels of anthocyanin accumulation in the hypocotyl region, respectively, while Q11 
had similar level of anthocyanins as compared to Col-0. Levels of extracted 
anthocyanins in Q10 were more than double, while Q2 had 70% higher anthocyanin 
than that in Col-0 (Fig. 4.2B). Hence, anthocyanin levels paralleled those of QuoA 
gene expression and enzymatic activity levels, respectively. As expected, the F3H 
mutant line tt6 had no observable coloration (Fig. 4.2A).  
 
Having described hypocotyls coloration as an indicator of perturbation in the lower 
phenylpropanoid pathways, we investigated phenotypic indicators of the upper 
phenylpropanoid pathway. As F3H is involved in the formation of dihydrokaempferol 
from naringenin, which leads to formation of quercetin in biosynthetic pathways, we 
used F3H mutant line tt6 to compare perturbation with QuoA expression lines. We 
focused on effects on lignin pathway based on two reasons. In the upper 
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phenylpropanoid pathway, lignin branch originates very closely from the point of 
perturbation by QuoA and second, that previous reports (Besseau et al., 2007; 
Vantrolime et al., 2008; Li et al., 2010) have established close relationship between 
flavonoid and lignin pathways. While Arabidopsis is not a woody plant, its 
lignification affects stiffness of stem internodes (Zhong et al., 2000, Allen et al., 
2009). We, therefore, tested mechanical strength of stems of the three transgenic and 
four control lines using mechanical tester (Fig 4.3A). Young’s modulus of stem 
internodal segments, which represents stiffness of the stem, was calculated. Tensile 
strength was significantly affected in the transgenic lines and the trend was in the 
following order, Q10>Q2>Col-0>Q11>Ler>tt6>ref8 (Fig. 4.3B). As expected, HCT 
mutant ref8, which has highly reduced lignin metabolites also had lowest tensile 
strength (Franke et al., 2002). The tensile strength of the three transgenic lines 
followed the same order as QuoA expression and enzymatic activity. In order to 
confirm that increase in stiffness is due to lignin accumulation, we stained internodal 
sections using phloroglucinol-HCl for lignin in the high expression line Q10. The 
lignin staining area is visibly larger in Q10 compared to the wild type (Fig. 4.4). 
 
As QuoA acts at the flavonoid pathway step involving F3H (Fig 4.1), we used F3H 
mutant line, tt6 to compare its effect with QuoA transgenic lines. Metabolic 
perturbations due to expression of QuoA in gain-of-function transgenic lines were 
expected to be in both upper and lower phenylpropanoid pathways. In comparison to 
QuoA lines which allow metabolic channelling in both upper and lower 
phenylpropanoid pathways, metabolic mutant tt6 is expected to block lower pathway, 
resulting in effects only in upper pathway perturbation. As expected, stiffness of tt6 
stems was significantly lower while lignin staining area was smaller than Ler (Fig. 4.3 
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and 4.4). In order to identify which branched pathways could account for increased 
lignin in QuoA transgenic lines compared to tt6, we next quantified intermediate 







Fig 4.2 Accumulation of anthocyanin levels in QuoA transgenic lines. A, QuoA 
transgenic seedlings showing accumulation of anthocyanins, tt6 mutant was used as 
negative control. B, Absorbance values of the anthocyanin extracts at 530nm. 
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absorbance measured at 530nm. Col-0 and tt6 seedling are shown as controls. All 







Fig 4.3 Stem stiffness increased in QuoA transgenic transgenic lines. A, Schematic 
diagram of tensile tester used to measure stem tensile strength. B, Measurement of 
Young’s Modulus of 35 day old stems of transgenic lines. Plants (n=9) were subjected 
to displacement speed of 0.5mm/min till the stem reached their break point in a tensile 
tester. Maximum load and extension at breaking point was measured and modulus 
calculated as stress over strain in MPa. Standard error of mean is based on nine 
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Fig 4.4 Lignin accumulation increased in QuoA transgenic lines. Phluoroglucinol 
staining of lignin in stem cross-sections of wild type Columbia and Landsberg (Col-0; 
Ler), QuoA transgenics (Q10) and tt6 mutant. Infloresence stems from 5-week-old 
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All images were taken at 80x magnification under a dissection microscope with bright 




4.1.2 QuoA perturbation leads to increase in lignin and anthocyanin levels and 
decrease in levels of phenolamide intermediates  
Metabolite levels from phenylpropanoid, phenolamide and lignin pathways were 
quantified in the three QuoA transgenic lines Q2, Q10 and Q11. Steady-state levels of 
quercetin were reduced by 1.5- to 2-folds and naringenin levels were increased by 4- 
to 7-folds in transgenic lines compared to wild type. These results can be explained by 
the QuoA activity that contributed towards naringenin pools at the expense of 
quercetin as substrate. As described in the previous section, increased hypocotyl 
coloration and anthocyanin accumulation of QuoA transgenic lines shows that 
metabolites from lower phenylpropanoid pathways increased in all transgenic lines. 
Hence, the levels of metabolites from both upper and lower pathways from the point 
of perturbation were significantly affected. Levels of cyanidin and leucopelargonidin 
increased 4- to 9-folds in the transgenic lines (Fig. 4.5), with highest level of change 
in Q10 compared to other transgenic lines, which is consistent with anthocyanin 
accumulation estimated in transgenic lines (Fig. 4.2B). 
 
Among the four metabolites from the upper phenylpropanoid pathway, only 4-
coumaroyl-CoA showed 1.6-fold significant increase (p<0.001) in transgenic lines 
when compared to Col-0. As the upper phenylpropanoid pathway is connected to 
lignin biosynthetic pathway via 4-coumaroyl-CoA, we tested perturbational effects in 
lignins. End-products and many intermediates of lignin metabolic pathways showed 
increased accumulation. Caffeoyl shikimate, coniferyl aldehyde, ferulate, 5-hydroxy 
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ferulic acid and end-product coniferin showed 4- to 10-folds accumulations in the 
transgenic lines with Q10 showing highest accumulation compared to other transgenic 
lines (Fig. 4.6). Highest change was that of coumaroyl alcohol with increase of 2- to 
11-folds. We next investigated possible pathways connected to lignins that could have 
been down-regulated leading to increase in level of lignins. We, therefore, tested 
intermediates of recently described phenolamide pathway, which is linked to lignins 
at multiple branch-points (Matsuno et al., 2009). Interestingly, all the metabolites of 
the phenolamide pathway except tri-coumaroyl spermidine were present at lower 
levels compared to those in WT (Fig. 4.7). Spermidine levels showed the most 
decrease by 64-fold in comparison to WT. 
 
As expected, the endogenous mutant tt6 showed absence of anthocyanins due to block 
in lower phenylpropanoid pathways (Fig. 4.1 and 4.2). Cyanidin and 
leucopelargonidin were also not detected in tt6 mutant line. The tt6 mutant line had 
increase in naringenin level by 1.3-fold (p<0.001) (Fig. 4.5). Metabolic changes in the 
lignin pathway were not as high as in the gain-of-function lines, although same trend 
of increased metabolite levels was observed (Fig. 4.6). Ferulate and coniferin levels, 
for example, were increased by 3- to 4-folds in tt6. Several lignin metabolites such as 
coumaroyl alcohol, coumaraldehyde and sinapyl alcohol showed 1.3- to 2-fold 
increase in concentration when compared to Ler. In tt6, levels of phenolamide 
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Fig 4.5 Quantification of metabolites from flavonoid metabolic pathways using 
multiple reaction monitoring (MRM) approach. Metabolites which showed 
differential levels with respect to control were quantified. QuoA transgenic lines were 
in Col-0 background, while tt6 was in Ler background. Comparisons of QuoA and tt6 
lines were done with their respective wild type lines. Pure standards or Mass bank 
database (http://www.massbank.jp/index.html?lang=en) was used to select daughter 
ions for multiple ion monitoring. Standard error of mean is based on three biological 
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Fig 4.6 Quantification of metabolites from lignin metabolic pathways using 
multiple reaction monitoring (MRM) approach. Metabolites which showed 
differential levels with respect to control were quantified. QuoA transgenic lines were 
in Col-0 background while tt6 was in Ler background. Metabolites from lignin 
metabolic pathways were all up-regulated in QuoA transgenic lines while moderately 
up-regulated in tt6 mutant line. Pure standards or Mass bank database 
(http://www.massbank.jp/index.html?lang=en) was used to select daughter ions for 
multiple ion monitoring. Standard error of mean is based on three biological replicates 
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Fig 4.7 Multiple reaction monitoring (MRM) of metabolites from phenolamide 
metabolic pathways. Differential metabolites from phenolamide metabolic pathways 
were quantified. QuoA transgenic lines were in Col-0 background while tt6 was in Ler 
background. Pure standards or Mass bank database 
(http://www.massbank.jp/index.html?lang=en) was used to select daughter ions for 
multiple ion monitoring. Standard error of mean is based on three biological replicates 
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4.1.3 Metabolic perturbation by QuoA leads to changes in expression of 
biosynthetic genes 
Since metabolite levels for multiple pathways were co-ordinately affected, we 
investigated whether some of these resulted from gene expression change or could be 
explained solely due to changes in metabolic channelling. We systematically 
compared the RNA levels for (eleven) genes associated with each step in the 
flavonoid and anthocyanin biosynthetic pathways and for key (six) genes in the lignin 
pathway. Expression levels of five genes, namely cinnamate-4-hydroxylase (C4H) 
and flavonol synthase (FLS) genes in the flavonoid pathway, a cytochrome 450 
(CYP98A8) from phenolamide pathway, and cinnamoyl-CoA reductase (CCR) and 
flavonol 3’-o-methyltransferase (OMT), genes of the lignin pathway, showed 
differential expression in QuoA lines compared to Col-0 levels (Fig. 4.8A). In tt6 
mutant line, C4H did not show any expression change but chalcone synthase (CHS) 
showed ~16-fold increase in expression (Fig. 4.8B). There was no change in 
expression levels of PAL, 4-coumarate ligase (4CL), chalcone isomerase (CHI), CHS, 
dihydroflavonol-4-reductase (DFR), flavanone-3-hydroxylase (F3H), flavanoid-3’-
monooxygenase (F’3H) leucoanthocyanidin dioxygenase (LDOX) and banyuls (BAN) 
genes in transgenic plants. In the lignin pathway, CCR and OMT showed differential 
expression (Fig. 4.8B). Decrease in RNA levels of flavonol synthase (FLS), CCR1 
and OMT1 showed corresponding changes in the metabolite levels in the transgenics. 
Significant change of 21-fold difference in expression was observed for CYP98A8, a 
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Fig 4.8 RNA levels of selected biosynthetic genes in 5-week-old QuoA transgenic 
lines and tt6 mutant. A, RNA levels of biosynthetic genes in QuoA transgenic plants 
B, RNA levels of biosynthetic genes in tt6 mutant.  Real‐time quantitative PCR was 
performed and Ct values normalized using tubulin as control. Fold changes were 
calculated based on Ct method. C4H: cinnamate hydroxylase FLS: Flavonol 
synthase, CYP98A8: Phenolamide pathway gene, CCR: cinnamoyl‐CoA reductase, 
OMT: Flavonol 3’‐o-methyltransferase. Standard error of mean is based on three 
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The overall nature of the metabolites, enzyme activity and transgene expression data 
in this study provide support that the perturbational effects in the transgenic lines 
result from QuoA expression and are specific in their nature in response to these 
perturbations. Three transgenic lines selected with low, medium and high levels of 
QuoA expression resulted in corresponding low, medium and high levels of QuoA 
enzyme activity, hypocotyl coloration due to anthocyanin accumulation and stem 
stiffness due to lignin accumulation, respectively. The overall QuoA perturbational 
effects observed are unlikely to be due to a general stress response. Several stress-
related metabolite markers, such as proline, glycine, betaine or sugar alcohols (Wang 
et al., 2003), were not affected in QuoA lines (data not shown). 
 
Perturbations in the phenylpropanoid network by the expression of bacterial QuoA 
allowed us to gain insights into the relationships between branched pathways. With 
the exception of F5H (Hang et al., 2009), reduction in the expression of at least 12 
lignin biosynthetic genes in its loss-of-function mutants , leads to decrease in lignin 
content and increase in various flavonoid metabolites (Besseau et al., 2007; Li et al., 
2008; Hoffmann et al., 2004; Vantrolime et al., 2008; Li et al., 2010). Lack of an 
increase in lignins in F3H mutant line tt6 in this study is also consistent with the 
previous report. In contrast, there is very little known about the reciprocal effects of 
direct perturbation of flavonoid pathway on the lignin pathway branch. Simultaneous 
increase in both anthocyanin and lignins by QuoA mediated perturbation clearly 
establishes the reciprocal effects of flavonoids perturbation on the lignin pathway. 
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This effect on lignins is also biologically relevant as shown by the increased stem 
stiffness of QuoA transgenic lines.  
 
One possible explanation of the difference in the perturbational effects between the 
gain-of-function and loss-of-function approaches here is that intact flavonoid enzyme 
complexes (Burbulis et al., 1999, Saslowsky et al., 2001, Conrado et al., 2008) are 
required for increased channelling of metabolites from flavonoid to lignin pathways. 
This possibility generates a testable hypothesis that some of the key enzymes of the 
lignin pathways are part of the flavonoid metabolic complexes. It is quite likely that 
change in metabolic channelling profile and increase in lignification have resulted 
from the QuoA gain-of-function approach. Phenolamide pathway, on the other hand, 
seems to be the likely candidate for increased channelling to lignin pathway in 
response to perturbation in flavonoid pathways. The low, medium and high 
expression lines of QuoA showed a corresponding effect on the overall reduction of 
the seven intermediates from the phenolamide pathway. The only exception was tri-
coumaroyl spermidine, which is associated with the first step in the phenylpropanoid 
pathways (Fig 4.9). F3H mutant tt6, which has no increase in lignification, also does 
not have any perturbational effect on the phenolamide pathway. Lignin up-regulation 
from QuoA perturbation, therefore, seems to occur at the expense of phenolamide 
pathway intermediates. Our study, therefore, suggests a strong relationship between 
lignin and phenolamide pathways and opens-up an additional approach to manipulate 
lignification and stem stiffness characteristics, especially of herbaceous plants.  
 
It is intriguing that QuoA-mediated perturbation led to up-regulation of both lignin 
and anthocyanin pathways, while flavonoid upper pathway intermediates were 
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unaffected. So, this raises the question, which pathway contributes towards 
simultaneous up-regulation of the above pathways? There are no input pathways 
below the perturbed step in the flavonoid pathway. Hence, increase of the 
anthocyanins can only be explained by increased channelling from the flavonoid 
pathways. In the case of lignin pathway, three other input pathways are likely 
contributors towards its increased channelling. These are upper flavonoid pathways, 
malonyl-CoA from Krebs cycle and phenolamide pathway. Contributions by the first 
two pathways cannot explain increased channelling to lignin pathway. In both cases, 
their respective metabolites levels were unaffected by QuoA-induced perturbation. 
The only exception was tri-coumaroyl spermidine from phenylpropanoid pathway.  
 
Our data strongly suggest that perturbation of metabolite levels is associated with a 
specific perturbation of gene expression level at the branch points. A complete survey 
of all genes from these four pathways revealed changes in expression of five genes, all 
of which are associated with branch points. In each case, the associated products 
encoded by these genes were also perturbed. The direction of these changes were 
similar in all cases, while all branch point genes were down-regulated, the products of 
these reactions were up-regulated.  
 
Several studies have established that the first two steps of flavonoid pathway are 
under feedback control of metabolites (Peltier et al., 1999; Peer et al., 2001; Morreel 
et al., 2006; Marinova et al., 2007). More recently, flavonoid glycosylation has been 
shown to affect PAL expression levels (Yin et al., 2012). However, this metabolite to 
gene expression regulation seems to be more widespread in the overall 
phenylpropanoid network. The mechanism of control of the gene-metabolites pair at 
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the branch points cannot be ascertained. Both possibilities remain open that either 
there is coordinated control of gene-metabolite pairs via common mechanism or that 
there are local regulatory controls at each branch point arising from the common 
primary perturbational effect. It will be interesting to investigate the regulatory 
mechanisms at such branch-points in the metabolic networks. 
 
Fig 4.9 Summary of perturbational effect metabolite and gene expression 
perturbation resulting from QuoA expression. The metabolites that showed over-
accumulation and genes that were over-expressed in QuoA transgenic plant Q10 are 
indicated in red while those that are down-regulated are shown in green respectively. 
The coloured arrows indicate the target genes of the regulators that showed 
differential expression in this study. Index for regulators is shown in the inset box. 
Point of perturbation is boxed in light orange. Only metabolic pathways belonging to 
Arabidopsis are shown (based on TAIR www.arabidopsis.org; Matsuno et al., 2009, 
Umezawa, 2009). PAL: Phenylalanine ammonia lyase, C4H: Cinnamate 4-
hydroxylase, 4CL: 4-coumaroyl-coenzyme A ligase, CHS: Chalcone synthase, CHI: 
Chalcone-flavanone isomerase; F3H: Flavanone 3-hydroxylase, F3’H: Flavonoid 
3’monooxygenase DFR: Dihydroflavonol 4-reductase, FLS: Flavonol synthase, LAR: 
Leucoanthocyanidin reductase, LDOX: Leucoanthocyanidin dioxygenase, BAN: 
Banyuls, ANR: Anthocyanidin reductase, ANS: Anthocyanidin synthase, FGT: 
Flavonoid glycosyl transferases, C3H: Coumarate-3-hydroxylase, F5H: Ferulate-5-
hydroxylase, CCR1: Cinnamoyl-CoA reductase 1, OMT1: Flavonol 3’-o-
methyltransferase, SGT: Sinapate-1-glucosyltransferase, SNG1: 
Sinapoylglucose:malate sinapoyltransferase, HCT: Hydroxycinnamoyl-CoA 
shikimate/quinate hydroxycinnamoyl transferase, CAD: Cinnamyl alcohol 
dehydrogenase, CCoAOMT: Caffeoyl CoA o-methyltransferase, UDP-GT: UDP 
glucose transferase, SHT: Spermidine hydroxycinnamoyl transferase, bHLH: basic 
Helix-Loop-Helix, WDR: WD-repeat protein with WRKY domains, TT: transparent 
testa, TTG1: Transparent testa glabra 1. The fold changes are represented as >2 Red; < 
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4.2 Comparative analysis of metabolic profiles of (ten) tt mutants with Q10 
revealed tt6 and ttg1 mutant lines as its biochemical phenocopy 
Preliminary characterization of (sixteen) independent QuoA transgenic lines showed 
several metabolic pathways to be perturbed in response to perturbation in 
phenylpropanoid metabolic network (Reuben, 2008). All transgenic lines were shown 
to have metabolic perturbation in pathways such as brassinosteroids, carotenoids, 
plant steroids, nucleotides biosynthesis pathways, which are parts of isoprenoid 
metabolic network. RNA levels of several biosynthetic genes from these pathways 
were also differentially expressed in QuoA transgenic lines. This suggested a possible 
crosstalk between phenylpropanoid and isoprenoid metabolic networks, which was 
maximum at young seedling stage and were diluted at later developmental stages of 
Arabidopsis.  
 
Among QuoA transgenic lines, maximum effect of phenylpropanoid metabolic 
perturbation was observed in the isoprenoid network in Q10 transgenic line, which is 
also high expression line of QuoA transgene. We investigated whether perturbation of 
these seemingly distant pathways were specific to QuoA or were also associated with 
loss-of-function of different phenylpropanoid genes. For this reason, we selected ten 
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4.2.1 Loss-of-function mutant lines tt6 and ttg1 have similar metabolic profiles as 
that of Q10 
Perturbation in different branches of isoprenoid metabolic network in response to 
perturbation created in phenylpropanoid metabolic network in QuoA transgenic lines 
led us to ask if this is specific to QuoA activity or due to native pathways being co-
ordinately regulated with phenylpropanoid metabolic network. To address this 
question, tt mutant lines tt1, tt2, tt3, tt4, tt5, tt6, tt7, tt8, tt8 (3), tt9, tt10 and ttg1 were 
profiled for their metabolites. These tt mutants were selected based on loss-of-
function of structural genes and transcription factors at different points of lower 
phenylpropanoid metabolic network. Among those selected transparent testa mutant 
lines, tt3, tt4, tt5, tt6, tt7, tt9 and tt10 are loss-of-function mutant of biosynthetic genes 
of phenylpropanoid metabolic network while tt1, tt2, tt8, tt8(3) and ttg1 are loss-of-
function mutants of transcription factors. Differential metabolites with p-value of 0.05 
and fold-change of 2 were then compared across transparent testa differentially 
expressed metabolites.  
 
Hierarchical clustering of tt mutant lines based on metabolic profiling showed 
formation of three groups (Fig 4.10A). First group (cluster 1) constituted by tt2, tt8, 
tt8 (3), Ler and Ws, second group (cluster 2) with tt1, tt3, tt7 and tt10  and third group 
(cluster 3) with tt4, tt5, tt6, tt9 and ttg1 mutants lines with ttg1 and tt6 clustered 
together (Fig 4.10A).  Cluster 1 represents transcription factors mutant lines,  tt8, tt2 
and tt8 (3) which are loss-of-function mutants of TT2 and TT8. Both TT2 and TT8 
have been shown to interact and form protein complex to regulate expression of BAN 
and DFR, biosynthetic genes from lower phenylpropanoid metabolic network (Baudry 
et al., 2004). Cluster 2 consisted of tt1, tt3, tt7 and tt10, all of which are associated 
Results and discussion 
 
Page | 91  
 
with lower phenylpropanoid metabolic network. Except tt1, all are loss-of-function 
mutants of biosynthetic genes. Cluster 3 consisted of tt4, tt5, tt6, tt9 and ttg1, all of 
which except ttg1 are loss-of-function mutants at the junction of upper and lower 
phenylpropanoid metabolic networks. PCA plot based on metabolic profiling of tt 
mutant lines showed similar pattern with ttg1 and tt6 clustering together while 
transcription factors and structural genes formed separate clusters (Fig 4.10B). 
 
Comparison of differential metabolites common between Q10 and tt mutant lines was 
done to test if there is any similarity between metabolic profile of Q10 resulting from 
QuoA activity and loss-of-function of native genes in Arabidopsis. Differential 
metabolites between Q10 and tt mutant with p-value 0.05 and fold-change 2 were 
selected. Fold change values of common metabolites of tt mutant lines were 
subtracted from the fold change values of corresponding metabolites in Q10. These 
values were then plotted as a box plot (Fig 4.11). Transgenic lines with maximum 
similarity in perturbational pattern with Q10 were closer to the central line or 0 
values, sharing higher similarity in metabolic perturbation behavior, while those 
transgenic lines with least similarity were far away from central lines. Among all tt 
loss-of-function transgenic lines, two tt mutants - tt6, loss-of-function of F3H, and 
ttg1, loss-of-function mutant of transcription factor TTG1, were shown to have 
similar biochemical phenotype as of Q10.  
 
As shown earlier, perturbation in phenylpropanoid metabolic network due to loss of 
F3H and due to QuoA activity results in accumulation of same metabolite naringenin 
(Fig 4.5), which is restricted to upper phenylpropanoid metabolic network in case of 
tt6, while may be channelled to both upper and lower pathways in Q10. Hence, 
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similarity of tt6 metabolic profile was corroborated with the results of immediate 
effects of QuoA mediated perturbation in Q10 transgenic lines. Showing similar 
metabolic perturbational behavior of ttg1 mutant line as that of tt6 and Q10 was a 
novel finding, since the point of perturbation was different than that of tt6 and Q10. 
Differential metabolites of tt6 were mapped on biosynthetic pathways which were 
mainly from carotenoids, brassinosteroids, steroids, phenylpropanoid and nucleotide 
synthesis pathway (Fig 4.12), similar to ttg1 showing same pattern of perturbation in 
isoprenoid metabolic network.  
 
In order to investigate possible causes of coordinate changes in multiple pathways, we 
tested RNA level changes of genes involved in phenylpropanoid and then selected 
pathways. RNA levels of TTG1, TT8 and F3H were tested in Q10, tt6, tt8 and ttg1 
transgenic lines. RNA levels of TTG1 and TT8 were down regulated in all the four 
transgenic lines (Fig 4.13). With the exception of tt8 mutant lines, F3H was shown to 
be down regulated in other three transgenic lines. Down regulation of TT8 and TTG1 
in all the four transgenic lines were consistent with the fact that these two proteins 
form a complex that co-ordinately regulates biosynthetic genes. However, down 
regulation of F3H in Q10 and ttg1 transgenic line was not expected since TTG1 does 
not regulate expression of F3H. Results thus established that perturbation in 
isoprenoid metabolic network in response to perturbation in phenylpropanoid 
metabolic network was not specific to QuoA activity, but loss-of-function mutants of 
native genes, F3H and TTG1 also showed similar perturbational pattern. Since other 
mutants of phenylpropanoid metabolic network did not show perturbation in 
isoprenoid network, this suggested existence of unique properties of metabolic 
network in ttg1 and tt6 loss-of-function mutant. 
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Fig 4.10 Hierarchical clustering (A) and 2D-PCA plot (B) of metabolic 
profile of tt mutant lines. Metabolites were extracted from 6-day-old seedlings 
and untargeted metabolic profiling of four biological replicate of mutant lines 
were performed, and each metabolic extract was injected 3 times to serve as 
technical replicate. Differential metabolites from all tt mutant lines were filtered 
with p-value 0.05 and fold-change 2. Experiments were repeated for two times. 
Both plots showed tt6 and ttg1 grouped together. Colour codes for hierarchical 
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Fig 4.11 Box plot showing similarities between different phenylpropanoid 
mutants with that of QuoA transgenics. The differential metabolites were first 
determined in tt mutants. Those metabolites that were common in the mutants and 
Q10 were then selected. The fold change for these metabolites in tt mutants w.r.t to 
Q10 has been plotted in this figure. This shows the similarity between transgenics and 
tt mutants both in the type of metabolites and in the accumulation levels (based on 
fold change). The top and bottom blue edges in each rectangular box are the 25th and 
75th percentiles of the fold change values, respectively. The distances between the top 
and bottom edges represent the inter-quartile range for the data. The black horizontal 
line in the middle of each box is the sample median.  If the median is not centred in 
the box, it shows sample skewness. Whiskers are drawn from the ends of the 
interquartile ranges to the furthest observations within the whisker length (the 
adjacent values). Observations beyond the whisker length are marked as outliers (red 
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Fig 4.12 Differential metabolites of tt6 w.r.t Ler were mainly associated to 
phenylpropanoid and isoprenoid metabolic network. Metabolites with +/- 2 
fold changes and p-value 0.05 were used to perform further analysis and 
mapping on metabolic pathways. As shown in this figure, most of the 
differential metabolites of fold-change +/- 5 were from phenylpropanoid and 
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Fig 4.13 RNA levels of F3H, TTG1 and TT8 in 6 day old seedlings in Q10, tt6, tt8 
and ttg1 transgenic line. RNA levels of F3H, TTG1 and TT8 were measured in Q10, 
tt6, ttg1 and tt8 mutant lines by real‐time quantitative PCR. Ct values were 
normalized using tubulin as control. Fold changes were calculated based on Ct 
method. Standard error of mean is based on three biological replications and 
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4.2.2 TTG1 loss-of-function in tt3, tt4 and tt5 single mutants caused perturbation 
in isoprenoid metabolic network 
Among selected tt mutants, F3H and TTG1 loss-of-function mutant lines showed 
perturbed isoprenoid metabolic network in response to perturbation in 
phenylpropanoid metabolic network. Metabolic perturbation was similar to Q10 
transgenic line, which also showed down-regulation of RNA levels of F3H and TTG1. 
To address the question if F3H or TTG1 loss-of-function caused perturbation in 
isoprenoid metabolic network, we performed metabolic profiling of single mutants 
tt3, tt4, tt5 and their double mutants with ttg1 or tt6. We reasoned that since tt3, tt4 
and tt5 did not have perturbation in isoprenoid metabolic network, if their double 
mutant with ttg1 or tt6 introduces perturbation in isoprenoid metabolic network, we 
may conclude TTG1 or F3H loss of function as being required to bring this change. 
Metabolites were extracted from 6-day-old seedlings of tt3, tt4, tt5, tt3-ttg1, tt3-tt6, 
tt4-ttg1, tt4-tt6, tt5-ttg1, tt5-tt6 and tt6-ttg1 mutant lines. Non-targeted metabolic 
profiling was performed. Hierarchical clustering and heat map of single and double 
mutants based on their metabolic profiling showed formation of two major clusters 
(Fig 4.14). First cluster consisted of tt3-ttg1, tt6-ttg1, tt4-ttg1 and tt5-ttg1. Second 
cluster had further four sub-clusters, tt6 and ttg1 was clustered together forming first 
group, Wt, tt5, tt6-tt5, tt6-tt3 and tt6-tt4 being the second group while tt3 and tt4 were 
represented by individual groups. As expected, ttg1 and tt6 were clustered together 
thus strengthening earlier observation of similar metabolic profile. Hierarchical 
clustering of single and double mutants showed the dominance of TTG1 in 
determining the metabolic perturbation behavior (Fig 4.14). ttg1 double mutants with 
tt3, tt4, tt5 and tt6 formed a single cluster which was further closer to ttg1 and tt6. 
This was not the case with tt6, for instance, tt6 and tt5-tt6 were clustered together 
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suggesting the dominance of tt5 in determining the metabolic profile pattern. tt6 
double mutants with tt3 and tt4 were clustered together along with tt3 and tt4. 2D 
PCA plot based on metabolic profiling of these loss-of-function single and double 
mutant lines also showed similar trend as observed by hierarchical clustering (Fig 
4.15). 2D PCA plot and hierarchical clustering thus conclusively suggests dominance 
of ttg1 in determining the metabolic profile of its double mutants with tt3, tt4, tt5 and 
tt6.  
 
In order to gain an insight into the effect of mutation of ttg1 and tt6 in tt3, tt4 and tt5 
single mutant lines, the differentially expressed metabolites of tt3, tt4 and tt5 single 
mutant were compared with their corresponding double mutants with ttg1 and tt6. As 
shown in Fig 4.16, effect of tt6 mutation in tt3, tt4 and tt5 single mutant was less 
severe than that of ttg1. For example, differential metabolites between ttg1-tt3 and tt3 
loss-of-function was 2231 as compared to only 644 differential metabolites between 
tt6-tt3 and tt3 loss-of-function (Fig 4.16). Similarly, other double mutants of ttg1 
showed more differential metabolites while double mutants of tt6 showed less 
differential metabolic ions. The result clearly suggests role of ttg1 in drastic change in 
metabolic profile of tt3, tt4 and tt5 single mutant as compared to tt6. Loss-of-function 
of TTG1 in tt3, tt4 and tt5 mutant lines showing more differential metabolites while 
fewer in case of F3H loss-of-function also suggests that transcriptional factor plays 
bigger role in regulating phenylpropanoid metabolic network than the metabolic 
channelling. 
 
We next looked for the pathways that were perturbed by introducing mutation of 
TTG1 or F3H in tt3, tt4, tt5 and tt6 mutant lines. List of differentially expressed 
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metabolites in ttg1 and tt6 double mutants (with tt3, tt4, tt5 and tt6) w.r.t single 
mutants tt3, tt4 and tt5 were fragmented and MS2 fragmentation pattern of daughter 
ions were matched to mass-bank (http://www.massbank.jp/index.html?lang=en)  
database to identified metabolites and those that were confirmed were mapped to 
respective metabolic pathways. Numbers of differential metabolites from a particular 
pathway were plotted in heat map to visualize metabolic pathways with number of 
differential metabolites in double mutant lines w.r.t single mutant lines. Double 
mutants of ttg1 showed higher number of differentially expressed metabolites related 
to isoprenoids and its branch pathways, while double mutants of tt6 showed fewer 
metabolites differentially expressed (Fig 4.17 and 4.18). Differential metabolites from 
ttg1 double mutants w.r.t single mutants were mainly from trans-zeatin biosynthetic 
pathway, phytate degradation I pathway, mevalonate pathway, cytokinin biosynthesis 
pathway and geranyl-diphosphate biosynthetic pathway. tt6 double mutants with tt3, 
tt4 and tt5 had fewer differential metabolites in isoprenoid metabolic network. Thus, 
comparing single and double mutant lines, we observed TTG1 loss-of-function 
resulting in perturbation of phenylpropanoid and isoprenoid metabolic network. These 
results suggested TTG1 as main factor associated with co-ordinated metabolic 
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Fig 4.14 Hierarchical clustering of metabolic profile of tt single and double 
mutants. Hierarchical clustering of differential metabolites w.r.t to Wt was performed 
based on euclidean distance matrix using ward’s linkage criterion. Normalized 
intensity values of metabolites were used for clustering. Metabolic profiling of 6-day-
old seedlings of double mutants were characteristic of either ttg1 or tt6 except the case 
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Fig 4.15 2D-PCA plot of metabolic profiling of single and double mutant line. 
Metabolites from 6 day old seedlings were extracted from single mutant lines tt3, tt4, 
tt5, tt6, ttg1 and double mutant lines tt3-tt6, tt3-ttg1, tt4-tt6, tt4-ttg1, tt5-tt6, tt5-ttg1 
and tt6-ttg1. Three groups emerged from PCA plot, group1 with ttg1, tt6-ttg1, ttg1-tt4 
and ttg1-tt3, group2 with ttg1-tt5, Wt, tt6-tt5 and tt6-tt3, and group3 being tt6-tt4 and 
tt5 while single mutants tt3, tt4 and tt6 were far apart from these groups with tt6 being 
closer to group1. It was expected for tt4 to be separated from these groups since lower 
phenylpropanoid metabolic pathway is completely blocked in it. Group1 is 
characterized by ttg1 single mutant and its double mutants with tt3, tt4 and tt6. Group 
2 and 3 were mainly tt6 double mutant with tt3, tt4 and tt5. PCA plot thus showed that 
metabolic profile of double mutant were similar to those characteristic of either ttg1 or 
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Fig 4.16 Comparison of differential metabolites between single and double 
mutant lines. Differential metabolites for single and double mutants filtered by p 
value <0.05 and fold-change >±2 w.r.t Wt were compared to identify effect of tt6 or 
ttg1 mutation on metabolic profile of single mutants tt3, tt4 and tt5. As evident from 
Venn diagram, double mutants with ttg1 showed more differential metabolites 
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Fig 4.17 Heat map representing number of differential metabolites from a 
particular metabolic pathway. Differential metabolites for single and double 
mutants filtered by p value <0.05 and fold-change >±2. Differential metabolites from 
ttg1 and tt6 double mutants w.r.t corresponding single mutants tt3, tt4, tt5 and tt6 
were identified by MS2 fragmentation and matching fragmentation pattern with mass-
bank database. Identified metabolites were then mapped to metabolic pathways, and 
number of metabolites differentially expressed from a particular metabolic pathways 
were visualized here as heat-map. 
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Fig 4.18 Heat map representing number of differential metabolites from a 
particular metabolic pathway. Differential metabolites for single and double 
mutants filtered by p value <0.05 and fold-change >±2. Differential metabolites from 
ttg1 and tt6 double mutants w.r.t corresponding single mutants tt3, tt4, tt5 and tt6 
were identified by MS2 fragmentation and matching fragmentation pattern with mass-
bank database. Identified metabolites were then mapped to metabolic pathways, and 
number of metabolites differentially expressed from a particular metabolic pathways 
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4.2.3 TT8 loss-of-function mutant lines had lower levels of glycosylated 
metabolites 
Metabolic profiling of tt mutant lines revealed a unique metabolic property of TT8 
loss-of-function mutant lines. Total spectra of Wt and tt8 mutant line were 
superimposed which showed Wt spectra consisting of metabolite ions of all mass 
range (50-1200), while tt8 mutant lines showed most of the metabolite ions from 
lower mass range (50-400) (Fig 4.19). This was interesting since none of the tt mutant 
lines other than tt8 showed such specific difference with Wt. One possibility of this 
behavior could be lowered conjugation processes in tt8 mutant lines. Different 
conjugation processes such as glycosylation, methylation, acylation and others results 
in synthesis of derived compounds from a small set of parent metabolites which are of 
higher masses and brings large metabolic diversity. To identify if lowered conjugation 
process was the main reason for low mass range metabolites in tt8 mutant lines and if 
that’s the case, then what types of conjugation processes were affected in tt8 mutant 
lines, differential metabolites from tt8 mutant line w.r.t Wt were identified. 
Differential metabolites were fragmented by MS2 and fragmentation patterns were 
matched with standards or mass-bank. Total of 159 metabolites were identified which 
then were mapped to their associated metabolic pathways.  
 
Metabolic pathways such as phenylpropanoid metabolic network, purine biosynthesis, 
pyrimidine biosynthesis, carotenoid biosynthesis, steroid biosynthesis pathways and 
nucleotide sugar metabolism and brassinosteroid biosynthesis pathways were affected 
in tt8 mutant lines (Fig 4.21). Phenylpropanoid metabolic pathway was significantly 
affected in tt8 mutant line, showing highest number of differential metabolites among 
all metabolic pathways affected. Interestingly, metabolites from phenylpropanoid 
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network, such quercetin, kaempferol, cyanidin, pelargonidine that undergo several 
types of sugar conjugation processes were affected in tt8 mutant lines, showing a 
specific glycosylation pattern for these aglycones. Glycosylated form of quercetin and 
cyanidin such as cyanidin-3,5-diglucoside, cyanidin-3-O-beta-D-glucoside, quercetin 
3,7-O-diglucoside, quercetin 3-O-rhamnoside-7-O-glucoside and quercetin-3-O-
glucoside-7-O-rhamnoside were down-regulated in tt8 mutant lines while that of 
kaempferol and pelargonidin such as kaempferol-7-O-glucoside, kaempferol-3-
glucoside and pelargonidin-3,5-diglucoside with exception of kaempferol 3,7-O-
diglucoside were up-regulated in tt8 mutant lines (Fig 4.20). Rhamnoside conjugated 
quercetin such as quercetin3,7-rhamnoside and quercetin 3-O-rhamnoside were up-
regulated in tt8 mutant lines while that with kaempferol such as kaempferol-3-
rhamnoside, kaempferol-3-O-gentiobioside-7-O-rhamnoside and kaempferol-3-
rhamnoside-7-rhamnoside were down-regulated in tt8 mutant lines (Table 4.1). 
Quercetin and kaempferol have been shown to compete for glycosylation process and 
our results showed that TT8 loss-of-function results in down-regulation of several of 
their derivatives with showing a specific pattern for glucosides and rhamnosides 
derivatives. Levels of aglycones such as quercetin and cyanidine were up-regulated in 
tt8 mutant line, consistent with earlier report which also showed increased quercetin 
levels in tt8 mutant line (Pelletier et al., 1999). Using HPLC based approach, Pelletier 
et al. 1999 suggested tt8 mutant to be impaired in glycosylation of quercetin, which 
was consistent with our study, and using high mass accuracy mass spectrometry, we 
identified several metabolites other than quercetin that were affected in glycosylation. 
Glycosylation of several nucleotides were also affected with different glycosylated 
forms of UDP such as UDP-arabinose, UDP-galactose, UDP-xylose, UDP-
glucuronate and UDP-apiose were down-regulated in tt8 mutant lines (Fig 4.20). 
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When all these observations are taken together, we can conclude that tt8 mutant line 
was affected in glycosylation where conjugation of sugar molecules to several 
metabolites were affected. Specificity in types of glycosylation affected suggested 
TT8 playing an important role in regulating glycosylation process. We created 
inducible over-expression and silencing transgenic lines for TT8 to identify direct 
targets of TT8 and to understand the mechanism through which TT8 regulates 
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Fig 4.19 Metabolic profiles of WS (Wt background for tt8(3) ) and tt8(3) mutant 
line over-lapped to highlight differences in the metabolites. Mass spectra of wild 
type showed all ranges of metabolite ions while tt8 mutant lines showed mainly lower 
mass range metabolites, a property specific to tt8 mutant line. This suggested 
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Fig 4.20 Heat map showing differential metabolites affected in glycosylation in 
tt8 mutant line. Differential metabolites with p-value 0.05 or below and fold change 
±2 w.r.t Ws were filtered. Only those metabolites that were associated with 
glycosylation have been shown in this heat map. All metabolites were confirmed by 
MS2 fragmentation and matching daughter ions with pure standards or mass-bank 
(http://www.massbank.jp/index.html?lang=en) database. Colour bar represents 
normalized intensity of metabolites. Complete list of differential metabolites is shown 
in Appendix III. 
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Table 4.1 Selected glycosylated metabolites differentially expressed in tt8 mutant 
line. 
Selected glycosylated metabolites in TT8 loss-of-function mutant lines w.r.t Wt 
 
Up-regulated Down-regulated 






pelargonidin-3,5-diglucoside quercetin 3,7-O-diglucoside 











Glucoside derivative of kaempferol and pelargonidin were up-regulated while that of 
quercetin and cyanidin were down-regulated. On the other hand, rhamnoside 
derivative of kaempferol were down-regulated while that of quercetin were up-
regulated. All metabolites shown here were confirmed by MS2 fragmentation and 
comparing with either pure standard or mass-bank database. All metabolites were 
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Fig 4.21 Metabolic pathways significantly affected in TT8 loss-of-function mutant 
lines. Differential metabolites were identified and mapped on metabolic pathways. 
Phenylpropanoid metabolic pathways showed highest number of metabolites affected 
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4.2.4 Discussion 
Previous study on characterization of QuoA transgenic lines showed several pathways 
to be altered by introduced perturbation at phenylpropanoid pathways (Reuben, 2008). 
These observed effects were at different branches of isoprenoid metabolic network, 
such as in carotenoid and brassinosteroid pathways. QuoA-mediated perturbation in 
transgenic lines at isoprenoid metabolic network was at both metabolites and gene 
expression levels. QuoA activity in transgenic lines resulting in isoprenoid metabolic 
network can be explained in two possible ways. First, there could be a regulatory 
system, connecting both phenylpropanoid and isoprenoid metabolic network. Second, 
QuoA may also act on metabolites of isoprenoid metabolic network resulting in its 
perturbation along with phenylpropanoid network. Second possibility is unlikely, as 
QuoA transgenic lines showed specific perturbational pattern, with increase in QuoA 
activity corresponding to increase in metabolites accumulation and phenylpropanoid 
pathways associated phenotypes of coloration and stiffness. This suggests QuoA 
specificity with its substrate quercetin.  
 
To identify regulatory network that might link phenylpropanoid with isoprenoid 
metabolic network, we analyzed metabolic profile of ten mutant lines from lower 
phenylpropanoid metabolic network. Comparison of metabolic profile of tt mutant 
lines against Q10 identified tt6 and ttg1 as two mutant lines, which showed similar 
crosstalk between phenylpropanoid and isoprenoid metabolic network (Fig 4.11). 
Perturbation in phenylpropanoid metabolic network due to loss of F3H and due to 
QuoA activity results in accumulation of same metabolite naringenin which is 
restricted to upper phenylpropanoid metabolic network in case of tt6 while in Q10, it 
may be channelled to both upper and lower pathways. Thus, tt6 mutant line showing 
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similar metabolic perturbational pattern corroborated with the results of immediate 
effects of QuoA-mediated perturbation in Q10 transgenic lines. On the other hand, 
ttg1 showing similar metabolic perturbational behavior as that of tt6 and Q10 was a 
novel finding, since the point of perturbation was different than that of tt6 and Q10.   
 
Hierarchical clustering based on metabolic profiling of tt mutant lines showed 
formation of two groups, one of mutants of transcription factors and second of 
mutants of structural genes (Fig 4.10A). Only exception was ttg1, a transcriptional 
factor, which was grouped with structural genes and showed high similarity with tt6. 
Similar metabolic profiles of ttg1, tt6 and Q10 transgenic lines suggests disruption of 
similar regulatory mechanism that links phenylpropanoid and isoprenoid metabolic 
networks. RNA levels of TTG1 and F3H were down-regulated in tt6, ttg1 and Q10 
transgenic lines in 6-day-old seedlings (Fig 4.13). 
 
To study if mutation of ttg1 or metabolic perturbation due to tt6 loss of function is the 
reason of the observed crosstalk, we performed metabolic profiling of double mutant 
lines for ttg1/tt6 with tt3, tt4 and tt5. Loss-of-function mutant lines tt3, tt4 and tt5 did 
not show significant perturbation in isoprenoid metabolic network. We intended to 
test if introducing mutation in TTG1 or F3H in these mutant lines will result in 
perturbation in isoprenoid metabolic network. Metabolic profiling of 6-day-old 
seedlings of double mutant lines ttg1/tt3, ttg1/tt4, ttg1/tt5, ttg1/tt6, tt6/tt3, tt6/tt4 and 
tt6/tt5 were performed and compared with single mutants of tt3, tt4 and tt5 to 
differential metabolites due to introduced TTG1 or F3H mutation. Hierarchical 
clustering of metabolic profile of double mutants showed ttg1 and all double mutants 
of ttg1 with tt3, tt4 and tt6 were grouped together except ttg1-tt5 (Fig 4.14). PCA plot 
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reflected the same trend (Fig 4.15), suggesting TTG1 as the dominating factor in 
deciding final metabolic state of transgenic lines. On the other hand, tt6 mutant was 
grouped with ttg1 mutant while its double mutants showed formation of two groups. 
TT4 and TT5 act up-stream while TT3 acts down-stream to F3H in phenylpropanoid 
pathways (Fig 4.1). Double mutants of tt6 with tt3, tt4 and tt5 showed small number 
of differential metabolites, suggesting metabolic channelling to be less important for 
creating metabolic perturbation (Fig 4.16). While double mutation of tt6 with tt3, tt4 
and tt5 did not show much difference with single mutants, ttg1 double mutants 
showed significant metabolic changes compared to single mutant. This was reflected 
by the fact that ttg1/tt3, ttg1/tt4, ttg1/tt6 and ttg1 were grouped together and also 
showed significantly high number of differential metabolites. TTG1, being a 
transcription factor thus seems to shape the metabolic state of tt3, tt4, tt5 and tt6. This 
was an interesting observation since while tt4 mutants are devoid of any flavonoids, 
tt3 mutant blocks pathways which lead to synthesis of anthocyanins and 
proanthocyanins. Although, tt3 and tt4 mutant lines showed highly different metabolic 
profile with no significant effect on isoprenoid metabolic network, double mutant 
lines showed similar metabolic state. This suggests TTG1 to have more targets than 
what is known so far. 
 
Differential metabolites from single and double mutants were mapped to metabolic 
pathways. Results showed ttg1 and its double mutants to be perturbed in isoprenoid 
metabolic network with mevalonate pathway, methylerythritol phosphate pathway, 
PRPP biosynthesis, IAA biosynthesis, nonaprenyl diphosphate biosynthesis, geranyl 
diphosphate biosynthesis being significantly perturbed in ttg1, ttg1/tt3, ttg1/tt4, 
ttg1/tt6 and ttg1/tt5 (Fig 4.17 and 4.18). On the other hand, tt6 and its double mutants 
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showed less effect on isoprenoid metabolic network. Effects on several other 
pathways such as anthocyanin biosynthesis, simple coumarins biosynthesis, quercetin 
and kaempferol glucoside biosynthesis were of different extent in all of its double 
mutants, thus not showing any specific pattern.  
 
Till date, there have been no reports suggesting interaction between phenylpropanoid 
and isoprenoid metabolic network. Characterization of sixteen independent QuoA 
transgenic lines showed perturbation of isoprenoid metabolic network while 
perturbing phenylpropanoid metabolic network (Reuben, 2008). Our results showed 
similar cross-talk in TTG1 and F3H loss-of-function mutant lines, suggesting a 
common link between these three transgenic lines showing metabolic network cross-
talk. Comparison of metabolic profiling of QuoA transgenic lines, tt mutant lines and 
double mutant lines thus conclusively showed ttg1 as a possible link between 
phenylpropanoid and isoprenoid metabolic network. 
 
TTG1 and TT8 have been shown to form ternary complex with TT2 to regulate 
expression levels of BAN and DFR (Baudry et al., 2004), two biosynthetic genes from 
phenylpropanoid metabolic network. Metabolic profiling of TT8 loss-of-function 
mutant line showed unique metabolic state feature compared to that of the other 
transparent testa mutant. The glycosylation process was impaired in TT8 loss-of-
function lines with down-regulation of several glycosylated metabolites. This effect 
was specific for glycosylation of quercetin, cyaniding, pelarogonidin and kaempferol 
and exhibited a unique pattern. While quercetin and cyanidin glucosides were down-
regulated in tt8 mutant line, the kaempferol and pelarogonidin glucosides were up-
regulated. On the other hand, the rhamnoside conjugates of quercetin and cyaniding 
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were up-regulated in tt8 mutant line while down-regulated in kaempferol. Earlier, 
HPLC based profiling of tt mutants showed increased accumulation of quercetin in tt8 
mutant with speculation of impaired glycosylation process (Peltier et al., 1999). 
Previously, metabolic profiling of root exudates from tt8 mutant line showed 
significantly down-regulation of glycosylated metabolites compared to Wt and other tt 
mutant lines (Narasimhan, 2003). Several sugar conjugated forms of UDP and GDP 
metabolites were affected in tt8 mutant line with glycosylated UDP were don-
regulated.  
 
Nucleotides serve as acceptor as well as donor of sugar molecules, thus facilitating 
process of glycosylation and its regulation (Butler, 2006; Vaistij et al., 2009). This, 
along with transferases, hydrolases and sugar transporters regulates process of 
glycosylation. In our study, several of the metabolites having affected glycosylation 
process were identified. Metabolic profiling data showed tt8 mutant to be defective in 
glycosylation. Since glycosylation involves a complex regulatory mechanism and 
participates in the toxification and detoxification of several secondary metabolites, 
understanding its process is of great importance. Therefore, regulation of 
glycosylation process was further studied using tt8 as a model system and is described 
in Section 4.3. 
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4.3 Identification of metabolic pathways and genes regulated by TTG1 and TT8 
Our study on metabolic profiling of tt mutant lines showed ttg1 and tt6 mutants as 
biochemical phenocopy of QuoA transgenic lines, showing perturbation to isoprenoid 
metabolic network in response to perturbation in phenylpropanoid metabolic network. 
To test whether ttg1 or F3H loss-of-function could be a reason for this perturbational 
behaviour, we tested double mutants of TTG1 and F3H with BAN (tt3), CHS (tt4) and 
CHI (tt5). Metabolic profiling of single and double mutants of ttg1 showed metabolic 
perturbation in isoprenoid metabolic network, which otherwise was unaffected in the 
single mutants tt3, tt4 and tt5 transgenic lines. These results suggested a possible role 
of TTG1 in regulation of members from isoprenoid metabolic network, thus 
explaining cross-talk between phenylpropanoid to isoprenoid metabolic.  
 
To further confirm if TTG1 directly regulates isoprenoid pathways and to identify 
direct targets of TTG1, we created transgenic lines expressing 2x35S:TTG1:GR 
(called as TTG1:GR). Since TT8 has been shown to form a complex with TTG1 to 
regulate its target, we also created inducible over-expression lines of TT8 (called as 
TT8:GR) to identify those targets that are common to both TTG1 and TT8 (See 
experimental workflow Fig 4.22). Metabolic profiling and gene expression profiling 
of ttg1, tt8 and tt2 loss-of-function mutant lines were performed to identify genes 
differentially expressed in all three mutant lines. These were than compared with 
inducible over-expression transgenic lines to identify metabolic pathways and 
processes that were directly regulated by TTG1 or TTG1-TT8 complex. Results were 
validated using RT-PCR approach and direct targets were tested against in-vivo 
binding of TTG1 by ChIP experiment. 
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Fig 4.22 Experimental work flow for functional characterization of TTG1 and 
TT8 using inducible over-expression gain-of-function and loss-of-function 
mutant lines. Dex inducible TT8:GR and TTG1:GR were treated with dex  or mock 
and samples were harvested to perform microarray and metabolic profiling based 
studies. List of genes showing reciprocal expression profile in loss-of-function and 
inducible transgenic lines were used to further analyze if they are direct targets of 
TTG1 and TT8. TTG1:GR and TT8:GR transgenic lines were then treated with mock 
or dex and/or chx to induce activity of TT8 and TTG1 in respective transgenic lines to 
identify direct targets of these transcriptional factors, which were then validated using 
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4.3.1 TTG1 and TT8 fusion with GR is functional and inducible 
Dex-inducible transgenic lines were created for inducible over-expression of TTG1 
and TT8 by transforming Col-0 with pGreenII vector with insert 2x35S-TTG1:GR 
and 2x35S-TT8:GR. To test if fusion of TT8 and TTG1 with GR were functional, 
positively selected transgenic lines for the insert were tested for associated phenotypes 
for TT8 and TTG1. TTG1 has been associated with trichome initiation and regulation. 
It is also associated with proanthocyanin formation which gets accumulated in seeds 
and oxidation of which gives rise to brownish coloured tannin, giving characteristic 
brown coloration of seeds. ttg1 loss-of-function transgenic lines shows phenotypes 
such as no trichome formation on leaf surface or stem base, yellow seeds due to 
absence of brown pigment in seed coat (testa) and no anthocyanins in leaves, stems 
and all tissues. TT8 loss-of-function results in yellow seed coloration due to absence 
of brown pigmentations, although it had no effect on trichome number or 
accumulation of anthocyanin.  
 
Inducible over-expression transgenic lines were grown on MS agar medium for 5 days 
before transferring them to MS agar medium with dex or equivalent amount of its 
solvent and incubated for 24 hours before observing if increased activity of TTG1 or 
TT8 fussed with GR resulted in expected phenotype. Dex treatment of seedlings 
resulted in ectopic trichome formation on petiolate, while there was no trichome 
formation on seedlings treated with mock (Fig 4.23 and 4.24). Col-O also did not 
show any formation of trichome with or without dex treatment, suggesting trichome 
formation as a result of TTG1 or TT8 induced activity in respective transgenic lines. 
TTG1 has been described earlier as essential for trichome initiation, thus ectopic 
trichome formation was expected. However, TT8 has not been shown to be associated 
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with trichome formation. Presence of its homologs such as EGL3 and GL3 has been 
shown to be more important bHLH transcription factor than TT8 that regulates 
trichome formation (Zhang et al., 2003). Triple mutants of egl3-gl1-tt8 showed ttg1 
phenotype of no trichome formation (Zhang et al., 2003; Zhao et al., 2007). Thus 
induced expression of TT8 leading to ectopic trichome formation at petiolates 
confirms that TT8 also participates in trichome formation. We then counted total 
number of trichome on first two true leaves of 6-day-old seedlings with or without 
DEX treatment. As expected, TTG1:GR and TT8:GR transgenic lines showed 
increased trichomes on adaxial side of leaves, while Col-0 and tt8 mutant did not 
showed any changes in trichome numbers. ttg1 loss-of-function mutant did not show 
any trichome formation on the leaves (Fig 4.25). As expected, dex treatment to 6-day-
old seedlings showed accumulation of anthocyanin in hypocotyl region, suggesting 
increased formation of anthocyanins in response to induced activity of TTG1 and TT8 
(Fig 4.26).  
 
Adult siliques of transgenic lines were then treated with dex or mock to observe any 
increase in seed coloration. As expected, both TTG1:GR and TT8:GR inducible lines 
showed increased brown pigmentation in seeds by dex treatment compared to mock or 
wild type seeds. There was no increase in seed coloration of Col-0 by dex or mock 
treatment, suggesting increased tannin formation in dex induced TTG1:GR or 
TT8:GR transgenic lines were due to TTG1 and TT8 activity (Fig 4.27 and 4.28). Dex 
treatment of 6-day-old inducible transgenic lines for TTG1 and TT8 also showed up-
regulation of BAN and DFR, two known direct targets of TTG1 and TT8 (Fig 4.29). 
These results thus establish that TTG1 and TT8 fusion with GR was fully functional. 
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Fig 4.23 Ectopic trichome formation by dex treatment on Col-0 transformed with 
2x35S:TTG1-GR or 2x35S:TT8-GR construct. (A, B) TT8:GR transgenic lines, (C, 
D) TTG1:GR transgenic lines, (E, F) Wt. All images were taken at 80x magnification 
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Fig 4.24 Formation of ectopic trichome in response to dex treatment in 
2x35S:TTG1-GR or 2x35S:TT8-GR transgenic lines to the tissues which do not 
produce trichome. All images were taken at 80x magnification under a dissection 
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Fig 4.25 dex treatment of TT8:GR and TTG1:GR transgenic lines showed 
increase in total adaxial trichomes on first two true leaves. Total numbers of 
trichomes were counted on adaxial side of first two true leaves of 7 day old seedlings 
after treating them with dex or mock for 24 hours. Data are given as mean ±SD (n > 
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Fig 4.26 Anthocyanin accumulation in hypocotyl region of dex and mock treated 
transgenic lines. (A,B) TT8:GR transgenic lines, (C,D) TTG1:GR transgenic lines, 
(E,F) Wt. All images were taken at 80x magnification under a dissection microscope 












Results and discussion 
 





Fig 4.27 Increased seed coloration due to dex treatment to TTG1:GR inducible 
transgenic lines. Transgenic lines and Wild type arabidopsis lines were watered with 
10µM final concentration of dex for 1 week before harvesting the seeds. Images were 
taken under a dissection microscope with bright field illumination. All images were 
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Fig 4.28 Increased seed coloration due to dex treatment to TT8:GR inducible 
transgenic lines. Transgenic lines were watered with 10µM final concentration of dex 
for 1 week before harvesting the seeds. Images were taken under a dissection 
microscope with bright field illumination. All images were taken at 80x magnification 
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Fig 4.29 Quantitative Real time PCR showed increased RNA levels of BAN and 
DFR in dex-treated TTG1:GR and TT8:GR transgenic lines while were down-
regulated in tt8 and ttg1 mutant lines. 6 day old seedlings were used for real-time 
PCR based quantification. BAN and DFR are two biosynthetic genes shown to be 
directly regulated by TT8 and TTG1 complex with TT2, thus this shows TTG1:GR 
and TT8:GR as functional transgenic lines. All fold changes values were of p-value 
0.05 or bellow. Each transgenic line was used with 3 biological-replicates, with each 
replicate consisting with 45 seedlings. Dex treatment was performed and seedlings 
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4.3.2 Non-targeted metabolic profiling of inducible over-expression transgenic 
lines showed up-regulation of metabolites from phenylpropanoid metabolic 
network 
Metabolites extracted from 6-day-old seedlings of inducible over-expression 
transgenic lines after dex or mock treatment for 24 hours were subjected to untargeted 
metabolic profiling using UHPLC-TOF. Raw data were processed using Mass Hunter 
software from Agilent and ions were selected from raw data by Mass Extraction 
feature parameters set and described in Material and Methods Section (Chapter 3). 
Extracted metabolic data were subjected to alignment, mass correction, RT correction, 
noise removal, normalized, filtered based on abundance and scaled using Gene Spring 
12.0 software from Agilent and were used for further multi-variant data analysis.  
Metabolic profiles of transgenic lines with and without treatment were plotted using 
PCA which showed transgenic lines forming three groups (Fig 4.30). Mock treated 
inducible over-expression transgenic lines showed similar metabolic profile as that of 
Wt and were grouped together in PCA plot. Other two groups formed in PCA plot 
were loss-of function mutants and dex induced transgenic lines (Fig 4.30). PCA plot 
showed that metabolic profiling of transgenic lines was determined by loss or induced 
expression of ttg1 or tt8. 
Metabolites with p-value <0.05 and fold change ≥ ±2 were filtered for further 
identification and mapping on to metabolic pathways. Differential metabolites were 
identified by matching fragmentation pattern of metabolite (MS2) with standards or 
MS2 data deposited in MassBank (http://www.massbank.jp/?lang=en). Since TTG1 
and TT8 have been shown to physically interact to form a complex and co-regulate 
gene-expression of genes in phenylpropanoid metabolic network, we first compared 
metabolic profile of differential metabolites for TTG1:GR and TT8:GR transgenic 
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lines with and without dex treatment. Dex treatment resulted in 1234 differential 
metabolites in TTG1:GR transgenic lines and 763 differential metabolites in TT8:GR 
transgenic lines as compared to corresponding metabolic profile of mock treatment, 
with 533 metabolites common to both transgenic lines after dex treatment (Fig 4.31). 
Out of total 1464 differential metabolites together in TTG1:GR and TT8:GR, we were 
able to identify 368 metabolites based on MS2 fragmentation pattern and mapped to 
metabolic pathways, part of which is shown in Table 4.2 and complete list is in 
appendix. 
 
 Overall metabolic perturbation showed up-regulation of metabolites in response to 
dex-induced activity of TTG1 and TT8, with 167 metabolites up-regulated and 73 
down-regulated in TTG1:GR and 185 metabolites up-regulated and 87 down-
regulated in TT8:GR. Among identified metabolites, 194 metabolites showed similar 
trend of perturbation in TTG1:GR and TT8:GR, with 139 metabolites showed up-
regulation and 55 metabolites were down-regulation in response to dex treatment. As 
expected, several metabolites from phenylpropanoid metabolic network, such as 
dihydrokaempferol, quercetin, 3,7-di-O-methylquercetin, cyanidin-3-O-beta-D-
glucoside, pelargonidin-3-O-beta-D-glucoside, pelargonidin-3,5-diglucoside, 
caffeoylquinate, 4-coumarate were all up-regulated in TTG1:GR and TT8:GR 
transgenic lines by dex treatment (Table 4.2). Levels of metabolites were consistent 
with observed phenotype of anthocyanin accumulation in young seedlings of 
transgenic lines in response to dex treatment (Fig 4.26). Conjugation processes such 
as methylation, sulphates, glycosylation of metabolites from phenylpropanoid 
metabolic network were up-regulated in transgenic lines. Methylated and sulphate 
form of quercetin such 3,7,4'-tri-O-methylquercetin, 3,7-di-O-methylquercetin, 
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quercetin-3,7,3',4'-tetrasulphate, quercetin-3,3',7-trissulfate and quercetin-3,3'-
bisulfate were all up-regulated in dex induced TTG1:GR and TT8:GR transgenic 
lines. Glycosylation of metabolites from phenylpropanoid metabolic network such as 
quercetin, cyanidin, sinapaldehyde, delphinin and pelargonidin were also up-regulated 
in dex induced TT8:GR and TTG1:GR. Interestingly, none of kaempferol conjugated 
forms were differentially expressed in either of TT8:GR and TTG1:GR transgenic 
lines. This is particularly important since quercetin and kaempferol competes for 
different conjugation processes and these results showed TT8 and TTG1 favouring 
conjugation of quercetin than of kaempferol. Glycosylation of metabolites other than 
those from phenylpropanoid metabolic network were also up-regulated particularly in 
TT8:GR lines. Many metabolic pathways other than phenylpropanoid metabolic 
network were also perturbed in response to dex treatment in TTG1:GR and TT8:GR. 
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Fig 4.30 PCA plot on metabolic profile of TT8 and TTG1 loss-of-function mutant 
lines and inducible over-expression transgenic lines with dex or mock treatment. 
Metabolic profiling for each treatment was done for 4 biological replicates and each 
replicates were injected 3 times to record metabolic profile. PCA showed mock 
treated TTG1:GR, TT8:GR grouped together with Wt while mutants and dex-treated 
lines were grouped together. 
 
 
Fig 4.31 Venn Diagram showing distribution of differentially expressed 
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Table 4.2 Differential metabolites from phenylpropanoid metabolic network in 







Quercetin 7.59 6.34 
Dihydrokamepferol -3.05 6.13 
Caffeoylquinate 3.58 3.06 
4-coumarate 0.18 0.74 
caffeate 10.74 12.36 
cyanidin 5.31 3.44 
3,7-di-O-methylquercetin 6.64 10.18 
Cyanidin-3-O-beta-D-glucoside 2.19 1.79 
cyanidin 3-(p-coumaroyl)-glucoside 2.8 9.7 
Pelargonidin-3-O-beta-D-glucoside 0.62 5.5 
Pelargonidin-3,5-diglucoside -12.61 -1.92 
3,7,4'-tri-O-methylquercetin 2.31 3.97 
3,7-di-O-methylquercetin 4.6 4.2 
Quercetin-3,7,3',4'-tetrasulphate 1.9 3.2 
Quercetin-3,3',7-trissulfate 2.1 2.91 
Quercetin-3,3'-bisulfate 3.12 2.09 
4-coumaroylshikimate -0.01 -1.9 
Shikimate 3.22 2.1 
Sinapoyl-(S)-malate 1.42 1.06 
Sinapaldehyde glucoside 5.41 11.26 
UDP-L-arabinose 4.2 4.83 
UDP-D-apiose 3.71 4.09 
UDP-4-dehydro-6-deoxy-D-glucose 5.33 3.95 
GDP-L-gulose -2.01 -3.66 
UDP-galactose 2.1 3.8 
 
 
Metabolites from phenylpropanoid metabolic network and its conjugation were up-
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4.3.3 Metabolites from isoprenoid metabolic pathways and its branches are up-
regulated in dex-treated TTG1:GR  
Perturbation in metabolic pathways in response to induced activation of TTG1 and 
TT8 was not limited to phenylpropanoid metabolic network, but other pathways too 
showed up-regulated response. Metabolic pathways other than phenylpropanoid 
metabolic network, which showed up-regulation of 4 or more metabolites from a 
pathways in both TTG1 and TT8 induced activation included mevalonate biosynthesis 
pathways, methylerythritol phosphate pathway (non mevalonate isoprenoid 
biosynthesis), trans-zeatin biosynthesis, methylquercetin biosynthesis, de novo 
biosynthesis of purine and pyrimidine nucleotides, brassinosteroid biosynthesis II, 
gibberellin biosynthesis I (non C-3, non C-13 hydroxylation) and chlorophyll a 
biosynthesis II (Table 4.3). Except de novo biosynthesis of purine and pyrimidine, 
rest all of the up-regulated metabolic pathways forms different branches of isoprenoid 
biosynthesis pathways and are collectively called as isoprenoid metabolic network.  
 
Isopentenyl diphosphate (IPP) and its isoform dimethylallyl-pyrophosphate (DMAPP) 
serves as building blocks for all isoprenoids and are acted upon by different enzymes 
leading to synthesis of cytokinins, sterols, polyprenoids, carotenoids and other 
isoprenoids. In plants, IPP and DMAPP are synthesized by two alternative pathways, 
namely mevalonate (MVP) that is localized in cytosol and methylerythritol phosphate 
pathway (MEP) which is localized in plastids. IPP and DMAPP were up-regulated by 
13.31 and 3.52 fold change respectively in dex-treated TTG1:GR transgenic lines. 
The cytoplasmic MVP begins with condensation of 3 units of acetyl-CoA to 3-
hydroxy-3-methylglutaryl-CoA (HMG-CoA) and continues by reduction to 
mevalonate (MVA), followed by two successive phosphorylation steps at C-5 of 
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mevalonate, and a decarboxylation/elimination step leading to IPP (Croteau et al., 
2000). In mevalonate pathways, levels of acetyl-CoA and mevalonate-diphosphate 
were up-regulated by more than 2 fold in dex-treated TTG1:GR while HMG-CoA, 
mevalonate-phosphate and mevalonate showed moderate up-regulation, suggesting 
over-all up-regulation of mevalonate pathways in dex-treated TTG1:GR (Fig 4.32).  
 
MEP pathway, also referred as non-mevalonate pathway is alternate pathway for IPP 
and DMAPP biosynthesis in plastids (chloroplast). The initial reaction of MEP 
pathway involves condensation of (hydroxyl ethyl) thiamine with the C-1 aldehyde 
group of D-glyceraldehyde-3-phosphate (GA-3P) resulting in production of 1-Deoxy-
D-xylulose 5 phosphate (DXP). DXP then undergoes intramolecular rearrangement 
and reduction leading to formation of 2-C-methyl-D-erythritol 4-phosphate (MEP). 
MEP thus formed undergoes several rearrangement and phosphorylation and finally 
leads to production of a mixture of IPP and DMAPP. Out of nine metabolic 
intermediates of MEP pathway, six of them were up-regulated by more than 2 fold 
change in dex-treated ttg1: gr transgenic lines (Fig 4.33). Metabolites such as 2-
phospho-4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol,4-(cytidine-5'diphospho)-
2-C-methyl-D-erythritol,1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate, 1-deoxy-
D-xylulose 5-phosphate, dimethylallyl-pyrophosphate, 2-C-methyl-D-erythritol-4-
phosphate and CMP from MEP pathway were all up-regulated in both TTG1:GR and 
TT8:GR. Induced activity of TTG1 showed stronger effect as up-regulation of 
metabolites from isoprenoid metabolic network with higher fold change in all 
metabolites compared to TT8. Metabolites from isoprenoid metabolic network such as 
geranyl diphosphate, mevalonate-5-diphosphate and isopentenyl diphospahte which 
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are very important steps in isoprenoid metabolic network were up-regulated only in 
TTG1:GR and not in TT8:GR (Fig 4.34).  
 
Synthesis of IPP and DMAPP can be conceptually viewed as the first module of 
isoprenoid metabolic network. The second order of complexity in isoprenoid 
synthesis requires condensation of IPP subunits (C5) to generate linear polymer of 
defined chain length (i.e. e.g. C10, C15, C12……. Cn).  These molecules serve as 
direct precursors for synthesis of different classes of isoprenoid compounds. For 
instance, DMAPP (C5) acts as precursor for synthesis of isoprene, cytokinins and 
other hemiterpenoids; geranyl diphosphate (GPP: C10) serves as precursor for 
monoterpenoids; geranyl geranyl diphosphate (GGPP: C20) is used as a precursor for 
synthesis of gibberellic acid and of side chains of chlorophyll, phylloquinones and 
tocopherols; squalene (C30) serves as precursor for sterols; brassinosteroids and other 
triterpenoids, phytoene (C40) is a precursor of abscisic acid (ABA), carotenoids and 
other apocarotenoids.  
 
Up-regulation of IPP and DMAPP resulted in increased synthesis of several of these 
isoprenoids. Metabolites from brassinosteroids biosynthesis pathway, namely 6-
Oxocampesterol, (22α) - hydroxycampesterol and (22α) -hydroxycampestan-3-one 
showed up-regulation in response to dex-treated ttg1: GR transgenic lines. Gibberellin 
biosynthesis pathway was also up-regulated with up-regulation of GA13, GA17, 
GA19, GA25 and GA36 by more than fold change of 2. Biosynthesis of essential 
isoprenoids synthesized from IPP and DMAPP such as cytokinins, IAA and abscisic 
acid (ABA) were also up-regulated in dex-treated TTG1:GR transgenic lines. 
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Intermediates of isoprenoid metabolic network serves as starting point for synthesis of 
several metabolic pathways such as brassinosteroids, carotenoids, cytokinins, 
dolichols, polyprenols, phytosteroids, sesquiterpenes, thiamine, isoprenes, 
ubiquinones, monoterpenes, chlorophylls, tocopherols, plastoquinones, 
phylloquinones, ABA and gibberellins biosynthetic pathways.   Among up-regulated 
metabolic pathways, methylerythritol phosphate pathways, brassinosteroid 
biosynthesis, chlorophyll a biosynthesis, trans-zeatin biosynthesis, gibberellin 
biosynthesis and cytokinins biosynthesis forms part of isoprenoid metabolic network 
(Table 4.3). Metabolites such as cis- zeatin, trans- zeatin riboside diphosphate, trans- 
zeatin riboside triphosphate, trans- zeatin riboside, kinetin-7-N-glucoside and , 
kinetin-9-N-glucoside from cytokinins pathway and 9’- cis- neoxanthin, L-leucine and 
indole-3-glycerol-phosphate from IAA biosynthesis pathway were up-regulated in 
dex-treated TTG1:GR transgenic lines (Table 4.3). Abscisic acid biosynthesis was 
also up-regulated with the up-regulation in the level of intermediate metabolites such 
as trans-neoxanthin, 9’- cis-neoxanthin, biolaxanthin, phaseic acid and 8’- 
hydroxyabscisate.  
 
Compared to dex-treated TTG1:GR, ttg1 mutant lines showed down-regulation of 
metabolites from isoprenoid metabolic network. Metabolites from both MVA and 
MEP pathways leading to synthesis of IPP and DMAPP were down-regulated in ttg1 
mutant lines (Fig 4.35). Overall, metabolites from isoprenoids and its branch 
pathways showed were significantly down-regulated while dex-treated TTG1:GR 
transgenic lines showed up-regulated trend in these pathways. Metabolic profiling of 
dex-treated TTG1:GR transgenic lines showed up-regulation in biosynthesis of 
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several isoprenoids, thus, suggesting important role of TTG1 in regulation of 
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Fig 4.32 Altered metabolites from mevalonate biosynthesis pathway. Mevalonate 
(MVA) pathway is localized to the cytosol and is responsible for the synthesis of 
sterols, certain sesquiterpenes, and the side chain of ubiquinone. All coloured 
metabolite shown in this pathways were differentially expressed metabolites in dex-
treated TTG1:GR w.r.t mock treatment with p-value 0.05 or bellow, red coloured 
metabolites showed up-regulation with 2 or above fold change while those coloured 
orange were above 1.5 but less than 2 fold change, black coloured metabolites showed 
no significant difference in dex and mock treated TTG1:GR transgenic lines. 
AACT1/AACT2- acetoacetyl- CoA thiolase; BAP1- 3-hydroxy-3-methylglutaryl 
coenzyme A synthase; HMG1/HMG2- 3-hydroxy-3-methylglutaryl coenzyme A 
reductase; MVK- mevalonate kinase; AT1G31910- phosphomevalonate kinase; 
MVD1- mevalonate diphosphate decarboxylase; IPP1/IPP2- isopentenyl diphosphate 
isomerase; GGPS1/GGPS6- geranylgeranyl pyrophosphate synthase. This pathways is 
adapted from aracyc (http://pmn.plantcyc.org/ARA/NEW-
IMAGE?type=PATHWAY&object=PWY-922). Data for these metabolites are shown 
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Fig 4.33 Altered metabolites from non-mevalonate biosynthesis pathway 
(methylerthritol biosynthesis pathways). Non-mevalonate biosynthesis pathway 
operates in plastids and is involved in providing the precursors for monoterpenes, 
certain sesquiterpenes, diterpenes, carotenoids, and the side chains of chlorophylls and 
plastoquinone. All coloured metabolite shown in this pathways were differentially 
expressed metabolites in dex-treated TTG1:GR w.r.t mock treatment with p-
value≤0.05, red coloured metabolites showed up-regulation with 2 or above fold 
change, black coloured metabolites showed no significant difference in dex and mock 
treated TTG1:GR transgenic lines. CLA1- 1-deoxy-D-xylulose-5-phosphate synthase; 
DXR- 1-deoxy-D-xylulose-5-phosphate reductoisomerase; MCT- 4-diphosphocytidyl-
2C-methyl-D-erythritol synthase; AT2G26930- 4-(cytidine 5’-diphospho)-2-C-
methyl-D-erythritol kinase; IspF- 2C-methyl-D-erythritol 2,4-cyclodiphosphate 
synthase; GcpE- 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase; IspH- 1-
hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase. This pathway map is 
adapted from 
aracyc(http://pmn.plantcyc.org/ARA/NEWIMAGE?type=PATHWAY&object=NON
MEVIPP-PWY&detail-level=2&detail-level=1&detail-level=2). Data for these 
metabolites are shown in Table 4.3. 
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Fig 4.34 Differentially metabolites from Isoprenoid metabolic network (MVP 
and MEP) in dex-treated TTG1:GR and TT8:GR w.r.t their mock treated 
transgenic lines. Here colour code represents fold change of dex-treated TTG1:GR 
and TT8:GR with their mock treated transgenic lines. Metabolites with p-value≤0.05 
and fold change±2 and mapped to isoprenoid metabolic network are presented here. 
GA- gibberellic acid; DEP- 1-deoxy-D-xylulose 5-phosphate; IPDP- 
isopentenyladenosine-5'-diphosphate; IPTP- isopentenyladenosine-5'-triphosphate; 
IPP- isopentenyl diphosphate; MVAPP-5PP- dimethylallyl diphosphate; MEP- 2-C-
methyl-D-erythritol-4-phosphate; DMAPP- dimethylallyl diphosphate; DXP- 1-
deoxy-D-xylulose 5-phosphate; HMBDP- (E)-4-hydroxy-3-methylbut 2-en-1-yl 
diphosphate; CDP-ME- 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol; GPP- 
geranyl diphosphate. Data for these metabolites are shown in Table 4.3. 
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Fig 4.35 Heat map showing number of differential metabolites from metabolic 
pathways affected in TTG1 loss-of-function mutant line and dex inducible 
transgenic lines. Metabolites that are up-regulated and down-regulated in ttg1 mutant 
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Table 4.3 Differential metabolites from isoprenoid branch pathways in dex-






Uridine 5.35 7.9 (deoxy)ribose phosphate degradation 
Cytidine 8.09 8.17 (deoxy)ribose phosphate degradation 
deoxyribose-5-phosphate 7.77 9.83 (deoxy)ribose phosphate degradation 
deoxyribose-1-phosphate 7.77 9.83 (deoxy)ribose phosphate degradation 
Thymine 16.94 16.94 (deoxy)ribose phosphate degradation 
Thymidine -0.09 -4.78 (deoxy)ribose phosphate degradation 
trans-neoxanthin 0.06 1.75 abscisic acid biosynthesis 
9'-cis-neoxanthin 0.06 1.75 abscisic acid biosynthesis 
cis-zeatin riboside 13.54 0 cis-zeatin biosynthesis 
trans-beta-D-Glucosyl-2-
hydroxycinnamate 4.64 9.46 coumarin biosynthesis 
UDP 0.38 0.7 coumarin biosynthesis 
coumarinic acid-beta-D-
glucoside 4.64 9.46 coumarin biosynthesis 
kinetin-7-N-glucoside 8.39 1.46 cytokinins 7-N-glucoside biosynthesis 
kinetin-9-N-glucoside 8.39 1.46 cytokinins 9-N-glucoside biosynthesis 
trans-zeatin riboside 13.54 0 cytokinins degradation 
4-carboxyaminoimidazole 
ribonucleotide 7.19 11.82 biosynthesis of purine nucleotides 
5-aminoimidazole 
ribonucleotide 8.09 8.41 biosynthesis of purine nucleotides 
5-phospho-beta-D-ribosyl-
amine 8.91 3.44 biosynthesis of purine nucleotides 
Caffeate 10.74 12.36 esculetin biosynthesis 
cis-caffeate 10.74 12.36 esculetin biosynthesis 
GDP-4-dehydro-6-deoxy-D-
mannose -2.28 -1.29 GDP-L-fucose biosynthesis I  
GA8-catabolite 7.11 9.56 gibberellin inactivation 
indole-3-glycerol-phosphate -10.84 -3.64 IAA biosynthesis I 
L-leucine -8.83 -4.92 IAA biosynthesis II 
indole-3-acetyl-beta-1-D-
glucose 11.05 10.58 IAA conjugate biosynthesis 
UTP 6.58 0 inositol oxidation pathway 
3-methylcrotonyl-CoA 0.8 4.16 leucine degradation 
UDP-N-acetyl-D-
glucosamine 0.97 1.24 lipid-A-precursor biosynthesis 
CMP 12.4 13.92 methylerythritol phosphate pathway 
sinapaldehyde glucoside 5.41 11.26 monolignol glucosides biosynthesis 
2,4-dihydroxycinnamate 10.74 12.36 simple coumarins biosynthesis 
Shikimate 2.67 1.89 simple coumarins biosynthesis 
sinapoyl-(S)-malate 1.42 1.06 sinapate ester biosynthesis 
beta-tocopherol 13.77 8.33 vitamin E biosynthesis 
6-oxocampestanol 6.91 3.11 brassinosteroid biosynthesis II 
(22alpha)-hydroxy-
campesterol 3.8 1.9 brassinosteroid biosynthesis II 
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 4.1 2.7 brassinosteroid biosynthesis II 
GA25 2.33 3.77 gibberellin biosynthesis I  
GA13 3.71 1.69 gibberellin biosynthesis I  
GA36 3.23 -1.76 gibberellin biosynthesis II  
GA19 4.12 -2.11 gibberellin biosynthesis III  
GA17 2.19 1.98 gibberellin biosynthesis III  
GA8-catabolite 1.66 2.33 gibberellin inactivation 
3-methyl-4-cis-hydroxy-2-
butenal 1.78 1.94 cytokinins degradation 
trans-lycopene 2.37 2.34 delta-carotene biosynthesis 
isopentenyladenosine-5'-
triphosphate 3.11 1.8 trans-zeatin biosynthesis 
zeatin riboside 
triphosphate 2.73 2.11 trans-zeatin biosynthesis 
zeatin riboside 2.56 2.97 cis-zeatin biosynthesis 
zeatin riboside diphosphate 5.63 2.54 trans-zeatin biosynthesis 
isopentenyladenosine-5'-
diphosphate 2.77 2.09 trans-zeatin biosynthesis 
GMP 6.97 0.02 purine degradation 
dGDP -5.52 -1.7 purine nucleotide metabolism 
dGTP 1.71 3.1 purine nucleotide metabolism 
dADP 4.85 7.9 purine nucleotide metabolism 
ADP -5.52 -1.7 pyrimidine nucleotide metabolism 
dTTP -6.49 -7.77 
biosynthesis of pyrimidine 
deoxyribonucleotides 
dTDP -6.4 -3.1 
biosynthesis of pyrimidine 
deoxyribonucleotides 
dUTP -6.54 -0.38 
biosynthesis of pyrimidine 
deoxyribonucleotides 
dUDP 1.59 0.98 
biosynthesis of pyrimidine 
deoxyribonucleotides 
GDP -6.85 1.59 
dolichyl-diphosphooligosaccharide 
biosynthesis 
dTMP 3.46 5.01 formylTHF biosynthesis 
dUMP -4.17 -2.44 formylTHF biosynthesis 
dTDP-alpha-L-rhamnose 8.99 4.7 dTDP-L-rhamnose biosynthesis 
dTDP-4-dehydro-6-deoxy-
D-glucose 3.84 3.09 dTDP-L-rhamnose biosynthesis 
 
All metabolites showed here were filtered with p-value≤0.05 and fold change ±2. 
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4.3.4 Microarray analysis of loss-of-function mutant lines tt2, tt8 and ttg1, and 
dex-treated TTG1:GR and TT8:GR  
Comparison of metabolic profiles of single transparent testa mutants and double 
mutant combinations of ttg1 and tt6 with tt3, tt4 and tt5 revealed TTG1 as playing an 
important role in isoprenoid metabolic network regulation as described in Section 4.2. 
Loss-of-function of TTG1 showed down-regulation of several metabolites from 
branch pathways of isoprenoid metabolic network. We next investigated whether the 
affect of TTG1 perturbation in isoprenoid pathway (1) might involve coordinated 
changes at RNA level and (2) might be direct responses of TTG1 perturbation. To 
establish pathways affected directly due to TTG1 activity, we created dex inducible 
TTG1:GR transgenic lines and analyzed their metabolic profiles. Non-targeted 
metabolic profiling of dex-treated TTG1:GR showed up-regulation of metabolites 
from isoprenoid metabolic network with several metabolites down-regulated in ttg1 
mutant lines were up-regulated in response to dex treatment (Section 4.3.3).  
 
In order to identify transcriptome changes directly in response to TTG1 and TT8 
perturbation, we performed gene microarray analysis of RNA from 6-days-old 
seedlings with dex or mock treated TTG1:GR, TT8:GR and loss-of-function 
transgenic lines of TT2, TT8 and TTG1. Gene expression profiles of all transgenic 
lines were plotted on 2D-PCA which showed formation of two clusters (Fig 4.36). 
Dex inducible transgenic lines formed one cluster in which mock treated lines were 
grouped together while dex-treated transgenic lines were far apart. Second group was 
formed of wild type and tt2, tt8 and ttg1 mutant lines with tt2 being closer to wild 
type. Differentially expressed genes were filtered based on p-value less than 0.05 and 
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2 or above fold change. Hierarchical clustering of differentially expressed genes 
showed that profile of dex inducible transgenic lines treated with mock were similar 
to Wt, suggesting that inducible system behaves like wild type until it is treated with 
dex (Fig 4.37). Similar to PCA plot, loss-of-function transgenic lines tt8 and ttg1were 
clustered together showing similar expression profile, while dex-treated TTG1:GR 
and TT8:GR showed similar expression pattern.  
 
We then compared gene expression of all loss-of-function transgenic lines with their 
Wt-Col line as control. Differential genes were filtered based on corrected p-value 
≤0.05 and fold change ±2 or above. Among, mutant lines, tt8, ttg1 and tt2 showed 
2480, 2453 and 849 differentially expressed genes respectively, with 302 genes 
common to all three (Fig 4.38). Differential genes common to all three mutant lines 
showed high similarity in expression pattern with 255 out of 302 differentially 
expressed genes similar trend. TTG1 and TT8 loss-of-function mutant lines showed 
high similarity with 743 differentially expressed genes out of 985 common genes 
showing similar expression pattern. 
 
Consistent with earlier reports, BAN and DFR, two biosynthetic genes regulated by 
TTG1-TT8-TT2 complex were down-regulated by more than 2-fold in all three 
mutant lines (Baudry et al., 2004, 2006). Other genes such as PCC1 (Pathogen and 
circadian controlled 1), STP1 (Sugar transporter 1), UGT85A1, RPS5 (Resistant to P. 
Syringae), ATMYB16, GL2 (GLABRA 2), UGT74D1, UGT73B5 and ERD5 (Early 
responsive to dehydration 5) were significantly down-regulated in tt2, tt8 and ttg1 
mutant lines. Several biosynthetic genes from phenylpropanoid metabolic network 
such as TTG2 (Transparent testa glabra 2), LDOX (Leucocyanidin oxygenase), TT7 
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(Transparent testa 7), TT5 (Transparent testa 5) and TTG1 were significantly down-
regulated in ttg1, tt8 and tt2 mutant lines.   
TTG1 loss-of-function transgenic lines showed several genes from isoprenoid 
metabolic network such as geranyl diphosphate synthase (GPPS), p-
hydroxyphenylpyruvate synthase (HPPS), farnesyl diphosphate synthase (FPPS2), 
gibberellin 20-oxidase, sterol C 22-desaturase (CYP710A1), sterol C5-desaturase 
(DWF7-2), isopentenyl transferase (IPT4), sesquiterpenoid/diterpenoid synthase 
TPS18 (TPS16), sesquiterpenoid synthase TPS27 (TPS03), dehydrodolichol 
diphosphate synthase (DDPPS), 3-hydroxy-3-methylglutaryl-CoA reductase 
(HMGR1), phosphomevalonate kinase (PMK), dehydrodolichol diphosphate synthase 
(DDPPS) and farnesyl transferase/geranyl geranyl transferase I, alpha subunit 
(FTase/GGTase1A) significantly down-regulated (Fig 4.40). Biosynthetic genes from 
isoprenoid branch pathways such as cytokinins, brassinosteroids, carotenoids, GA 
biosynthesis and ABA biosynthesis were also down-regulated in ttg1 and tt8 mutant 
line. Table of entire list of differentially expressed genes and comparison for ttg1, tt8 
and tt2 mutant lines have been shown in Appendix1. TT2 loss-of-function transgenic 
lines showed no differentially expressed gene from isoprenoid metabolic network 
while TT8 loss-of-function transgenic line showed few down-regulated genes. This 
was consistent with metabolic profiling of loss-of-function transgenic lines that 
showed lowered levels of several metabolic intermediates from isoprenoid metabolic 
network in TTG1 loss-of-function transgenic lines (Section 4.2 and 4.3.3). Major 
metabolic pathways other than phenylpropanoid and isoprenoid metabolic network 
that showed differential expressed genes includes sciadonic acid biosynthesis, 
pyrimidine ribonucleotides de novobiosynthesis, jasmonic acid biosynthesis, 
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glutathione-mediated detoxification II, coumarin biosynthesis (via 2-coumarate), 
quercetin glucoside biosynthesis and sucrose degradation III.  
To identify direct target genes of TTG1 and TT8, we analyzed microarray-based gene 
expression profile of TTG1:GR and TT8:GR with dex and mock treatment. Our 
rationale was that differentially expressed genes down-regulated in loss-of-function 
transgenic lines and up-regulated in dex induced transgenic lines would be ideal 
candidates for being a direct target. As many as 1,253 and 1,283 differentially 
expressed genes were identified from dex-treated TT8:GR and TTG1:GR, 
respectively, with 137 genes common to both transgenic lines. Interestingly, only 4 
out of 137 common differentially expressed genes differed in expression pattern, 
suggesting many common targets but not all among TTG1 and TT8. This was 
expected since both transcriptional factors have been shown to physically interact 
(baudry et al., 2006).  
 
Gene ontology of differentially expressed genes of loss-of-function mutants and dex-
treated TTG1:GR and TT8:GR transgenic lines were plotted for molecular functions 
and biological processes using http://www.arabidopsis.org/tools/bulk/go/index.jsp. 
Biological processes such as metabolic process, stress response, stress response to 
biotic and abiotic stress, developmental process, protein metabolism, cell organization 
and biogenesis, DNA-RNA metabolism were enriched in all transgenic lines. TTG1 
loss-of-function and dex induced transgenic lines showed high enrichment of 
developmental processes compared to rest transgenic lines which is consistent with 
several reports suggesting TTG1 involved in various developmental processes in 
Arabidopsis. GO subcategories terms of differentially expressed genes for all 
transgenic lines are given in Appendix. For example, GO subcategories term for 
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oxidation-reduction reaction, secondary metabolic process and phenylpropanoid 
biosynthesis process was enriched in both dex-treated TT8:GR and TTG1:GR while it 
was comparatively less in other transgenic lines. 
After GO enrichment analysis, we analyzed genes that showed reciprocal behavior, i.e 
down-regulated in mutant lines and up-regulated in dex-treated transgenic lines and 
vice-versa for TT8 and TTG1. For TTG1, there were 261 common differentially 
expressed genes between ttg1 mutant and dex-treated TTG1:GR, with 185 genes 
showing reciprocal behaviour. Among 185 common genes with reciprocal expression 
pattern, 113 were down-regulated in ttg1 mutant and were up-regulated in dex-treated 
TTG1:GR. Overall, dex-treated TTG1:GR transgenic lines showed increased 
expression of genes that were down-regulated in TTG1 loss-of-function. Among 
common genes showing reciprocal expression pattern in TTG1 loss-of-function and 
dex-induced transgenic lines, genes such as GL2 (Glabra 2), AT1G77210 (sugar 
transporter), AT3G11930 (universal stress protein family protein), ATPSK4 
(Phytosulfokine 4 precursor), ERD5 (Early responsive to dehydration), BGL2 (Beat-
1,3-glucanase 2), VSP1 (Vegetative storage protein 1), PCC1 (Pathogen and circadian 
controlled 1), PR1, PR5, DFR, BAN, TT7, TT10, CYP710A1 (Sterol C 22-desaturase), 
UPPS (Undecaprenyl diphosphate synthase), At5g56300 (methyltransferases; 
predominant methylation of C19-GAs), PPH (Pheophytine pheophorbide hydrolase), 
GPPS (geranyl diphosphate synthase), HPPD (p-hydroxyphenylpyruvate 
dioxygenase), TPS18 (Sesquiterpenoid/diterpenoid synthase TPS13), HPPS (p-
hydroxyphenylpyruvate synthase) and KAO (ent-kaurenoic acid oxidase) were down-
regulated in ttg1 and up-regulated in dex-treated TTG1:GR transgenic lines (Fig 
4.40). As expected, BAN and DFR from phenylpropanoid metabolic network were 
up-regulated in dex-treated TTG1:GR and down-regulated in ttg1 mutant lines. 
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Interestingly, expression levels of TT7 and TT10 from phenylpropanoid metabolic 
network expression showed dependence upon TTG1 which has not been reported 
earlier. Genes related to pathogenesis and circadian controllers such as PCC1, PR1 
and PR5 were significantly down-regulated in ttg1 mutant and were up-regulated in 
TTG1:GR lines. Several genes from isoprenoid metabolic network genes such as 
GPPS, UPPS, CYP710A1, At5g56300, PPH, HPPD, HPPS and KAO showed 
increased expression levels in dex-treated TTG1:GR while were down-regulated in 
ttg1 mutants. Thus genes from phenylpropanoid, isoprenoid metabolic network and 
from biotic-abiotic stress response showed reciprocal expression profile for ttg1 
mutant and dex-treated TTG1:GR transgenic lines. 
 
Apart from genes showing reciprocal behaviour in ttg1 loss-of-function and dex-
induced transgenic lines, there were several other genes that showed increased 
expression in dex-treated TTG1:GR while were unaffected or slightly down-regulated 
(-1 to -1.4-fold change) in ttg1 mutant lines. Genes such as UGT76E12, HMG1, 
HMG2, SUS2, SUS3, SUS4, DMR6, LOX1, LOX5, AOC2, A1CSGL2, YAP169, 
AT1G22400, SAG13, AOXID, CYP71A13, XDH1, XGD1, IBR3, AAO1, ACS2, VSP2, 
DDTG1, DXR and DXPS3 among several others were up-regulated in dex-treated 
TTG1:GR while unaffected in TTG1 loss-of-function transgenic lines. Out of above 
mentioned genes, HMG1, HMG2, DXR, DXPS3, YAP169, UGT76E12 and IBR3 are 
from isoprenoid metabolic network while LOX1, LOX5 and AOC2 are associated with 
jasmonic acid biosynthesis. Overall, isoprenoid metabolic network, phenylpropanoid 
metabolic network, jasmonic acid biosynthesis, scaidonic acid biosynthesis and 
galactose degradation pathways were among major metabolic pathways that were up-
regulated in TTG1:GR transgenic lines in response to dex treatment. Metabolic 
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profiling of dex induced TTG1:GR transgenic lines also showed increased 
accumulation of metabolites from phenylpropanoid and isoprenoid metabolic network 
which was down-regulated in TTG1 loss-of-function mutant lines. Thus, gene 
expression pattern of metabolic pathways was consistent with our metabolic profiling 
results. 
 
Twenty seven genes were selected based on showing reciprocal expression pattern for 
both TT8 and TTG1 to validate micro-array expression profile (Table 4.4). These 27 
genes were grouped under three major categories based on their function, namely 
genes related to metabolic pathway, genes related to biotic stress response and 
glucoside transporters, transferases and hydrolases. In TTG1:GR, all genes grouped 
under metabolic pathway genes were up-regulated in dex-treated TTG1:GR and 
down-regulated in TTG1 loss-of-function mutant lines while only BAN, DFR, 
BR6OX1, CBB2 and GGR showed such reciprocal behaviour in TT8 (Fig 4.41). Also, 
as expected the expression level of BAN and DFR were up-regulated in both dex-
treated TTG1:GR and TT8:GR transgenic lines and down-regulated in their respective 
mutant lines. The expression pattern of only BR6OX1, CBB2 and GGR genes 
grouped under metabolic pathway genes were similar to that observed for BAN and 
DFR while others such as GL2, TT10, HMG2, ISPD and GPPS showed such 
reciprocal behaviour only for TTG1. These results suggests TTG1 to be a universal 
regulator possibly involved in expression regulation for several of these biosynthetic 
genes while TT8 serves as one of the interacting partners of TTG1 which together 
regulates expression of some of these genes. Again, all genes grouped under biotic 
stress resistance genes and glucoside transporters, transferases and hydrolases were 
up-regulated in dex-treated TTG1:GR transgenic lines and down-regulated in TTG1 
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loss-of-function mutant lines while in TT8, all genes except PR1 grouped under biotic 
stress resistance genes and all glucoside transporters, transferases and hydrolases 
genes showed reciprocal behaviour. This suggests involvement of both TTG1 and 
TT8 in regulation of biotic stress response in Arabidopsis.  
To test whether the genes showing reciprocal behaviour are direct targets of TTG1 
and TT8, their expression levels were tested in chx (Cycloheximide), dex+chx, dex 
and mock treated 6-day-old seedlings of TTG1:GR and TT8:GR transgenic lines. The 
expression levels of those genes that would be up-regulated in both dex and dex+chx 
treatments would possibly be direct targets of TTG1 and TT8. In TTG1:GR, the 
expression levels of genes such as CYP76C2, CBB2, PR1 and SUS4 were up-
regulated in dex-treated seedlings while down-regulated in dex+chx treated seedlings 
suggesting TTG1 to be indirectly related to these genes (Fig 4.42F). The expression 
levels of genes such as GPPS, DOGT1, SUC7, NIT4, UGT75B1 and CSLE1 in 
TTG1:GR were up-regulated by dex treatment while moderately up-regulated by 
dex+chx treatment suggesting TTG1 to be involved in regulating the expression level 
of these genes (Fig 4.42-D, E, F). Genes such as GL2, TT10, BAN, DFR, HMG2, 
ISPD, GPPS, BR6OX1, GGR, PR5, LURP1, PCC1, PDR12, SAG13, WAK1, WAK3, 
SUS2 and UGT85A1 showed significant up-regulated expression levels in both dex 
and dex+chx treated TTG1:GR seedlings suggesting TTG1 to be directly involved in 
regulation of expression levels of these genes (Fig 4.42).  
In TT8:GR transgenic lines, genes such as BAN, DFR, GPPS, BR6OX1, GGR, 
LURP1, DOGT1, PCC1, PDR12, SAG13, CY76C2, WAK1, WAK3, SUS2, SUS4, 
SUC7, UGT85A1 and UGT75B1 showed significant up-regulation of expression 
levels for both dex and dex+chx treatment (Fig 4.42-A, B, C). Genes such as BAN, 
DFR, GPPS, BR6OX1, GGR, WAK1, WAK3, PCC1, SUS2, SUC7, UGT85A1, LURP1 
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and SAG13 were significantly up-regulated for dex and dex+chx treatment in both 
TTG1:GR and TT8:GR transgenic lines suggesting TTG1 and TT8 transcriptional 
complex as possible regulator of these genes.  
Our microarray results suggested TTG1 to be involved in regulation of several genes 
from isoprenoid and phenylpropanoid metabolic networks as well as genes related to 
biotic stress response. Quantitative real-time PCR showed genes such as TT10, BAN, 
BR6OX1, CBB2, HMG2, GGR, ISPD, PCC1, GPPS and PDR12 among several others 
to be directly associated with TTG1 expression level and activity. To further test if 
TTG1 physically interacts with promoters of these biosynthetic genes, chromatin 
Immunoprecipitation assay (ChIP) was performed. Anti-GR antibodies were used to 
pull down by chromatin bound GR-tagged TTG1 complexes and using quantitative 
real-time PCR, enrichment of promoters in mock and dex-treated TTG1:GR 
transgenic lines were tested. Western blotting results for anti GR antibodies showed 
specific single band suggesting specificity of ChIP experiment (Fig 4.43A). Western 
blotting results showed increased levels of GR tagged ttg1 in the nucleus compared to 
mock treated transgenic lines while it was undetected in WT. This suggested that dex 
treatment was effective and transgenic lines were not leaky i.e., only dex-treated 
samples showed the protein in nucleus. ChIP samples were then tested for promoter 
enrichment analysis for 10 selected genes using qRT- PCR approach along with actin 
as internal control. Promoter fragment for each gene was selected from their 
respective 0 to -1000 bp regions and 5 sets of primers were designed spanning the 
selected promoter regions of the target genes. Chip-Quantitative qRT-PCR showed 
promoter enrichment for all 10 genes in dex-treated TTG1:GR transgenic lines while 
no effect was observed in mock treated TTG1:GR transgenic lines (Fig 4.43B). This 
confirmed physical interaction of TTG1 with promoters of these genes, and that TTG1 
Results and discussion 
 
Page | 154  
 
as direct regulator of these structural genes. As expected, for BAN, enriched promoter 
were in agreement of bio-informatics predicted regions as well as cis-region predicted 
by promoter fragmentation and GUS assay (Debeaujon et al., 2003). This result was 
consistent with our qRT- PCR data suggesting these genes to be directly associated 
with TTG1. Thus, combining all these results, we have identified new targets of 
TTG1 transcriptional factor. These target genes are related with phenylpropanoid, 
isoprenoid metabolic network as well as pathogen responsive genes, showing the 
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Fig 4.36 2D-PCA plot representing gene expression profile of loss of function and 
inducible over-expression lines with or without dex treatment. Gene expression 
profiling for each transgenic lines were performed for 3 biological replicates. PCA 
showed mock treated TTG1:GR, TT8:GR grouped together while mutants and dex-
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Fig 4.37 Hierarchical clustering of differentially expressed genes of loss of 
function and inducible over-expression lines with or without dex treatment. 
Colour code here represents normalized intensity values of each gene represented in 
the rows. Differential genes were filtered based on p-value≤0.05 and fold change ±2 
in at least one of all transgenic lines. Expression values were averaged across 
biological replicates and each transgenic line had 3 biological replicates that were 
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Fig 4.38 Differentially expressed genes between three loss-of-function transgenic 
lines. Differential genes were filtered based on p-value≤0.05 and fold change ±2 or 
above. Each transgenic line had 3 biological replicates used for microarray 
hybridization and samples for all loss-of-function lines were hybridized on single 
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Fig 4.39 Broad GO categories of differentially expressed genes from mutants and 
inducible over-expression lines. Differentiallly expressed genes of transgenic lines 
were analyzed using online tool (http://www.arabidopsis.org/tools/bulk/go/index.jsp ) and 
% value of each feature enriched was plotted to visualize biological and molecular function 
features enriched in different transgenic lines. Here, differential genes were filtered based 
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Fig 4.40 Heat map of differential gene list from metabolic pathways showing 
reciprocal expression pattern between loss-of-function and dex induced 
transgenic lines. FC stands for fold change. Genes shown here are associated with 
either metabolic pathways or other biological features. Genes that are associated with 
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Table 4.4 List of differentially expressed genes selected for quantitative real time 
PCR analysis. 
















GL2 1.37 -2.10 -2.17 -1.15 1.70 -1.16 -1.11 
TT10 1.35 1.16 -1.04 1.02 44.10 1.08 1.20 
SUS2 -1.04 -1.32 -1.06 1.08 5.10 -1.11 1.13 
SUS4 1.09 -1.54 -1.40 2.25 1.55 1.01 -1.16 
PR5 -1.90 -1.62 1.18 1.18 3.44 4.08 1.89 
ATSUC7 -1.10 1.10 -1.37 3.18 2.33 2.57 2.61 
PR1 -7.59 -5.85 -7.60 -1.03 11.03 9.59 6.66 
LURP1 -2.93 -1.06 -1.67 3.12 3.11 6.12 2.46 
DOGT1 -2.47 -3.13 -1.11 4.98 2.25 1.24 1.22 
PCC1 -3.94 -44.42 -110.25 3.74 18.17 6.01 1.04 
WAK1 -1.68 -1.07 -4.03 3.44 1.90 2.31 1.59 
UGT85A1 -2.13 -4.78 -3.65 2.53 1.73 1.28 1.11 
NIT4 -1.62 -1.73 -1.78 10.04 5.21 1.74 1.64 
WAK3 -1.67 -1.42 -1.73 3.30 2.33 2.21 3.23 
CSLE1 -2.01 -2.17 -1.67 2.00 1.63 1.62 -1.10 
UGT75B1 -1.60 -2.66 -1.46 2.67 1.59 -1.02 1.20 
SAG13 -1.11 -1.10 -1.35 22.11 3.96 2.62 2.05 
PDR12 -1.35 -1.51 -1.25 9.04 2.69 1.09 1.26 
CYP76C2 -1.38 -1.27 -1.23 9.62 9.98 1.35 1.62 
GPPS 1.04 1.13 1.53 1.66 1.14 -1.09 1.20 
BIN2 -1.09 -1.74 -1.59 2.03 3.04 -1.05 2.08 
BR6OX1 -1.58 -1.55 -1.52 3.19 3.02 1.12 1.90 
CBB2 -1.10 -1.99 -1.36 2.50 1.80 1.01 1.08 
GGR -3.01 -1.03 -2.35 3.43 2.27 1.73 1.02 
BAN -2.14 -3.19 -2.07 4.04 5.09 1.86 1.55 
DFR -2.02 -8.14 -5.09 4.24 3.36 1.69 1.99 
myb96 1.94 5.66 1.11 -2.20 -1.32 -1.38 -1.16 
 
Selected genes showed reciprocal expression pattern, i.e. down-regulated in tt8, tt2 
and ttg1 mutant lines while up-regulated in dex-treated TT8:GR and TTG1:GR 
transgenic lines in two tissues, 6 day old seedlings and siliqs. Complex list of genes 
differentially expressed among transgenic lines is shown in Appendix II. Differential 
genes were filtered based on p-value≤0.05 w.r.t respective controls. 
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Fig 4.41 Quantitative real time PCR for 27 selected genes to confirm reciprocal 
expression pattern in tt8, ttg1 mutant lines and dex-treated TTG1:GR and 
TT8:GR transgenic lines w.r.t respective controls. A, represents genes from 
phenylpropanoid and isoprenoid metabolic network; B, represents genes related to 
stress response and C, represents genes from other metabolic pathways such as 
transferases or sugar transporters. These genes were tested for RNA levels in tt8 and 
ttg1 mutant lines and dex-treated TTG1:GR and TT8:GR w.r.t their controls. Ct 
values were normalized against Tubulin and fold change was calculated using ∆∆Ct 
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Fig 4.42 Quantitative real time PCR for 27 selected genes tested in 6 day old 
seedlings of TTG1:GR and TT8:GR transgenic lines with dex, dex+chx, chx and 
mock treatment to identify direct targets of TTG1 and TT8. A,D, represents genes 
from phenylpropanoid and isoprenoid metabolic network; B,E, represents genes 
related to stress response; C,F, represents genes from other metabolic pathways such 
as transferases or sugar transporters. A, B and C represents RNA levels of selected 
genes in TT8:GR transgenic lines tested for dex, dex+chx, chx and mock treatment. 
D, E and F represents RNA levels of selected genes in TTG1:GR transgenic lines 
tested for dex, dex+chx, chx and mock treatment.  These genes were tested for RNA 
levels in mock treated TT8:GR and TTG1:GR transgenic lines. Ct values were 
normalized against Tubulin and fold change was calculated using ∆∆Ct method. Data 
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Fig 4.43 Protein gel blot analysis and ChIP-quantitative real time PCR assay for 
10 selected genes from isoprenoid, phenylpropanoid metabolic pathways and 
stress response process. A, Western blotting showed specificity of used antibodies and 
that only dex-treated transgenic lines showed tagged protein in the nucleus. B, ChIP data 
showed enrichment of promoters of 10 selected genes showing them to be direct targets of 
TTG1. 5 set of primers were designed to cover -1 to -1000bps (P1-P5, where P1 is near 
coding region) of promoter region of all selected genes and were used to perform quantitative 
real time PCR using ChIP samples as template. Y-axis represents normalized Ct value of 
promoter region enriched in ChIP samples while X-axis represents promoter’s fragments 
enriched by 5 primer set designed for each gene promoter (P1-P5). Ct values of Actin were 
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Transparent testa glabra1 (TTG1) encodes a protein containing WD40 repeats (Walker 
et al., 1999), a domain to promote interaction with other proteins and acts as a 
transcriptional factor, TTG1 regulates several developmental and biochemical 
pathways in Arabidopsis. This regulator does not bind directly to chromatin but helps 
in stabilizing complex that binds to chromatin to regulate gene expression. TTG1 has 
been shown to be expressed in all developmental stages in Arabidopsis, corroborating 
its role in more than one biological process. It has been shown to participate in 
regulation of processes such as trichome (formation of hairs on leaves, stems, and 
roots) and the production of seed mucilage and anthocyanin pigments (Walker et al., 
1999; Payne et al., 2000; Gonzalez et al., 2008; Zhao et al., 2008). Several studies 
have shown TTG1 along with GL1, EGL1, GL3, CPC and TRY physically interact 
and form a complex to initiate and regulate trichome formation (Zhang et al., 2003; 
Cheng, 2009). TTG1 is also involved in the regulation of flavonoid production. In ttg1 
mutants, anthocyanins are absent (Shirley et al., 1995) and so are the dense brown 
tannin produced by the inner layer of the integument of the seed coat (Debeaujon et 
al., 2000). As a consequence, the testa of seeds appears transparent in ttg1 mutants. 
The TTG1 protein forms a complex with bHLH and MYB proteins encoded by TT8 
(Nesi et al., 2000) and TT2 (Nesi et al., 2001) to regulate expression of the genes 
encoding enzymes BAN and DFR. 
 
TTG1 is distantly related to the β-subunits of heterotrimeric G proteins, which 
suggests role for TTG1 in signal transduction to multiple downstream transcription 
factors (Walker et al., 1999). Indeed, metabolic profiling results for TTG1 loss-of-
function mutants and its double mutants with tt3, tt4, tt5 and tt6 mutant lines showed 
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TTG1 loss as an important factor resulting in isoprenoid metabolic network 
perturbation along with phenylpropanoid metabolic network, suggesting TTG1 to 
have more targets than the two that have been described till date. Similarly, metabolic 
profiling for tt8 mutant line showed defected glycosylation, a biochemical phenotype 
which was specific to loss-of function of TT8, suggesting more targets of TT8. In 
order to identify direct targets of TTG1 and TT8, dex-inducible TTG1 and TT8 over-
expression transgenic lines and estrogen inducible TTG1 and TT8 silencing 
transgenic lines were generated using amiRNA approach and systems biology 
approach were used to characterize the responses. Due to time constraint, we were not 
able to use inducible transgenic lines to test reciprocal expression pattern and at 
metabolic profiling, as these transgenic lines are at T2 generation. These lines will be 
used in future to further validate the results. 
 
Induced activity of TTG1 in transgenic lines showed ectopic trichome formation on 
petioles and significant increase in number of adaxial trichomes as compared to that 
of mock treatment, which was expected since TTG1 initiates trichome development. 
Interestingly, induced activity of TT8 in transgenic lines also showed ectopic 
trichome formation with increased trichome number, although the effect was less 
pronounced than from TTG1 induction (Fig 4.23-25). Previous studies on trichome 
formation have reported formation of a ternary complex between myb-bHLH-
ttg1transcriptional factors. GL2 as myb factor and GL3, EGL3 as bHLH factor were 
shown as members of ternary complex with TTG1 (Qi et al., 2011). TT8, a bHLH 
transcriptional factor has been shown to work as EGL3 and GL3, although effect of 
TT8 on trichome formation has not been described yet (Zhang et a., 2003; Maes et al., 
2008). Previous studies reported that the triple mutant of tt8/gl3/egl3 has a similar 
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trichome-less phenotype as that of ttg1 loss-of-function mutant line, while tt8 was 
shown to have minimal or no effect on trichome number as compared to that of gl3 
and egl3 mutant lines, which suggested TT8 to be less important for trichome 
formation (Zhang et al., 2003). Our results showed that induced activation of TT8 
alone was sufficient for increased trichome formation, although the effect was less 
pronounced than that observed by TTG1 activation. This result further validates that 
GL3, EGL3 and TT8 have functional redundancies because increased activity of TT8 
is sufficient to increase trichome formation. It would be interesting to test if such 
activation for GL3 or EGL3 also results in ectopic trichome formation and if its effect 
is stronger than that of TT8.  
 
Differential metabolites from induced verses non-induced levels of TTG1 and TT8 in 
6-day-old seedlings of transgenic lines showed high similarity between the two lines. 
Of the 368 metabolites mapped to metabolic pathways, 194 metabolites showed 
similar perturbational trends in both sets of induced transgenic lines with 139 
metabolites up-regulated and 55 being down-regulated. As TTG1 and TT8 share 
common targets for regulation in a single complex, such high similarity of common 
metabolites was indeed expected. Several metabolites from phenylpropanoid 
metabolic network were up-regulated by induction of the two regulators. Metabolites 
such as dihydrokaempferol, quercetin, glucoside derivatives of cyanidin, 
pelarogonidin, quercetin and metabolites intermediates from lignin branch of 
phenylpropanoid metabolic network were up-regulated in these lines. Hence known 
pathways of phenylpropanoid metabolic network were perturbed, thus validating the 
experimental set-up. 
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Interestingly, none of the glucoside or any other sugar conjugated form of kaempferol 
were differentially expressed in both TTG1 and TT8 induced lines. Metabolic 
profiling of tt8 and ttg1 mutant lines showed several sugar conjugated form of 
kaempferol affected specifically in tt8 mutant line. Sugar conjugates of quercetin, 
cyanidin and pelarogonidin showed increased level in both TTG1 and TT8 induced 
lines as compared to that of mock treated transgenic lines, which were down-regulated 
in tt8 mutant line. These observations thus suggest role of TT8 in regulation of 
glycosylation process involving quercetin, cyanidin and pelarogonidin as substrate, 
while having minimal or no effect on kaempferol. Methylated and sulphated forms of 
quercetin were up-regulated by TTG1 and TT8 up-regulation suggesting members of 
these processes as potential targets regulated by the two transcriptional factors. 
Quercetin and kaempferol compete for conjugation with sugar molecules (Burbulis et 
al., 1999), which appears to be favoured to quercetin in TT8-induced transgenic lines. 
Glycosylation of metabolites were also affected by TTG1 induction, but only few 
metabolites were up-regulated compared to those upon TT8 induction. Since 
glycosylation occurs through activity of UGTs, which shows specificity both the 
aglycone substrate to be glycosylated as well as type of sugar molecule conjugated, 
one of the possible explanation for this specificity could be TT8 acting as regulator of 
glucoside transferases, which act specifically on quercetin aglycone. Reverse genetics 
using the advantage of a huge amount of microarray data publically available through 
sources such as Genevestigator and TAIR could be used to identify if any quercetin-
specific glucoside transferases have correlation of expression with TT8. We are 
intending to perform ChIP-seq for samples from TT8-induced transgenic lines and 
compare with non-induced forms to further identify carbohydrate active genes that 
might be involved in glycosylation process.  
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Metabolic perturbation in TTG1 and TT8 induced lines were not limited to 
phenylpropanoid metabolic network, but also included novel targets of isoprenoid and 
its branch pathways. Both MVP and MEP pathways that synthesize, precursors of 
isoprenoids (IPP and DMAPP) were up-regulated in TTG1 induced lines while down-
regulated in ttg1 mutant line. Branch pathways of isoprenoid metabolic network such 
as trans-zeatin biosynthesis, and biosynthetic pathways of brassinosteroids , 
carotenoids , abscisic acid, tocopherols , cytokinins , gibberellin (non C-3, non C-13 
hydroxylation), and chlorophyll a  along with other metabolic pathways were up-
regulated upon induction of TTG1 while down-regulated in ttg1 mutant line (Fig 
4.35). Isoprenoids are linked very tightly and are formed by several condensation 
reactions of a single precursor (Vranova´ et al., 2012). Further studies on MVP and 
MEP pathways have shown to have a crosstalk between these two cytosolic and 
plastid localized pathways (Laule et al., 2003). Interestingly, some of these pathways 
occur in different compartments. MVP pathways, being cytosolic, could be explained 
by possibilities that expressions of key structural genes from MVP pathways are 
regulated by TTG1. MEP pathways being located in plastids and up-regulated by 
TTG1 could be the result of crosstalk with MVP as described by Laule et al. (2003). 
Another possibility could be TTG1 directly or indirectly regulating genes from 
plastids. It is not clear if TTG1 may enter plastids to regulate their structural genes, or 
it can influence gene expression in plastids by any indirect mechanism. Experiments 
can be designed to track intracellular localization of TTG1 to answer parts of this 
question. Detailed knowledge of chloroplast gene expression and the nucleus-encoded 
proteins that influence it are prerequisites for understanding nuclear-organellar cross 
talk and chloroplast evolution, and will aid in optimizing transgene expression in the 
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plastid compartment. TT8 induction also showed increased accumulation of 
metabolites from isoprenoid metabolic network, but its effect was not as pronounced 
as that from TTG1 induction (Fig 4.34). For instance, IPP and DMAPP, precursor of 
isoprenoid metabolic network were down-regulated upon TT8 induction, while 
metabolites from mevalonate and methylerythritol phosphate pathway showed 
increased accumulation. Further, three out of nine metabolites from methylerythritol 
phosphate pathway were up-regulated compared to six metabolites being up-regulated 
in dex-treated TTG1:GR transgenic lines. These results shows TTG1 induced 
transgenic lines to have higher levels of isoprenoid compared to that of TT8 induced 
transgenic lines.  
 
Metabolic profiling of gain- and loss-of-function transgenic lines of TTG1 and TT8 
revealed several important metabolic pathways being affected by these transcriptional 
factors. TTG1 and TT8 being the two transcriptional factors, regulates metabolic 
pathways by exerting a control over expression levels of biosynthetic genes associated 
with these metabolic pathways. To identify target genes of TT8 and TTG1, 
microarray-based gene expression analysis of dex and mock treated TTG1:GR, 
TT8:GR and loss-of-function TT2, TT8 and TTG1 mutant lines were performed. 
Differential genes for tt8, ttg1 and tt2 showed high similarity with similar expression 
pattern for 273 genes out of 332 common genes. Since complex formed by TT2, TT8 
and TTG1 have been shown to regulate expression of BAN and DFR (Baudry et al., 
2004, 2006), some level of similarity of expression pattern was expected. The tt2 
mutant line showed fewer differentially expressed genes as compared to tt8 and ttg1 
mutant lines. This could be possibly due to TT2 being involved in regulation of few 
processes and its specific interaction with TT8 and TTG1. On the other hand, TT8 and 
Results and discussion 
 
Page | 177  
 
TTG1 has been shown to play a major role in regulation of several developmental and 
metabolic pathways, thus, their loss-of-function mutant lines showing higher number 
of differentially expressed genes was expected. Gene expression profile of loss-of-
function of TTG1, TT8 and their induced forms in transgenic lines revealed similar 
expression pattern of several genes. GO analysis of loss-of-function of TT2 and TTG1 
and induced forms of TTG1 and TT8 in transgenic lines showed enrichment of several 
features in these transgenic lines (Fig 4.39). TTG1 loss-of-function mutant line and 
dex-treated TTG1:GR showed enrichment of several developmental processes. This 
observation was in accordance with earlier studies, which reported TTG1 to be 
involved in several developmental processes such as trichome development, root hair 
development and elongation, seed coat formation and several others. The tt8 mutant 
line and its induced over-expression lines showed enrichment of hydrolases and 
transferases process, some of which have been reported previously (Zhang et al., 
2003; Zhang et al., 2007; Qi et al., 2011). Interestingly, TT8 and TTG1 loss-of-
function and their induced activity in transgenic lines also showed enrichment of 
biotic and abiotic stress response processes. GO enrichment analysis thus implicated 
role of TT8 and TTG1 to be involved in metabolic processes and extending to other 
processes related to biotic and abiotic responses. Isoprenoid and phenylpropanoid 
metabolic networks contribute to those metabolites, which play a major role in 
conferring biotic and abiotic stress responses. For instance, flavonoids and camalexins 
from phenylpropanoid metabolic network participate in UV damage and pathogenic 
infection responses in plants. Thus, enrichment of biotic and abiotic stress response in 
dex-treated TTG1:GR and TT8:GR indirectly relates TTG1 and TT8 to stress 
responsive metabolic pathways including phenylpropanoid and isoprenoid metabolic 
network. 
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We then focused on those genes that showed reciprocal expression patterns between 
loss-of-function and dex induced transgenic lines, and gave more weightage for genes 
showing similar expression pattern for TT8 and TTG1 loss or gain-of-function 
transgenic lines. Comparison of gene expression profiles of tt8, ttg1, dex-treated 
TTG1:GR and TT8:GR helped in identifying 185 genes showing reciprocal behavior 
pattern along with several other genes that were up-regulated in dex-treated TTG1:GR 
and TT8:GR transgenic lines but were not differentially expressed in ttg1 and tt8 
mutant lines. Metabolic pathwayassociated genes such as PBS3, TT10, GL2, BAN, 
DFR, CBB2, BIN2, HMG2, BR6OX1, GGR, GPPS, ISPD, UGT85A1 and UGT75B1 
showed reciprocal expression pattern. BAN and DFR showing reciprocal expression 
patterns was expected since these genes are reported to be direct targets of TT8 and 
TTG1. Genes such as CBB2, BIN2, BR6OX1, HMG2, GGR, GGPS and ISPD 
associated with isoprenoid metabolic network were up-regulated in dex-treated 
TTG1:GR transgenic lines while were down-regulated in ttg1 mutant line. Apart from 
metabolic genes, other genes related to biotic and abiotic stress responses such as 
PR1, PR5, PCC1, PBS3, WAK1 and PDR12 also showed reciprocal behavior for 
TTG1. Genes such as SUC7, SUS2, SUS4, CSLE1 serve as sugar transporter and 
transferases and were seen to be up-regulated in TTG1 or TT8 induced transgenic 
lines and down-regulated in ttg1 and tt8 mutant lines. Functions of all these genes 
have been described previously using mutant associated phenotypes (Sauer et al., 
2004), but their regulation is still not well understood.  
 
From the list of genes showing reciprocal behavior, twenty seven genes were selected 
and further tested for gene expression in lines carrying loss- or induction of TTG1 and 
TT8. Quantitative real-time PCR data for these genes showed similar expression 
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pattern as that was observed by microarray gene expression. Cycloheximide (chx) 
treatment combined with TTG1 and TT8 induction helped us to identify genes 
affected at transcriptional level. Genes such as GL2, TT10, BAN, DFR, HMG2, ISPD, 
GPPS, BR6OX1, GG2, PR5, LURP1, PCC1, PDR12, SAG13, WAK1, UGT85A1 and 
SUS2 are likely to be direct targets of TTG1 (Fig 4.40). For TT8, genes such as SUS4, 
SUC7, UGT75B1 and CSLE1 were observed as direct targets, while these genes were 
not detected in TTG1 set of transgenic lines suggesting them to be indirect targets of 
TTG1. These observations revealed that apart from BAN, DFR, UGT85A1, PCC1, 
PDR12, and WAK1, which seemed to be direct targets of both TTG1 and TT8, there 
were several other genes that were direct target for one but not for the other. Although 
TTG1 has been shown to interact with other transcriptional factors such as GL3 and 
EGL3, TT8 has only been shown to interact with TTG1 and TT2 to regulate the 
expression of target genes. Our data suggests possibility of additional partners of TT8 
other than TTG1 for regulation of sugar transporters and transferases, which are direct 
targets of TT8. Hence, their possible regulation by TTG1 and TT8 opens new research 
avenues to pursue. 
 
From the list of genes shown to be the direct targets of TTG1, ten genes were selected 
to perform the ChIP experiment in order to confirm whether TTG1 directly binds to 
promoter region of these selected genes. TTG1 has been reported to bind to the 
promoter of BAN; hence BAN was used as a control. ChIP-RT-PCR results showed 
the enrichment of promoters of all ten genes, namely TT10, HMG2, GGR, BAN, 
PCC1, BR6OX1, GPPS, ISPD, PDR12 and CBB2 (Fig 4.41). Among these, GGR, 
HMG2, GPPS, ISPD and BR6OX1, are all associated with MVP pathway from 
isoprenoid metabolic network, while BAN and TT10 are from phenylpropanoid 
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metabolic network. We intentionally did not select genes specific to MEP pathways, 
since only DXR from MEP pathways showed reciprocal expression patterns in TTG1 
and TT8, and we do not have any experimental proof if TTG1 could be a direct target 
for genes from MEP pathways. Thus, using systems biology approach, this study has 
identified nine new targets of TTG1. Our study confirmed the involvement of TTG1, 
having four WD40 repeat domains, in regulation of several processes. ChIP-Seq of 
ChIP samples of TTG1:GR would play an important role in identification of different 
motifs and target genes to further improve our knowledge of TTG1-mediated 
regulation of different processes. 
 
These results taken together confirmed TTG1 as a common regulator for genes from 
both isoprenoid and phenylpropanoid metabolic networks, and explain the crosstalk 
observed between these two secondary metabolism pathways (Fig 4.42). ChIP assay 
also confirmed PCC1 and PDR12, of biotic and abiotic stress response pathways to be 
regulated by TTG1. This is an interesting finding since there is no systems level study 
that reports direct regulation of abiotic and biotic responsive genes by a known 
regulator of secondary metabolism pathway (such as TTG1 in this case). Apart from 
these two, there were other genes such as PR1, PR5, WAK1, WAK3 and SAG13, 
which also showed reciprocal gene expression behavior, and could be direct targets of 
TTG1. This study has thus identified a common regulatory mechanism for stress-
response pathways and distant secondary metabolic networks. Therefore, a 
longstanding question of how secondary metabolism network is triggered during 
stress response seems to have been partially answered. Further studies involving this 
mechanism will be useful in better understanding of how plants coordinate their large-
scale responses to various biotic and abiotic stresses. 
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Fig 4.44 Cross-talk between isoprenoid and phenylpropanoid metabolic network 
mediated by TTG1 through transcriptionally regulating biosynthetic genes from 
these pathways. Genes shown connected to TTG1 are those which were confirmed 
through ChIP as directly associated with TTG1. Enzymes full name described here 
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CHAPTER 5 
CONCLUSIONS, INFERENCES AND FUTURE DIRECTIONS 
 
5.1 Conclusions and inferences 
In this chapter the main conclusions derived from this study are presented, as well as 
the possible future research which should contribute to elucidation of some of the 
issues which were not covered here. 
Major conclusions from this research are summarized as follows. 
 Metabolic profiling of QuoA transgenic lines and comparative analysis with 
tt6 mutant lines showed that lignification of transgenic lines resulted at the 
expense of phenolamide metabolic pathway. Further study on association of 
phenolamide and lignin pathway can give us an important tool to manipulate 
lignin metabolic pathway. 
 Gene-metabolite association in phenylpropanoid metabolic network in QuoA 
transgenic lines showed metabolic network to be tightly regulated at the 
branch points. All five branch points of phenylpropanoid metabolic network 
showed increased levels of metabolites and down-regulation of associated 
genes, suggesting possibility of feed-back regulation at all the branch points.  
 Metabolic profiling of dex-treated TTG1:GR showed increased levels of 
metabolite intermediates from phenylpropanoid and isoprenoid metabolic 
network, thus showing for the first time direct association of two secondary 
metabolic pathways via a common transcriptional regulator.  
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 Metabolic profiling of tt8 mutant line showed specificity to glycosylation of 
quercetin, kaempferol, cyanidin and pelarogonidin with quercetin and cyanidin 
showing reciprocal behavior as compared to that of kaempferol and 
pelarogonidin. On the other hand, dex-treated TT8:GR showed increase in the 
glycosylation of several metabolites such as quercetin, cyanidin, 
pelarogonidin, zeatin, cytokinins and others, although no effect was observed 
for kaempferol and its glycosylated metabolites.  
 Several genes from different metabolic pathways such as TT10, GL2, BAN, 
DFR from phenylpropanoid pathway and GGR, HMG2, ISPD, GPPS, CBB2, 
BIN2, BR6OX1 from isoprenoid metabolic network were up-regulated in  dex 
treated TTG1:GR and TT8:GR transgenic lines while down-regulated in ttg1 
and tt8 mutant lines. Dex-treated TT8:GR transgenic lines also showed up-
regulation of several transferases while hydrolases were down-regulated. 
 Several genes related to pathogen resistance and response process such as 
PCC1, PR1, PR5, WAK3, PAD3 were up-regulated in dex treated TTG1:GR 
and TT8:GR transgenic lines while down-regulated in their mutant lines. 
 ChIP analysis for TTG1:GR transgenic lines using antiGR antibody and 
quantitative RT-PCR based approach showed secondary metabolic genes and 
stress responsive genes as direct targets of TTG1. This is the first report 
showing common regulatory mechanism for stress-response pathways and 
distant secondary metabolic networks. Therefore, a longstanding question of 
how secondary network triggered during stress response seems to have been 
partially answered.  
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5.2 Future directions 
Some specific lines of future investigations are listed below 
 QuoA activity resulted simultaneous accumulation of lignin and anthocyanin. 
It would be interesting to test this system in model crop species, such as Rice 
to study if perturbation resulting from QuoA leads to similar phenotype. 
Increased anthocyanin and lignification are very useful traits and hence will 
improve rice variety. 
 The mechanisms to regulate isoprenoid pathways described in this study can 
be used to develop synthetic compounds in yeast or other heterologous hosts.  
 The stress responsive of transgenic lines with altered expression of TTG1 or 
TT8 can be studied. Outcomes of these investigation will have develop 
improve stress responsiveness of plants. 
 ChIP-Seq could be performed for TTG1 and TT8 to identify the type of 
domains and target genes that are being regulated by these transcriptional 
factors. Identifying direct targets of these two regulators will help in 
modifying or enhancing stress responsiveness in plant.  
 
Taken together, these future directions will help not only in improving our 
understanding of relationship between stress response and secondary metabolism in 
plants, but it will also be useful in improving plant performance and in biotech 
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GO subcategories enriched in differentially expressed gene list from mutants and inducible 
over-expression lines 




oxidation reduction 5.548098 5.398111 5.409091 9.05982906 9.333333 
secondary metabolic process 2.46085 2.519118 3.977273 4.273504274 3.111111 
response to water 2.639821 1.079622 2.159091 1.709401709 2.888889 
response to water deprivation 2.595078 1.079622 2.159091 1.709401709 2.444444 
phenylpropanoid biosynthetic 
process 
0.805369 0.899685 0 1.452991453 1.333333 
response to organic substance 7.785235 0 9.886364 9.05982906 7.777778 
response to endogenous stimulus 6.353468 0 7.5 7.692307692 7.333333 
response to hormone stimulus 6.085011 0 6.931818 7.094017094 6.444444 
response to oxidative stress 1.744966 1.979307 3.863636 5.299145299 0 
response to temperature stimulus 2.818792 2.384166 3.75 4.957264957 0 
response to radiation 3.176734 2.834008 5.113636 4.444444444 0 
response to light stimulus 3.176734 2.699055 5.113636 4.358974359 0 
intracellular signaling cascade 4.250559 0 0 4.273504274 0 
response to heat 0.760626 1.124606 1.477273 3.931623932 0 
response to osmotic stress 3.131991 2.024291 3.181818 2.991452991 0 
cellular response to hormone 
stimulus 
2.550336 0 0 2.991452991 0 
hormone-mediated signaling 2.550336 0 0 2.991452991 0 
response to salt stress 2.639821 0 3.068182 2.820512821 0 
response to bacterium 1.47651 0 2.386364 2.735042735 0 
cellular amino acid derivative 
biosynthetic process 
1.073826 1.304543 1.477273 2.051282051 0 
response to ethylene stimulus 1.923937 0 2.5 1.709401709 0 
defense response to bacterium 1.252796 0 1.818182 1.709401709 0 
response to carbohydrate stimulus 1.655481 0 3.181818 1.623931624 0 
response to high light intensity 0.357942 0 0.795455 1.623931624 0 
response to red or far red light 1.655481 1.169591 2.840909 1.452991453 0 
toxin catabolic process 0.357942 0.494827 0.681818 1.367521368 0 
toxin metabolic process 0.357942 0.494827 0.681818 1.367521368 0 
cellular polysaccharide metabolic 
process 
0.939597 1.124606 1.590909 1.282051282 0 
response to chitin 1.252796 0 2.386364 1.196581197 0 
response to salicylic acid stimulus 1.073826 0.854701 1.363636 1.111111111 0 
response to gibberellin stimulus 1.252796 0 1.25 1.025641026 0 
cellular glucan metabolic process 0.760626 0.989654 1.590909 1.025641026 0 
response to red light 0.805369 0.62978 1.25 0.598290598 0 
glycosinolate metabolic process 0.357942 0.359874 0 0.512820513 0 
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S-glycoside metabolic process 0.357942 0.359874 0 0.512820513 0 
glucosinolate metabolic process 0.357942 0.359874 0 0.512820513 0 
lignin biosynthetic process 0.357942 0 0 0.512820513 0 
heat acclimation 0.223714 0 0 0.512820513 0 
response to reactive oxygen species 0 1.124606 2.045455 3.846153846 1.555556 
response to hydrogen peroxide 0 0.989654 1.931818 3.760683761 1.333333 
oxygen and reactive oxygen 
species metabolic process 
0 0.674764 1.136364 2.307692308 1.777778 
cellular response to reactive 
oxygen species 
0 0.674764 1.136364 2.136752137 1.555556 
cellular response to oxidative stress 0 0.674764 1.136364 2.136752137 1.555556 
cellular response to hydrogen 
peroxide 
0 0.584795 1.136364 2.136752137 1.333333 
hydrogen peroxide catabolic 
process 
0 0.584795 1.136364 2.136752137 1.333333 
hydrogen peroxide metabolic 
process 
0 0.584795 1.136364 2.136752137 1.333333 
lipid localization 0 0.989654 1.704545 1.794871795 5.333333 
lipid transport 0 0.989654 1.590909 1.794871795 4 
phenylpropanoid metabolic process 0 1.034638 0 1.709401709 1.555556 
response to cold 2.192394 1.214575 2.272727 0 2 
aging 0 0.494827 0 0 1.111111 
systemic acquired resistance 0 0.31489 0 0 0.888889 
cell wall organization 0 0 0 2.905982906 3.333333 
external encapsulating structure 
organization 
0 0 0 2.905982906 3.333333 
plant-type cell wall organization 0 0 0 2.222222222 1.111111 
cell wall modification 0 0 0 2.051282051 2 
response to oxygen levels 0 0 0 0.341880342 0.666667 
response to hypoxia 0 0 0 0.341880342 0.666667 
































 GGR  
     
farnesyl diphosphate biosynthesis 
 GGPS6  
     
farnesyl diphosphate biosynthesis 
GPPS 
     
farnesyl diphosphate biosynthesis 
 UGT73B2  
     
2,4,6-trinitrotoluene degradation 
AT1G05680 
     
2,4,6-trinitrotoluene degradation 
 UGT73B4  
     
2,4,6-trinitrotoluene degradation 
 PKT3 
     
4-hydroxybenzoate biosynthesis V 
 ATASE2 
     
ribonucleotide biosynthesis I 
UGT75B1  
     
abscisic acid glucose ester 
biosynthesis 
 SAG13  
     
acetaldehyde biosynthesis I 
 ADH1 
     
acetaldehyde biosynthesis I 
 PDC2  
     
acetaldehyde biosynthesis I 
 AOX1D  
     
aerobic respiration 
 UGT72E2  
     
anthocyanin biosynthesis 
 UGT71D1  
     
anthocyanin biosynthesis 
 ASP4  
     
aspartate biosynthesis 
CBB3 
     
brassinosteroid biosynthesis I 
 BR6OX1 
     
brassinosteroid biosynthesis I 
 ROT3  
     
brassinosteroid biosynthesis I 
 BAS1 
     
brassinosteroids inactivation 
UGT73C5  
     
brassinosteroids inactivation 
 PAD3 
     
camalexin biosynthesis 
 CYP71A12  
     
camalexin biosynthesis 
 CYP71A13  
     
camalexin biosynthesis 
AT1G12640 
     
CDP-diacylglycerol biosynthesis I 
 ATCSLE1 
     
cellulose biosynthesis 
 ATCSLG2 
     
cellulose biosynthesis 
 PCB2  
     
chlorophyllide <i>a</i> biosynthesis 
I 
 SQP2  
     
cholesterol biosynthesis I 
 SQS1 
     
cholesterol biosynthesis I 
 SQS2 
     
cholesterol biosynthesis I 
AT1G73600 
     
choline biosynthesis I 
 PYK10 
     
coumarin biosynthesis (via 2-
coumarate) 
 BGLU21  
     
coumarin biosynthesis (via 2-
coumarate) 
 BGLU10  
     
coumarin biosynthesis (via 2-
coumarate) 
 BGLU27  
     
coumarin biosynthesis (via 2-
coumarate) 
 DIN2 
     
coumarin biosynthesis (via 2-
coumarate) 
 NIT4  
     
cyanide detoxification II 
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UGT73C5  
     
cytokinins glucoside biosynthesis 
 CKX4 
     
cytokinins degradation 
 UGT85A1 
     
cytokinins glucoside biosynthesis 
AT2G36780 
     
cytokinins glucoside biosynthesis 
 UGT76E12  
     
cytokinins glucoside biosynthesis 
 CAT1  
     
ethanol degradation IV  
 ACS2 
     
ethylene biosynthesis I  
 CAC1 
     
fatty acid biosynthesis initiation I 
GPP2  
     
flavin biosynthesis I  
 DMR6  
     
flavonoid biosynthesis 
ATSRG1  
     
flavonoid biosynthesis 
 SUS4 
     
galactose degradation III 
 SPS2  





     
gibberellin inactivation I 
AT1G14130 
     
gibberellin inactivation I  
 PGM  
     
gluconeogenesis I 
AT2G25450 
     
glucosinolate biosynthesis 
 CYP79F2  
     
glucosinolate biosynthesis 
NSP1 
     
glucosinolate breakdown 
 NSP5  
     
glucosinolate breakdown 
 GDH2  
     
glutamate degradation I 
 GAD4  
     
glutamate degradation IV 
 PPDK  
     
glutamine biosynthesis III 
 ATGPX6 
     
glutathione redox reactions I 
GST20  




     
glutathione-mediated detoxification 
II 
 ATGSTU11  




     
glutathione-mediated detoxification 
II 
 ADS1  
     
glycolipid desaturation 
 PFK3  
     
glycolysis I 
XDH1  
     




     
homogalacturonan degradation 
AT5G49180 





     
homogalacturonan degradation 
 AAO1 
     
IAA biosynthesis I 
 NIT2  
     
IAA biosynthesis I 
 IAR3 
     
IAA biosynthesis II 
 IBR3  
     
IAA biosynthesis VII 
AT4G18440 
     
inosine-5'-phosphate biosynthesis II 
 BCAT4  
     
isoleucine biosynthesis I 
ACAT2  
     
isoleucine degradation I 
 ACX1 
     
jasmonic acid biosynthesis 
 OPR2 
     
jasmonic acid biosynthesis 
 BEN1  
     
leucodelphinidin biosynthesis 
AT1G09500 
     
leucodelphinidin biosynthesis 
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 CYP89A5  
     
leucodelphinidin biosynthesis 
AT1G76470 
     
leucodelphinidin biosynthesis 
LUT5  
     
lutein biosynthesis 
 ISPD 
     
methylerythritol phosphate pathway 
 DXPS1  
     
methylerythritol phosphate pathway 
 ISPF, 
MECPS  
     
methylerythritol phosphate pathway 
GST8  
     
methylglyoxal degradation I 
 HMG1 
     
mevalonate pathway I 
AT1G31910 
     
mevalonate pathway I 
 HMG2 
     
mevalonate pathway I 
 PAP3 
     
NAD/NADH 
 PSAD-2  
     
oxygenic photosynthesis 
AT5G39050 




     
phenylpropanoid biosynthesis 
CAD1  
     
phenylpropanoid biosynthesis 
 CAD5 
     
phenylpropanoid biosynthesis 
PSBQ-2 
     
photosynthesis light reactions 
 CYP710A1  
     
plant sterol biosynthesis 
 atnudt21  
     
pyridine nucleotide cycling (plants) 
 NAPRT1  
     
pyridine nucleotide cycling (plants) 
 UGT73B3  
     
quercetin glucoside biosynthesis 
(Arabidopsis) 
SCPL19  
     
sinapate ester biosynthesis 
 SPDS3 
     
spermidine biosynthesis I 
AT1G69200 
     
sucrose degradation III 
AT5G51830 
     
sucrose degradation III 
AT4G33070 
     
sucrose degradation to ethanol and 
lactate (anaerobic) 
 NPQ1 
     




     
superpathway of carotenoid 
biosynthesis 
LUT5  
     
superpathway of carotenoid 
biosynthesis 
 LUT2  
     
superpathway of carotenoid 
biosynthesis 
CHY2  
     
superpathway of carotenoid 
biosynthesis 
 ABA1 
     
superpathway of carotenoid 
biosynthesis 
 TSB1 
     
phenylalanine, tyrosine and 
tryptophan biosynthesis 
AT3G49160 
     
 starch degradation to pyruvate 
 BAM1 
     
sucrose and starch metabolism II 
AT3G44830 
     
triacylglycerol biosynthesis 
TLL1  
     
triacylglycerol degradation 
 ATBCAT-2  
     
valine biosynthesis 
 HPT1 
     
vitamin E biosynthesis 
 XGD1  
     
xylogalacturonan biosynthesis 
       
 

















List of differential metabolites in tt8 mutant line w.r.t Wild type. A part of this list has been 
described in figure 4.20. These metabolites were identified and mapped to metabolic 
pathways using Aracyc databases 
 
Mass fold Common_Name Pathway 
290.163 -19.73 
D-sedoheptulose-7-
phosphate (deoxy)ribose phosphate degradation 
227.219 6.44 deoxycytidine (deoxy)ribose phosphate degradation 
214.111 -3.56 deoxyribose-1-phosphate (deoxy)ribose phosphate degradation 









1,4-dihydroxy-2-naphthoate biosynthesis II 
(plants) 
744.418 -74.12 NADP+ 2,3-cis-flavanols biosynthesis 
301.232 32.51 delphinidin 2,3-cis-flavanols biosynthesis 
348.2 4.07 
2-O-(6-phospho-alpha-
mannosyl)-D-glycerate 2-O-alpha-mannosyl-D-glycerate degradation 
103.121 -2.68 4-aminobutyrate 4-aminobutyrate degradation I 
600.88 -16.00 9'-cis-neoxanthin abscisic acid biosynthesis 
384.558 16.00 C25-allenic-apo-aldehyde abscisic acid biosynthesis 
426.463 -4.84 abscisic acid glucose ester abscisic acid glucose ester biosynthesis 
666.583 -2.72 stachyose ajugose biosynthesis (galactinol-dependent) 
180.157 2.56 myo-inositol ajugose biosynthesis (galactinol-dependent) 
104.111 -2.85 3-cyanopyridine aldoxime degradation 
122.126 -2.19 E-pyridine-3-aldoxime aldoxime degradation 
122.126 -2.19 nicotinamide aldoxime degradation 
134.091 2.22 (S)-ureidoglycolate 
allantoin degradation to ureidoglycolate 
(ammonia producing) 
867.608 -2.90 succinyl-CoA alpha-ketoglutarate dehydrogenase complex 
174.11 9.21 L-dehydro-ascorbate antheraxanthin and violaxanthin biosynthesis 
287.248 2.73 cyanidin 
anthocyanin biosynthesis (pelargonidin 3-O-
glucoside, cyanidin 3-O-glucoside) 
507.183 -4.13 ATP arginine biosynthesis II (acetyl cycle) 
113.116 -3.70 pyrroline 5-carboxylate arginine degradation II 
60.055 -2.04 urea arginine degradation II 
605.345 16.00 GDP-L-gulose ascorbate biosynthesis II (L-gulose pathway) 
180.157 2.56 L-gulose ascorbate biosynthesis II (L-gulose pathway) 
605.345 16.00 GDP-L-galactose ascorbate biosynthesis III (VTC2 cycle) 
Page | 208  
 
605.345 16.00 GDP-D-glucose 
ascorbate biosynthesis IV (extended VTC2 
cycle) 
90.079 -2.13 3-hydroxy-propionate beta-alanine biosynthesis II 
132.119 2.09 3-ureidopropionate beta-alanine biosynthesis III 
418.702 11.21 (6alpha)-hydroxycampestanol brassinosteroid biosynthesis I 
450.701 -8.94 6-deoxocastasterone brassinosteroid biosynthesis I 
416.686 -8.56 6-oxocampestanol brassinosteroid biosynthesis I 
432.685 -5.13 
3-dehydro-6-
deoxoteasterone brassinosteroid biosynthesis I 
432.685 -5.13 cathasterone brassinosteroid biosynthesis I 
400.687 3.29 (5alpha)-campestan-3-one brassinosteroid biosynthesis I 
434.701 -2.97 6-deoxoteasterone brassinosteroid biosynthesis I 
434.701 -2.97 6-deoxotyphasterol brassinosteroid biosynthesis I 
448.685 -2.63 teasterone brassinosteroid biosynthesis I 
448.685 -2.63 typhasterol brassinosteroid biosynthesis I 
466.7 2.04 6alpha-hydroxy-castasterone brassinosteroid biosynthesis I 
418.702 11.21 6-deoxocathasterone brassinosteroid biosynthesis II 
416.686 -8.56 
(22alpha)-hydroxy-5alpha-
campestan-3-one brassinosteroid biosynthesis II 
416.686 -8.56 
(22alpha)-hydroxy-
campesterol brassinosteroid biosynthesis II 
414.67 4.67 
(22alpha)-hydroxy-campest-
4-en-3-one brassinosteroid biosynthesis II 
400.687 3.29 campest-4-en-3beta-ol brassinosteroid biosynthesis II 
180.157 2.56 2-carboxy-arabinitol CA1P biosynthesis 
180.157 2.56 hamamelose CA1P biosynthesis 
340.117 -2.26 
hamamelose-21,5-
bisphosphate CA1P biosynthesis 
186.058 20.53 3-phosphoglycerate Calvin cycle 
370.143 -2.11 
D-sedoheptulose-1,7-
bisphosphate Calvin cycle 
893.503 3.52 chlorophyll a chlorophyll a biosynthesis I 
891.487 -5.40 
tetrahydrogeranylgeranyl-
chlorophyll a chlorophyll a biosynthesis II 
887.455 2.91 geranylgeranyl-chlorophyll a chlorophyll a biosynthesis II 
630.982 -2.50 7-hydroxy-chlorophyllide a chlorophyll cycle 
598.983 -3.19 
Mg-protoporphyrin 
monomethyl ester chlorophyllide a biosynthesis 
396.655 -11.07 
4alpha-methyl-5alpha-
cholesta-8,24-dien-3-one cholesterol biosynthesis 
428.654 -6.39 
4alpha-carboxy-5alpha-








ol cholesterol biosynthesis 





3beta-ol cholesterol biosynthesis 
382.628 2.51 
5alpha-cholesta-8,24-dien-3-
one cholesterol biosynthesis 
61.083 -2.41 ethanolamine choline biosynthesis II 
75.11 -2.07 N-monomethylethanolamine choline biosynthesis II 
254.133 56.98 shikimate-3-phosphate chorismate biosynthesis 
172.137 -5.33 3-dehydro-shikimate chorismate biosynthesis 
190.152 -2.56 3-dehydroquinate chorismate biosynthesis 
174.153 -2.25 shikimate chorismate biosynthesis 
324.18 2.18 
5-enolpyruvyl-shikimate-3-
phosphate chorismate biosynthesis 
431.341 -5.22 
cis-zeatin riboside 
monophosphate cis-zeatin biosynthesis 
785.556 17.20 FAD citrulline biosynthesis 




CMP-KDO biosynthesis II (from D-ribulose 5-
phosphate) 
687.554 -23.51 dephospho-CoA coenzyme A biosynthesis 
60.032 -2.04 carbamate cyanate degradation 
147.13 -4.75 O-acetyl-L-serine cysteine biosynthesis 
377.356 16.00 kinetin-7-N-glucoside cytokinins 7-N-glucoside biosynthesis 
543.53 16.00 
trans-zeatin-O-glucoside-7-N-
glucoside cytokinins 7-N-glucoside biosynthesis 
377.356 16.00 kinetin-9-N-glucoside cytokinins 9-N-glucoside biosynthesis 
335.362 -2.34 isopentenyl adenosine cytokinins degradation 
545.545 -3.85 
dihydrozeatin-9-N-glucoside-
O-glucoside cytokinins-O-glucoside biosynthesis 
314.188 6.37 
5'-phosphoribosyl-N-
formylglycineamide de novo biosynthesis of purine nucleotides 
338.213 -3.31 AICAR de novo biosynthesis of purine nucleotides 
339.198 3.27 
4-carboxyaminoimidazole 
ribonucleotide de novo biosynthesis of purine nucleotides 
463.297 2.06 adenylo-succinate de novo biosynthesis of purine nucleotides 
468.144 8.58 dUTP 
de novo biosynthesis of pyrimidine 
deoxyribonucleotides 
308.184 6.70 dUMP 
de novo biosynthesis of pyrimidine 
deoxyribonucleotides 
402.191 6.53 dTDP 
de novo biosynthesis of pyrimidine 
deoxyribonucleotides 
482.171 -3.29 dTTP 
de novo biosynthesis of pyrimidine 
deoxyribonucleotides 
387.179 -2.56 dCDP 





de novo biosynthesis of uridine-5'-
monophosphate 
368.193 2.05 orotidine-5'-phosphate de novo biosynthesis of uridine-5'-
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monophosphate 
90.079 -2.13 D-lactate 
D-lactate + UQ or MQ  =  pyruvate + UQH2 or 
MQH2 





glucose dTDP-L-rhamnose biosynthesis 
548.333 6.57 dTDP-alpha-L-rhamnose dTDP-L-rhamnose biosynthesis 
564.333 -2.26 dTDP-D-glucose dTDP-L-rhamnose biosynthesis 
450.448 -10.44 ent-copalyl diphosphate ent-kaurene biosynthesis 
258.121 -3.67 
2-keto-3-deoxy-6-phospho-
gluconate Entner-Doudoroff pathway I 
410.725 -6.33 squalene epoxysqualene biosynthesis 
586.684 -5.29 presqualene diphosphate epoxysqualene biosynthesis 
256.257 2.81 isoliquiritigenin flavonoid biosynthesis 
316.267 -4.74 isorhamnetin flavonol biosynthesis 
335.331 -2.34 S-formylglutathione 
formaldehyde oxidation (glutathione-
dependent) 
459.461 -5.57 5-methyl-THF formylTHF biosynthesis 
180.16 2.56 caffeate free phenylpropanoid acid biosynthesis 
180.157 2.56 D-galactose galactose degradation II 
566.305 -2.06 UDP-galactose galactose degradation II 
129.115 2.33 5-oxoproline gamma-glutamyl cycle 
523.183 -3.79 GTP GDP-D-mannose biosynthesis 
589.345 -4.24 GDP-L-fucose 





GDP-L-fucose biosynthesis I (from GDP-D-
mannose) 
346.422 -6.07 GA24 
gibberellin biosynthesis I (non C-3, non C-13 
hydroxylation) 
348.438 -3.79 GA14 
gibberellin biosynthesis II (early C-3 
hydroxylation) 
348.438 -3.79 GA15 
gibberellin biosynthesis II (early C-3 
hydroxylation) 
118.089 -3.03 succinate 
gibberellin biosynthesis II (early C-3 
hydroxylation) 
348.395 -3.79 GA1 
gibberellin biosynthesis III (early C-13 
hydroxylation) 
346.379 -5.10 GA29-catabolite gibberellin inactivation 
346.379 -5.10 GA34-catabolite gibberellin inactivation 
348.438 -3.79 GA110 gibberellin inactivation 
348.395 -3.79 GA29 gibberellin inactivation 
348.395 -3.79 GA34 gibberellin inactivation 
348.438 -3.79 GA53 gibberellin inactivation 




104.105 -2.85 4-hydroxybutyrate glutamate degradation II 
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186.058 20.53 2-phosphoglycerate glycolysis I (plant cytosol) 
340.117 -2.26 fructose-1,6-bisphosphate glycolysis I (plant cytosol) 
192.125 6.80 citrate glyoxylate cycle 
562.667 -3.90 protoporphyrin IX heme biosynthesis from uroporphyrinogen 
580.289 5.84 UDP-D-galacturonate homogalacturonan biosynthesis 
546.392 -9.30 1,4-alpha-D-galacturonosyl homogalacturonan degradation 
973.732 -10.98 sinapoyl-CoA 
hydroxycinnamic acid tyramine amides 
biosynthesis 
343.379 -5.50 sinapoyltyramine 
hydroxycinnamic acid tyramine amides 
biosynthesis 
172.074 -5.33 sn-glycerol-3-phosphate IAA biosynthesis I 
156.187 -4.31 indole-3-acetonitrile IAA biosynthesis I 
203.197 2.64 indole-3-pyruvate IAA biosynthesis I 
175.187 2.00 indole-3-acetate IAA biosynthesis II 
966.743 -7.09 3-keto-indole-3-butyryl-CoA IAA biosynthesis III 
274.121 7.73 
alpha-D-glucuronate 1-
phosphate inositol oxidation pathway 
130.143 2.25 2-keto-3-methyl-valerate isoleucine biosynthesis 
865.635 -19.85 2-methylacetoacetyl-CoA isoleucine degradation 
849.636 -10.29 tiglyl-CoA isoleucine degradation 
787.572 -6.48 FADH2 isoleucine degradation 
867.651 -2.90 
2-methyl-3-hydroxybutyryl-
CoA isoleucine degradation 
294.433 -4.44 
3-oxo-2-(cis-2'-pentenyl)-




kaempferol glucoside biosynthesis 
(Arabidopsis) 
448.382 9.14 kaempferol 7-O-glucoside 
kaempferol glucoside biosynthesis 
(Arabidopsis) 
448.382 9.14 kaempferol-3-glucoside 
kaempferol glucoside biosynthesis 
(Arabidopsis) 
610.524 -8.95 kaempferol 3,7-O-diglucoside 
kaempferol glucoside biosynthesis 
(Arabidopsis) 
432.383 -3.13 kaempferol-3-rhamnoside 






kaempferol glucoside biosynthesis 
(Arabidopsis) 
314.211 6.37 geranyl-PP linalool biosynthesis 
216.127 53.00 
2-C-methyl-D-erythritol-4-
phosphate methylerythritol phosphate pathway 
521.311 10.41 
4-(cytidine 5'-diphospho)-2-C-
methyl-D-erythritol methylerythritol phosphate pathway 
246.093 -6.17 isopentenyl diphosphate methylerythritol phosphate pathway 
214.111 -3.56 
1-deoxy-D-xylulose 5-
phosphate methylerythritol phosphate pathway 
346.293 -5.10 3,7-di-methylquercetagetin methylquercetin biosynthesis 
316.267 -4.74 3-O-methylquercetin methylquercetin biosynthesis 
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344.32 -3.49 3,7,4'-tri-O-methylquercetin methylquercetin biosynthesis 
308.118 6.70 mevalonate-5-PP mevalonate pathway 
586.684 -5.29 
all-trans-hexaprenyl 
diphosphate nonaprenyl diphosphate biosynthesis 
518.566 -2.58 geranylfarnesyl diphosphate nonaprenyl diphosphate biosynthesis 
200.085 -2.69 D-erythrose-4-phosphate 
non-oxidative branch of the pentose 
phosphate pathway 
189.168 -9.50 N-acetyl-L-glutamate ornithine biosynthesis 
173.168 -2.55 
N-acetyl-L-glutamate 5-
semialdehyde ornithine biosynthesis 
276.136 -7.01 6-phospho-D-gluconate 





oxidative branch of the pentose phosphate 
pathway 
595.533 35.02 pelargonidin-3,5-diglucoside pelargonidin conjugates biosynthesis 
280.32 -5.63 8'-hydroxyabscisate phaseic acid biosynthesis 
280.32 -5.63 phaseic acid phaseic acid biosynthesis 
264.321 3.68 (+)-abscisate phaseic acid biosynthesis 
208.213 -11.37 sinapaldehyde phenylpropanoid biosynthesis 
192.168 6.80 quinate phenylpropanoid biosynthesis 
460.273 -4.36 CDP-N-methylethanolamine phosphatidylcholine biosynthesis III 
155.09 -2.65 
N-methylethanolamine 
phosphate phosphatidylcholine biosynthesis III 
446.247 -4.96 CDP-ethanolamine phosphatidylethanolamine biosynthesis II 
141.063 -3.34 phosphoryl-ethanolamine phosphatidylethanolamine biosynthesis II 
323.199 -8.23 CMP phosphatidylglycerol biosynthesis I (plastid) 
184.152 10.44 phosphoryl-choline phospholipases 
104.062 -2.85 hydroxypyruvate photorespiration 
436.676 -17.92 demethylphylloquinone phylloquinone biosynthesis 
450.703 -8.94 phylloquinone phylloquinone biosynthesis 
336.215 4.12 nicotinic acid mononucleotide pyridine nucleotide cycling (plants) 
256.235 2.81 nicotinate riboside pyridine nucleotide cycling (plants) 
123.111 -2.10 nicotinate pyridine nucleotide cycling (plants) 
249.16 6.13 pyridoxine-5'-phosphate pyridoxal 5'-phosphate salvage pathway 
248.175 -2.37 pyridoxamine 5'-phosphate pyridoxal 5'-phosphate salvage pathway 
112.088 -2.35 uracil pyrimidine salvage pathway 
90.079 -2.13 lactate pyruvate fermentation to lactate 
550.306 -16.00 UDP-L-rhamnose quercetin glucoside biosynthesis 
302.24 10.25 a quercetin quercetin glucoside biosynthesis 
448.382 9.14 quercetin 3-O-rhamnoside quercetin glucoside biosynthesis 
610.524 -8.95 
quercetin 3-O-rhamnoside-7-
O-glucoside quercetin glucoside biosynthesis 
610.524 -8.95 
quercetin-3-O-glucoside-7-O-
rhamnoside quercetin glucoside biosynthesis 
596.541 16.00 
quercetin-3-rhamnoside-7-
rhamnoside quercetin glucoside biosynthesis 
626.524 -4.08 quercetin 3,7-O-diglucoside quercetin glucoside biosynthesis 




phosphoribosylamino)uracil riboflavin and FMN and FAD biosynthesis 
184.085 10.44 
3,4-dihydroxy-2-butanone-4-
P riboflavin and FMN and FAD biosynthesis 
276.249 -9.84 
5-amino-6-ribitylamino-
2,4(1H,3H)-pyrimidinedione riboflavin and FMN and FAD biosynthesis 
310.091 -2.12 D-ribulose-1,5-bisphosphate Rubisco shunt 
915.695 4.14 hydroxycinnamoyl-CoA salicylic acid biosynthesis 
704.672 2.99 
tetrahydropteroyltri-L-
glutamate SAM cycle 
943.705 -17.95 feruloyl-CoA scopoletin biosynthesis 
180.16 2.56 2,4-dihydroxycinnamate simple coumarins biosynthesis 
336.298 2.45 caffeoylshikimate simple coumarins biosynthesis 
386.355 -5.10 1-O-sinapoyl-beta-D-glucose sinapate ester biosynthesis 




3beta-ol sterol biosynthesis 
410.682 -6.33 5-dehydroavenasterol sterol biosynthesis 
414.713 -4.66 sitosterol sterol biosynthesis 
400.687 3.29 24-epi-campesterol sterol biosynthesis 
400.687 3.29 campesterol sterol biosynthesis 
165.191 -6.92 L-phenylalanine suberin biosynthesis 
566.305 -2.06 UDP-D-glucose sucrose biosynthesis 
170.058 -2.53 dihydroxyacetone phosphate 





superpathway of anthocyanin biosynthesis 




superpathway of anthocyanin biosynthesis 
(from cyanidin and cyanidin 3-O-glucoside) 
611.532 -2.74 cyanidin 3-O-sophoroside 
superpathway of anthocyanin biosynthesis 
(from cyanidin and cyanidin 3-O-glucoside) 
611.532 -2.74 cyanidin-3,5-diglucoside 
superpathway of anthocyanin biosynthesis 
(from cyanidin and cyanidin 3-O-glucoside) 
838.868 3.16 heme o 
superpathway of proto- and siroheme 
biosynthesis 
616.498 -2.55 protoheme IX 
superpathway of proto- and siroheme 
biosynthesis 
536.279 -7.86 UDP-D-xylose UDP-D-xylose biosynthesis 
180.157 2.56 D-fructose UDP-glucose biosynthesis (from sucrose) 
536.279 -7.86 UDP-L-arabinose 




glucose UDP-L-rhamnose biosynthesis 
301.189 32.51 
N-acetyl-D-glucosamine-6-
phosphate UDP-N-acetyl-D-glucosamine biosynthesis 
301.189 32.51 
N-acetyl-glucosamine-1-
phosphate UDP-N-acetyl-D-glucosamine biosynthesis 
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348.208 4.07 inosine-5'-phosphate urate biosynthesis 
152.112 -2.71 xanthine urate biosynthesis 




carboxylate urate degradation to allantoin 
167.104 -2.72 urate urate degradation to allantoin 
416.686 -8.56 
2,3-dimethyl-6-phytyl-1,4-
benzoquinone vitamin E biosynthesis 
416.686 -8.56 beta-tocopherol vitamin E biosynthesis 
416.686 -8.56 gamma-tocopherol vitamin E biosynthesis 
767.534 2.49 coenzyme A volatile benzenoid ester biosynthesis 














































Enhanced mass scan of mix of 5 metabolites, 2 of them are aglycone while rest 3 are glucoside 
derivative 
Q-quercetin Q3G-  quercetin-3 glucoside Q34G- quercetin-3,4 glucosie 
K- kaempferol K7G- kaempferol-7 glucoside 
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Product Ion scan for Q3G at collision energy 30ev. 
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Product Ion scan for Q at collision energy 30ev. 
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Product Ion scan for Q3G at collision energy 30ev. This shows release of Q, and shows that it is 
derivative of quercetin 
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Product Ion scan for k7G at collision energy 30ev. 285 mass represents Kaempferol. 
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Product Ion scan for k at collision energy 30ev. 
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HPLC method established for LC-MS runs for all the samples described in this thesis. Here green 
graph represents total ion chromatogram, blue represents gradient for organic solvent (%B refers to 


















HPLC profile of Wt (red) superimposed upon that of tt8 mutant line (Green), showing several peaks absent in tt8 mutant lines. Selecting fraction 6 and 7th of 
HPLC run and MS scan showed several glycosylated metabolites absent in tt8 mutant lines. Here in this example, mass ion 447.11 and 463.09 were 
fragmented and showed derivative of kaempferol and quercetin which was then confirmed by MS2 of 285 (kaempferol) and 303(quercetin) which 
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